
<html lang="en"     class="pb-page"  data-request-id="8f51fea6-dac7-4d62-9531-893574b61acc"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-15;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c00940"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention" /></meta><meta name="dc.Creator" content="Li  Sun" /></meta><meta name="dc.Creator" content="Youmei  Peng" /></meta><meta name="dc.Creator" content="Wenquan  Yu" /></meta><meta name="dc.Creator" content="Yan  Zhang" /></meta><meta name="dc.Creator" content="Lan  Liang" /></meta><meta name="dc.Creator" content="Chuanjun  Song" /></meta><meta name="dc.Creator" content="Jiao  Hou" /></meta><meta name="dc.Creator" content="Yan  Qiao" /></meta><meta name="dc.Creator" content="Qingduan  Wang" /></meta><meta name="dc.Creator" content="Jingyu  Chen" /></meta><meta name="dc.Creator" content="Mengli  Wu" /></meta><meta name="dc.Creator" content="Dongwei  Zhang" /></meta><meta name="dc.Creator" content="Ertong  Li" /></meta><meta name="dc.Creator" content="Zhifu  Han" /></meta><meta name="dc.Creator" content="Qingxia  Zhao" /></meta><meta name="dc.Creator" content="Xia  Jin" /></meta><meta name="dc.Creator" content="Bailing  Zhang" /></meta><meta name="dc.Creator" content="Zhiwei  Huang" /></meta><meta name="dc.Creator" content="Jijie  Chai" /></meta><meta name="dc.Creator" content="Jian-Hua  Wang" /></meta><meta name="dc.Creator" content="Junbiao  Chang" /></meta><meta name="dc.Description" content="In preclinical and phase I and II clinical studies, 2′-deoxy-2′-β-fluoro-4′-azidocytidine (FNC) displays a potent and long-lasting inhibition of HIV-1 infection. To investigate its mechanism of act..." /></meta><meta name="Description" content="In preclinical and phase I and II clinical studies, 2′-deoxy-2′-β-fluoro-4′-azidocytidine (FNC) displays a potent and long-lasting inhibition of HIV-1 infection. To investigate its mechanism of act..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 17, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00940" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00940" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00940" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00940" /></link>
        
    
    

<title>Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00940" /></meta><meta property="og:title" content="Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0007.jpeg" /></meta><meta property="og:description" content="In preclinical and phase I and II clinical studies, 2′-deoxy-2′-β-fluoro-4′-azidocytidine (FNC) displays a potent and long-lasting inhibition of HIV-1 infection. To investigate its mechanism of action, we compared it with the well-documented lamivudine (3TC). Pharmacokinetic studies revealed that the intracellular retention of FNC triphosphate in peripheral blood mononuclear cells was markedly longer than that of the 3TC triphosphate. FNC selectively enters and is retained in HIV target cells, where it exerts long-lasting prevention of HIV-1 infection. In addition to inhibition of HIV-1 reverse transcription, FNC also restores A3G expression in CD4+ T cells in FNC-treated HIV-1 patients. FNC binds to the Vif-E3 ubiquitin ligase complex, enabling A3G to avoid Vif-induced ubiquitination and degradation. These data reveal the mechanisms underlying the superior anti-HIV potency and long-lasting action of FNC. Our results also suggest a potential clinical application of FNC as a long-lasting pre-exposure prophylactic agent capable of preventing HIV infection." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00940"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00940">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00940&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00940&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00940&amp;href=/doi/10.1021/acs.jmedchem.0c00940" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 8554-8566</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00909" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00967" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Li Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Li Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, College of Life Science, Henan Normal University, Xinxiang 453007, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Li++Sun">Li Sun</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Youmei Peng</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Youmei Peng</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Youmei++Peng">Youmei Peng</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Wenquan Yu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Wenquan Yu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Chemistry, Zhengzhou University, Zhengzhou 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Wenquan++Yu">Wenquan Yu</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3711-0006" title="Orcid link">http://orcid.org/0000-0002-3711-0006</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yan Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yan Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, College of Life Science, Henan Normal University, Xinxiang 453007, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Zhang">Yan Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lan Liang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lan Liang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang 453007, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lan++Liang">Lan Liang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Chuanjun Song</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Chuanjun Song</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Chemistry, Zhengzhou University, Zhengzhou 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Chuanjun++Song">Chuanjun Song</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7733-578X" title="Orcid link">http://orcid.org/0000-0001-7733-578X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jiao Hou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiao Hou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Chemistry, Zhengzhou University, Zhengzhou 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiao++Hou">Jiao Hou</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yan Qiao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yan Qiao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">College of Chemistry, Zhengzhou University, Zhengzhou 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yan++Qiao">Yan Qiao</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6357-8203" title="Orcid link">http://orcid.org/0000-0001-6357-8203</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qingduan Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qingduan Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qingduan++Wang">Qingduan Wang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jingyu Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jingyu Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, College of Life Science, Henan Normal University, Xinxiang 453007, China</div><div class="loa-info-affiliations-info">Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jingyu++Chen">Jingyu Chen</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mengli Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mengli Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, College of Life Science, Henan Normal University, Xinxiang 453007, China</div><div class="loa-info-affiliations-info">Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mengli++Wu">Mengli Wu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dongwei Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dongwei Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, College of Life Science, Henan Normal University, Xinxiang 453007, China</div><div class="loa-info-affiliations-info">Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dongwei++Zhang">Dongwei Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ertong Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ertong Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ertong++Li">Ertong Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhifu Han</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhifu Han</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhifu++Han">Zhifu Han</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Qingxia Zhao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Qingxia Zhao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Infection, Zhengzhou Sixth People’s Hospital, Zhengzhou 450000, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Qingxia++Zhao">Qingxia Zhao</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xia Jin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xia Jin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Shanghai Public Health Clinical Center Affiliated to Fudan University, Shanghai 201508, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xia++Jin">Xia Jin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Bailing Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Bailing Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Bailing++Zhang">Bailing Zhang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhiwei Huang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiwei Huang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiwei++Huang">Zhiwei Huang</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jijie Chai</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jijie Chai</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, College of Life Science, Henan Normal University, Xinxiang 453007, China</div><div class="loa-info-affiliations-info">Tsinghua-Peking Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#04676c656d6e6e4469656d682a70776d6a636c71652a6160712a676a"><span class="__cf_email__" data-cfemail="b8dbd0d9d1d2d2f8d5d9d1d496cccbd1d6dfd0cdd996dddccd96dbd6">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jijie++Chai">Jijie Chai</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jian-Hua Wang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jian-Hua Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#c9bea8a7ae96a3a0a8a7a1bca889aea0aba1e7a8aae7aaa7"><span class="__cf_email__" data-cfemail="4f382e21281025262e21273a2e0f28262d27612e2c612c21">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jian-Hua++Wang">Jian-Hua Wang</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Junbiao Chang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Junbiao Chang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Henan Key Laboratory of Organic Functional Molecule and Drug Innovation, College of Life Science, Henan Normal University, Xinxiang 453007, China</div><div class="loa-info-affiliations-info">College of Chemistry, Zhengzhou University, Zhengzhou 450001, China</div><div class="loa-info-affiliations-info">College of Chemistry and Chemical Engineering, Henan Normal University, Xinxiang 453007, China</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#4d2e252c232a2738232f242c220d37373863282938632e23"><span class="__cf_email__" data-cfemail="7c1f141d121b1609121e151d133c06060952191809521f12">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Junbiao++Chang">Junbiao Chang</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6236-1256" title="Orcid link">http://orcid.org/0000-0001-6236-1256</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00940&amp;href=/doi/10.1021%2Facs.jmedchem.0c00940" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 8554–8566</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 17, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>2 June 2020</li><li><span class="item_label"><b>Published</b> online</span>17 July 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00940" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00940</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8554%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DLi%2BSun%252C%2BYoumei%2BPeng%252C%2BWenquan%2BYu%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D15%26contentID%3Dacs.jmedchem.0c00940%26title%3DMechanistic%2BInsight%2Binto%2BAntiretroviral%2BPotency%2Bof%2B2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-%25CE%25B2-fluoro-4%25E2%2580%25B2-azidocytidine%2B%2528FNC%2529%2Bwith%2Ba%2BLong-Lasting%2BEffect%2Bon%2BHIV-1%2BPrevention%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8566%26publicationDate%3DAugust%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00940"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">841</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">3</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00940" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Mechanistic Insight into Antiretroviral Potency of 2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) with a Long-Lasting Effect on HIV-1 Prevention&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Youmei&quot;,&quot;last_name&quot;:&quot;Peng&quot;},{&quot;first_name&quot;:&quot;Wenquan&quot;,&quot;last_name&quot;:&quot;Yu&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Lan&quot;,&quot;last_name&quot;:&quot;Liang&quot;},{&quot;first_name&quot;:&quot;Chuanjun&quot;,&quot;last_name&quot;:&quot;Song&quot;},{&quot;first_name&quot;:&quot;Jiao&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Yan&quot;,&quot;last_name&quot;:&quot;Qiao&quot;},{&quot;first_name&quot;:&quot;Qingduan&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Jingyu&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Mengli&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Dongwei&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Ertong&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Zhifu&quot;,&quot;last_name&quot;:&quot;Han&quot;},{&quot;first_name&quot;:&quot;Qingxia&quot;,&quot;last_name&quot;:&quot;Zhao&quot;},{&quot;first_name&quot;:&quot;Xia&quot;,&quot;last_name&quot;:&quot;Jin&quot;},{&quot;first_name&quot;:&quot;Bailing&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Zhiwei&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Jijie&quot;,&quot;last_name&quot;:&quot;Chai&quot;},{&quot;first_name&quot;:&quot;Jian-Hua&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Junbiao&quot;,&quot;last_name&quot;:&quot;Chang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;8554-8566&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00940&quot;},&quot;abstract&quot;:&quot;In preclinical and phase I and II clinical studies, 2′-deoxy-2′-β-fluoro-4′-azidocytidine (FNC) displays a potent and long-lasting inhibition of HIV-1 infection. To investigate its mechanism of action, we compared it with the well-documented lamivudine (3TC). Pharmacokinetic studies revealed that the intracellular retention of FNC triphosphate in peripheral blood mononuclear cells was markedly longer than that of the 3TC triphosphate. FNC selectively enters and is retained in HIV target cells, where it exerts long-lasting prevention of HIV-1 infection. In addition to inhibition of HIV-1 reverse transcription, FNC also restores A3G expression in CD4+ T cells in FNC-treated HIV-1 patients. FNC binds to the Vif-E3 ubiquitin ligase complex, enabling A3G to avoid Vif-induced ubiquitination and degradation. These data reveal the mechanisms underlying the superior anti-HIV potency and long-lasting action of FNC. Our results also suggest a potential clinical application of FNC as a long-lasting pre-exposure prophylac&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00940&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00940" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00940&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00940" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00940&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00940" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00940&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00940&amp;href=/doi/10.1021/acs.jmedchem.0c00940" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00940" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00940" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00940&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00940%26sid%3Dliteratum%253Aachs%26pmid%3D32678592%26genre%3Darticle%26aulast%3DSun%26date%3D2020%26atitle%3DMechanistic%2BInsight%2Binto%2BAntiretroviral%2BPotency%2Bof%2B2%25E2%2580%25B2-Deoxy-2%25E2%2580%25B2-%25CE%25B2-fluoro-4%25E2%2580%25B2-azidocytidine%2B%2528FNC%2529%2Bwith%2Ba%2BLong-Lasting%2BEffect%2Bon%2BHIV-1%2BPrevention%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D15%26spage%3D8554%26epage%3D8566%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290677" title="Toxicological synergy">Toxicological synergy</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/jmcmar.2020.63.issue-15/20200813/jmcmar.2020.63.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In preclinical and phase I and II clinical studies, 2′-deoxy-2′-β-fluoro-4′-azidocytidine (FNC) displays a potent and long-lasting inhibition of HIV-1 infection. To investigate its mechanism of action, we compared it with the well-documented lamivudine (3TC). Pharmacokinetic studies revealed that the intracellular retention of FNC triphosphate in peripheral blood mononuclear cells was markedly longer than that of the 3TC triphosphate. FNC selectively enters and is retained in HIV target cells, where it exerts long-lasting prevention of HIV-1 infection. In addition to inhibition of HIV-1 reverse transcription, FNC also restores A3G expression in CD4<sup>+</sup> T cells in FNC-treated HIV-1 patients. FNC binds to the Vif-E3 ubiquitin ligase complex, enabling A3G to avoid Vif-induced ubiquitination and degradation. These data reveal the mechanisms underlying the superior anti-HIV potency and long-lasting action of FNC. Our results also suggest a potential clinical application of FNC as a long-lasting pre-exposure prophylactic agent capable of preventing HIV infection.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81817" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81817" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Since the approval by the Food and Drug Administration (FDA) in 1987 of the first antiretroviral drug zidovudine, a nucleoside reverse transcriptase inhibitor (NRTI), more than 30 antiretroviral drugs that target either viruses or host molecules to block different stages of the HIV-1 life cycle have been developed and used clinically. Since 1995, the use of combination antiretroviral therapy (cART) has substantially reduced morbidity and mortality related to HIV and has changed HIV-1 infection from a fatal condition into a generally manageable medical condition. Current antiretroviral treatments, however, need daily administration, and their long-term use can lead to cumulative toxicity. Drug-resistant viral strains reduced the efficacy of cART and create a major economic burden on individuals and medical care systems.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The development of anti-HIV-1 drugs with higher efficiency, lower toxicity, and longer-lasting effects could help to solve these problems.</div><div class="NLM_p">Clinically available NRTIs are 2′,3′-dideoxynucleosides (ddN).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although they are effective in most of the drug-naïve patients, they are less useful with HIV mutants that can discriminate between ddN and the physiological 2′-deoxynucleosides (dN). These HIV mutant strains cannot take ddN into the active centers of their reverse transcriptase (RT), and thus, they selectively separate the incorporated ddN from their proviral DNA terminus.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Consequently, nucleoside drugs capable of inhibiting drug-resistant HIV variants must have a 3′-hydroxy group as the chain terminator of proviral DNA biosynthesis.</div><div class="NLM_p">2′-Deoxy-2′-β-fluoro-4′-azidocytidine (FNC) (<b>1</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>) is a novel NRTI developed recently in our laboratory.<a onclick="showRef(event, 'cit3b ref4'); return false;" href="javascript:void(0);" class="ref cit3b ref4">(3b,4)</a> It was tested in phase II clinical trials, in which lamivudine (3TC) was replaced by FNC in a three drug combination, which also includes tenofovir and efavirenz (study number: GQ-FNC-201, 2017–2019), and was demonstrated to be safe and possibly efficacious. The superior potency of FNC was explored previously. FNC is a 4′-<i>C</i>-substituted-2′-deoxynucleoside (4′sdN) bearing a 3′-OH group. It mimics dN, and its 2′-fluoro substituent improves its stability in acidic media.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The 4′sdNs retain all functional groups of dN, and HIV can discriminate between a 4′sdN and dN only with difficulty. The 3′-OH group of 4′sdN is unlikely to be used by HIV for elongation of proviral DNA synthesis, and 4′sdN, once incorporated, can cause immediate chain termination of proviral DNA biosynthesis by blocking further addition of nucleotides.<a onclick="showRef(event, 'cit3b'); return false;" href="javascript:void(0);" class="ref cit3b">(3b)</a> For these reasons, FNC shows potent activity against both wild-type and drug-resistant HIV strains in preclinical studies<a onclick="showRef(event, 'cit3b ref4'); return false;" href="javascript:void(0);" class="ref cit3b ref4">(3b,4)</a> and has demonstrated desirable pharmacokinetics and safety profiles in the phase I study: GQ-FNC-2014-2; 2015–2016.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. The Anti-HIV Activity of FNC and Its <i>N</i><sup>4</sup>-Modified Derivatives<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0006.gif" alt="" id="gr6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">HEK293T cells (1 × 10<sup>5</sup>) were infected with HIV-luc/VSV-G (1 ng p24<sup>Gag</sup>), in the presence of FNC or its <i>N</i><sup>4</sup>-modified derivatives for 3 h. After washing, the cells were further cultured in the presence of the same concentrations of compounds for an additional 72 h. Cells were harvested and lysed, and viral infection was measured by measuring the luciferase activity. The EC<sub>50</sub> values were calculated and are listed. Cytotoxicity was evaluated with an MTT colorimetric assay, and CC<sub>50</sub> values were calculated and are listed.</p></div></div><div></div></div><div class="NLM_p">In addition to its higher anti-HIV activity compared to conventional NRTIs such as 3TC,<a onclick="showRef(event, 'cit3b ref4'); return false;" href="javascript:void(0);" class="ref cit3b ref4">(3b,4)</a> FNC also displayed a long-lasting effect on HIV-1 infection in our preclinical and phase I and II clinical studies (unpublished results). Although other anti-HIV drugs with RT binding affinity comparable to that of FNC have been reported, none have exhibited a similar anti-HIV efficacy. This suggests that FNC may also have additional anti-HIV pathways.</div><div class="NLM_p">The discovery of HIV-1 restriction factors has offered new and attractive opportunities for the development of adjunct therapeutic agents. A major strategy for new drug development involves targeting the interactions between host factors and HIV-1 proteins. One of these host factors is a cytidine deaminase, APOBEC3G (A3G). A3G can be encapsulated into the HIV-1 virions where it catalyzes the conversion of cytosine to uracil in the minus-sense single-strand viral DNA, thus causing G-to-A hypermutations in the subsequent plus-strand viral DNA and repressing HIV-1 replication. To antagonize the A3G-mediated HIV-1 restriction, the viral protein Vif recruits A3G into the E3 ubiquitin ligase complex composed of Cullin5, Elongin B/C, and a core binding factor subunit beta (CBFβ), thus inducing A3G degradation through the ubiquitin-proteasome pathway.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Due to the preferential recognition of the deamination motif, A3G-induced hypermutagenesis of HIV-1 proviral DNA reduces the infectivity of newly produced virions without inducing the viral evolution that may lead to drug resistance.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Consequently, targeting Vif or A3G or their interaction has become an attractive strategy for anti-HIV drug development.<a onclick="showRef(event, 'cit7c ref8'); return false;" href="javascript:void(0);" class="ref cit7c ref8">(7c,8)</a></div><div class="NLM_p last">In this study, we uncovered the mechanisms of FNC-mediated potent and long-lasting HIV-1 inhibition. In vivo pharmacokinetic studies demonstrate that FNC could be rapidly absorbed and retained for a long time in rhesus macaque peripheral blood mononuclear cells (PBMCs), rendering these HIV-1 target cells resistant to infection for an extended time. We also found that FNC restored A3G expression in peripheral blood CD4<sup>+</sup> T cells derived from FNC-treated HIV-1 patients. Biochemical and cell-based assays showed that FNC specifically bound to the Vif-containing E3 ubiquitin ligase complex, preventing Vif-induced degradation of A3G. Together with the previous demonstrations of inhibition of HIV-1 reverse transcription,<a onclick="showRef(event, 'cit3b ref4'); return false;" href="javascript:void(0);" class="ref cit3b ref4">(3b,4)</a> these data reveal a dual role of FNC in the prevention of HIV-1 infection, a direct antiviral effect blocking viral replication and an indirect antiviral effect of augmenting the level of the host antiviral factor, A3G. The long-term retention of FNC in target cells suggests the possibility that this small molecule can be used as a long-lasting pre-exposure prophylaxis (PrEP) agent for the prevention of HIV-1 infection.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">2.  Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73646" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73646" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5">2.1.  FNC Exhibits Potent HIV-1 Inhibitory Activity</h3><div class="NLM_p last">We have previously designed and synthesized a series of <i>N</i><sup>4</sup>-substituted 2′-deoxy-2′-β-fluoro-4′-azido-β-<span class="smallcaps smallerCapital">d</span>-arabinofuranosyl cytidines (<b>2</b>).<a onclick="showRef(event, 'cit5b ref9'); return false;" href="javascript:void(0);" class="ref cit5b ref9">(5b,9)</a> We analyzed their anti-HIV activity using a vesicular stomatitis virus glycoprotein (VSVG) pseudotyped single-cycle infectious virus (HIV-luc/VSV-G) (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Based on infection of HEK293T cells, the EC<sub>50</sub>, the concentration that causes 50% inhibition of HIV-1 infection, was determined. The cytotoxicity of these compounds, represented by the concentration required to induce 50% cell death (CC<sub>50</sub>), was also evaluated by quantifying the viability of cells. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, FNC (<b>1</b>), with an EC<sub>50</sub> of 0.063 nM, displayed the most potent inhibition of HIV-1 infection among the compounds tested. Thus, FNC is 4700-fold better than the commercial drug 3TC at a 0.3 μM concentration. FNC also showed a low cytotoxicity, with a CC<sub>50</sub> value above 25 μM (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). <i>N</i><sup>4</sup>-modification, the specific structural feature important for the anti-HIV activity of FNC, impairs the antiviral activity of FNC. For example, methylation at this position, giving compound <b>2a</b> with an EC<sub>50</sub> of 6.7 μM, led to a 100,000-fold decrease of the anti-HIV-1 activity of FNC. Incremental extension of the group or introduction of a cyclohexyl ring gave compounds <b>2b</b>–<b>2f</b> and a complete loss of the antiviral activity (EC<sub>50</sub> > 10 μM). The <i>N</i><sup>4</sup>-hydroxylated analog (<b>2g</b>) displayed an anti-HIV activity of EC<sub>50</sub> 0.7 μM, but further <i>N</i>- and/or <i>O</i>-alkylation (<b>2h</b> and <b>2i</b>) completely abolished the activity (EC<sub>50</sub> > 10 μM). Among the compounds bearing hydroxyalkyl groups, the bis(2-hydroxyethyl) analog (<b>2m</b>) maintained moderate activity with an EC<sub>50</sub> of 0.8 μM, but the corresponding cyclized morpholine derivative (<b>2n</b>) is inactive. Analogs containing aromatic rings in the <i>N</i><sup>4</sup> side chain (<b>2o</b>–<b>2r</b>) exhibit moderate antiviral activity. None of the tested 4′-<i>C</i>-substituted nucleoside analogs were obviously cytotoxic (CC<sub>50</sub> ≥ 25 μM). Overall, among the 4′-<i>C</i>-substituted nucleoside analogs, FNC shows the most potent activity in inhibition of HIV-1 infection and low cytotoxicity. Of note, by performing in human CD4<sup>+</sup> T cells, we have previously demonstrated the potent inhibitory activity of FNC on the replication of both wild-type and drug-resistant HIV-1 strains.<a onclick="showRef(event, 'cit3b ref4'); return false;" href="javascript:void(0);" class="ref cit3b ref4">(3b,4)</a></div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">2.2.  Synergy between FNC and Other Antiretroviral Drugs</h3><div class="NLM_p">By determination of the EC<sub>50</sub> values of FNC in HIV-1-infected human CD4<sup>+</sup> T cells treated with different antiretroviral drugs, we investigated whether FNC is synergistic with other antiretroviral drugs. We first tested FNC alone in human CD4<sup>+</sup> T cells (Hut/CCR5) infected with pseudotyped HIV-luc/JRFL for 72 h by examination of luciferase activity. FNC potently suppressed HIV-1 infection with an EC<sub>50</sub> of 0.0136 nM (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>A) and had low cytotoxicity with a CC<sub>50</sub> of 340 nM (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). The selective index (CC<sub>50</sub>/EC<sub>50</sub>) is 25,000. We tested whether FNC has synergy with routinely used antiretroviral drugs such as dolutegravir, an HIV-1 integrase inhibitor, and rilpivirine, a non-nucleoside reverse transcriptase inhibitor, (NNRTI) using similar assays. The combination index (CI) values for the dolutegravir/FNC (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>C) or rilpivirine/FNC (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>D) combinations at 50, 75, 90, and 95% inhibition of infection were no more than 0.1, indicating a strong synergy between FNC and these two anti-HIV drugs. These results confirm that FNC has potent HIV-1 inhibitory activity and show that it has strong synergy with other antiretroviral drugs.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potent anti-HIV activity of FNC and its synergistic effect with other antiretroviral drugs. (A) Anti-HIV activity<b>.</b> Hut/CCR5 cells (0.5 × 10<sup>5</sup>) were infected with HIV-luc/JRFL (1 ng p24<sup>Gag</sup>) in the presence of different concentrations of FNC for 3 h; after washing, cells were further cultured in the presence of the same concentrations of FNC for additional 72 h. Cells were harvested and lysed, and viral infection was measured by detection of luciferase activity. EC<sub>50</sub> was calculated. (B) Cytotoxicity. Hut/CCR5 cells (0.5 × 10<sup>5</sup>) were treated with different concentrations of FNC for 72 h, and cell viability was analyzed with an MTT colorimetric assay. CC<sub>50</sub> was calculated. (C, D) Synergy assay. Hut/CCR5 cells (0.5 × 10<sup>5</sup>) were infected with HIV-luc/JRFL (1 ng p24<sup>Gag</sup>) in the presence of different combinations of FNC/dolutegravir (C) or FNC/ rilpivirine (D). CI values were calculated with the Chou and Talalay method, and the CI values for the combinations at 50, 75, 90, and 95% inhibition of infection are shown; where the <i>y</i>-axis represents the log of infection inhibited (Fa)/fraction virus uninhibited (Fu), and the <i>x</i>-axis represents the log of the drug dose [Log(D)] (nM) tested; concentrations plotted for the combination curve represent the concentrations of the total drug amount for the median effect plots. For dose–response plots, data points represent the concentration of each drug. Data are presented as mean ± standard deviations (SD); one representative result from four independent experiments is shown (A–D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">2.3.  Rapid Accumulation and Long-Term Intracellular Retention of FNC in Rhesus Macaque PBMCs</h3><div class="NLM_p">The pharmacokinetics of FNC was evaluated in rhesus macaques. Three 7–10 kg adult male rhesus macaques were treated with a single oral administration of 1 or 6 mg/kg of FNC or 20 mg/kg of 3TC. FNC was rapidly absorbed, with peak plasma levels of 196.5 and 2068.3 nM at 1 h after intragastric administration of 1 and 6 mg/kg dose, respectively (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A), while the plasma FNC dropped 320-fold to 6.5 nM at 24 h in the animal that was administered 6 mg/kg. In comparison, 3TC reached a high peak plasma level of 31,349.7 nM at 1 h after intragastric administration and dropped 330-fold to 93.57 nM at 72 h (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>A).</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pharmacokinetic studies of FNC. (A, B) Concentration–time profiles of FNC (3TC) in plasma and FNC-TP (3TC-TP) in PBMCs of rhesus macaques. Three 7–10 kg adult male rhesus macaques were treated with a single oral administration of FNC at 1 and 6 mg/kg or lamivudine at 20 mg/kg. At the indicated times post-administration, the LC–MS/MS method was used to monitor the presence of FNC or 3TC in plasma (A), and the active form of FNC-TP or 3TC-TP in PBMCs (B). (C) FNC distribution in tissues or organs of rats. The Sprague–Dawley rats were administered a single oral dose of 0.5 mg/kg by gavage, and the tissues and organs were excised at the different times post-administration and used to monitor the FNC concentration with LC–MS/MS methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Failing to have found substantially better plasma levels of FNC over 3TC, we examined the cell distribution of these drugs. FNC, but not 3TC, could enter rhesus macaque PBMCs and form the active nucleoside triphosphate FNC-TP, which is retained in these cells for several days (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B), and had intracellular half-lives of 133.15 and 112.40 h in the 1 and 6 mg/kg dosed rhesus macaques, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In contrast, 3TC was mainly distributed in the plasma with a <i>t</i><sub>1/2</sub> of 13.5 h. The intracellular concentration of 3TC-TP was extremely low and was undetectable 24 h after a single oral administration (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>B).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Comparative Pharmacokinetic Parameters in Rhesus Macaque after Intragastric Administration of a Single Dose of FNC or 3TC<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">plasma</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">PBMCs</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameters</th><th class="colsep0 rowsep0" align="center">units</th><th class="colsep0 rowsep0" align="center">FNC 1 mg/kg</th><th class="colsep0 rowsep0" align="center">FNC 6 mg/kg</th><th class="colsep0 rowsep0" align="center" char=".">3TC 20 mg/kg</th><th class="colsep0 rowsep0" align="center" char=".">FNC-TP 1 mg/kg</th><th class="colsep0 rowsep0" align="center" char=".">FNC-TP 6 mg/kg</th><th class="colsep0 rowsep0" align="center">3TC-TP 20 mg/kg</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0-<i>t</i></sub></td><td class="colsep0 rowsep0" align="left">nmol h L<sup>–1</sup> (pmol h 10<sup>6</sup> cells<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">499.1</td><td class="colsep0 rowsep0" align="left">7581.0</td><td class="colsep0 rowsep0" align="char" char=".">394851.0</td><td class="colsep0 rowsep0" align="char" char=".">99.33</td><td class="colsep0 rowsep0" align="char" char=".">249.22</td><td class="colsep0 rowsep0" align="left">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="char" char=".">13.5</td><td class="colsep0 rowsep0" align="char" char=".">133.15</td><td class="colsep0 rowsep0" align="char" char=".">112.40</td><td class="colsep0 rowsep0" align="left">NA</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">h</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="char" char=".">6.0</td><td class="colsep0 rowsep0" align="left">1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub></td><td class="colsep0 rowsep0" align="left">nM (pmol 10<sup>6</sup> cells<sup>–1</sup>)</td><td class="colsep0 rowsep0" align="left">196.5</td><td class="colsep0 rowsep0" align="left">2068.3</td><td class="colsep0 rowsep0" align="char" char=".">31349.7</td><td class="colsep0 rowsep0" align="char" char=".">2.10</td><td class="colsep0 rowsep0" align="char" char=".">4.07</td><td class="colsep0 rowsep0" align="left">0.03</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">AUC<sub>0-<i>t</i></sub> = area under the plasma/PBMC concentration–time curve from time 0 to 24 h. <i>t</i><sub>1/2</sub> = elimination half-life. <i>T</i><sub>max</sub> = time to reach <i>C</i><sub>max</sub>. <i>C</i><sub>max</sub> = maximum plasma/PBMC concentration. NA = not acquired.</p></div></div></div><div class="NLM_p">We then tracked the tissue distributions of FNC. Sprague–Dawley rats were administered a single oral dose of 0.5 mg/kg of FNC by gavage, and then tissues and organs were excised at different times post-administration. FNC in the tissues and organs was quantified with LC–MS/MS. The results showed that the FNC derivatives were mainly distributed in the thymus, reaching a maximum concentration at 7–12 h post-administration (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>C).</div><div class="NLM_p last">These in vivo pharmacokinetic studies demonstrate that FNC can be rapidly absorbed and accumulated in tissues and PBMCs and retains a long-term intracellular retention.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9">2.4.  The Selective Entry of FNC into Target Cells Provides a Long-Lasting Prevention of HIV-1 Infection</h3><div class="NLM_p">Following our demonstration of the entry and retention of FNC in PBMCs, we delineated the cell type-specific retention of FNC. Human PBMCs from healthy donors were isolated and incubated for 4 h with FNC. HIV-1 target cells, CD14<sup>+</sup> monocytes, and CD4<sup>+</sup> T cells were subsequently selected using antibody-coated magnetic beads and used for quantification by LC–MS/MS of the intracellular active form, FNC-TP. FNC was found mainly to accumulate in these HIV-1 target cells, and the retention of FNC-TP was 2–4 times higher than in other types of cells (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selective entry of FNC into target cells providing a long-lasting prevention of HIV-1 infection. (A) Cell distribution of FNC. Human PBMCs from healthy donors were isolated and further incubated with FNC (350 nM) for 4 h. CD14<sup>+</sup> monocytes and CD4<sup>+</sup> T cells were subsequently isolated using antibody-coated magnetic beads with a positive selection. The intracellular active forms of FNC-TP from CD14<sup>+</sup> monocytes, CD4<sup>+</sup> T cells, and the remaining cells were quantified by LC–MS/MS assay. Results from three donors are shown. (B–D) Long-lasting prevention of HIV-1 infection. Hut/CCR5 cells (1 × 10<sup>6</sup>) were incubated with different concentrations of FNC (0.1, 1, and 10 nM) or 3TC (1000 and 10,000 nM) at 37 °C for 4 h. After washing and removal of cell-free drugs, the cells were further incubated. At the indicated times, 0.5 × 10<sup>5</sup> cells were collected for infection with HIV-luc/JRFL (1 ng p24<sup>Gag</sup>) for an additional 72 h, and viral infection was measured by detecting luciferase activity. The inhibition of HIV-1 infection was analyzed (B), the time needed to reach 50% reduction of HIV-1 infection was calculated based on a regression cure of HIV-1 inhibition (C), and at each time-point, the cell number was counted by microscopy (D). Data were presented as mean ± SD. One representative result from at least three independent experiments is shown (B–D). *<i>p</i> < 0.05 and **<i>p</i> < 0.01 denote significant difference levels as determined by a paired <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To investigate whether the retention of FNC in HIV-1 target cells can provide a long-lasting prevention of HIV-1 infection, human CD4<sup>+</sup> T cells Hut/CCR5 were incubated for 4 h with different concentrations of FNC or 3TC as a control. The cells were then washed, incubated, and infected by HIV-luc/JRFL at different time points. HIV-1 infection was measured by the luciferase activity, and the inhibitory effect was calculated. In terms of prevention of HIV-1 infection, FNC was much more active than 3TC (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B), and 3TC lost activity more quickly than FNC. Inhibition of HIV-1 infection by 0.1 nM FNC was still observed even 72 h post-treatment, when 10,000 nM 3TC exhibited a much lower activity (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B). To quantitatively compare FNC and 3TC, we calculated the time needed to reach 50% reduction of HIV-1 prevention (<i>T</i><sub>50%-prevention</sub>) based on a regression analysis and found that the <i>T</i><sub>50%-prevention</sub> values of FNC were higher than those of 3TC at all concentrations tested (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>C). The <i>T</i><sub>50%-prevention</sub> values of 0.1 and 10 nM FNC were 68.6 and 123.1 h, respectively. In comparison, the <i>T</i><sub>50%-prevention</sub> value of 3TC at 10,000 nM was 42.7 h. The differences are unlikely to be due to cytotoxicity of these drugs because FNC and 3TC both had no adverse effect on cell growth during drug treatment for 120 h (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>D). Overall, these data demonstrate that FNC has a long-lasting prophylactic effect on HIV-1 infection.</div><div class="NLM_p">Non-specific activation of host cells can provide more susceptible target cells for HIV-1 infection,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and we investigated whether FNC could activate host cells non-specifically by incubating human PBMCs from healthy donors with a high concentration of FNC (100 nM) for 48 h. Subsequently, CD4<sup>+</sup> T cells and CD14<sup>+</sup> monocytes were gated and analyzed by flow cytometry. The surface expressions of CD25, CD69, and HLA-DR were detected to monitor the non-specific activation of these cells. The results showed that the treatment of FNC had little effect on the expressions of these markers (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_001.pdf" class="ext-link">Figure S1</a>), indicating that FNC does not have a non-specific activation effect on these HIV-1 target cells. In control cells, the expression of these markers was strongly upregulated by a mitogen PHA-P.</div><div class="NLM_p last">Taken together, these data demonstrate that the selective entry of FNC into the target cells of HIV-1 provides a long-lasting prevention of HIV-1 infection.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">2.5.  FNC Blocks Vif-Induced A3G Degradation through Its Interaction with a Vif-Containing E3 Ligase</h3><div class="NLM_p">Targeting the Vif/A3G interaction represents a novel approach to the design of antiviral drugs.<a onclick="showRef(event, 'cit8a cit8i'); return false;" href="javascript:void(0);" class="ref cit8a cit8i">(8a,i)</a> Having shown that FNC is retained in HIV-1 target cells, we investigated whether FNC could upregulate A3G expression to potentiate host anti-HIV activity. Three HIV-1-infected human individuals were recruited and were administered daily with FNC (trade name azvudine) tablets containing 4 mg of FNC for a total of 6 days (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, upper panel). Blood was drawn at day 0, immediately before initiation of treatment, and on day 7, 1 day after completion of treatment, and CD4<sup>+</sup> T cells were isolated to detect A3G expression by Western blotting. Before treatment with FNC, the expression of A3G was barely detectable, but after the 6 day FNC monotherapy, A3G levels in the T cells were markedly increased (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>A, lower panel). Although this short-term treatment obviously failed to restore CD4<sup>+</sup> T cell counts, FNC completely suppressed plasma viremia (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>B).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. FNC restoring A3G expression. (A, B) FNC restoring A3G expression in HIV-infected patients. Three HIV-1-infected, treatment-naïve individuals were recruited and administered daily azvudine tablets containing 4 mg of FNC for 6 consecutive days. At day 0, immediately before initiation of treatment, and day 7, 1 day after completion of treatment, 20 mL of peripheral blood was collected for isolation of PBMCs and CD4<sup>+</sup> T cells. A3G expression in CD4<sup>+</sup> T cells was detected by Western blotting (A). Plasma viremia was measured by (RT-)qPCR quantification, and the peripheral CD4<sup>+</sup> T cell count was detected by flow cytometry (B). (C, D) FNC protecting A3G from Vif-induced degradation. A3G-expressing plasmids and/or pcDNA-Vif-HA were co-transfected into HEK293T cells, and cells were further treated with FNC (10 nM) or 3TC (1000 nM) for 24 h. MG132 (10 μM) was added 16 h prior to sample collection. A3G expression was detected by Western blotting with immunostaining with antibodies against Myc-tag, and Vif expression was indicated with antibodies against HA-tag (C); alternatively, A3G expression was detected by measuring the GFP intensity by flow cytometry (D). (E) Kinetic analysis of FNC or 3TC incorporation with the E3 ubiquitin ligase complex. A CM5 chip-based Biacore T200 system was used to measure the FNC incorporation with the Vif–CBFβ–ELOB–ELOC complex, and the dynamics of association was analyzed for different concentrations of FNC or 3TC. The binding phase of FNC or 3TC with the Vif complex was between 0 and 180 s, and the dissociation phase was between 180 and 330 s. (F) FNC inhibiting A3G polyubiquitination. The plasmids of pcDNA-APOBEC3G-Myc, pcDNA-ubiquitin-His, and/or pcDNA-Vif-HA were co-transfected into HEK293T cells, and cells were further treated with FNC (3.5 or 35 nM) for 24 h. MG132 (10 μM) was added 16 h prior to sample collection. Cells were harvested and lysed for Western blotting to detect the expression of His-ubiquitin with immunostaining with anti-His antibodies. Data were presented as mean ± SD. **<i>p</i> < 0.01 denotes significant difference levels as determined by a paired <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The HIV-1 accessory protein, Vif, antagonizes A3G-mediated HIV-1 restriction by recruiting A3G into an E3 ubiquitin ligase complex for degradation by proteasomes.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> To determine if FNC can block Vif-induced A3G degradation, HEK293T cells were co-transfected with A3G-expressing plasmid pcDNA-A3G-Myc and the Vif-expressing plasmid pcDNA-Vif-HA and then treated with FNC for 24 h, using 3TC treatment as a control. The results showed that the co-expression of the two plasmids led to a pronounced reduction in A3G expression of HEK293T cells and that the treatment of the cells with the proteasome inhibitor, MG132, strikingly restored the expression of A3G (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). Treatment with FNC, but not with 3TC, similarly blocked Vif-mediated reduction of A3G expression (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C). A fluorescence-based approach was used to confirm this observation. HEK293T cells were co-transfected with plasmids of pcDNA-A3G-eGFP and pcDNA-Vif-HA in the presence of FNC or 3TC. Similarly, Vif-mediated reduction of A3G expression was observed, as indicated by the decreased GFP intensity (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, left panel). Treatment with FNC, but not with 3TC, blocked Vif-induced A3G reduction (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>D, right panel).</div><div class="NLM_p">We then investigated the underlying mechanism by which FNC blocks Vif-reduced expression of A3G. Vif antagonizes A3G-mediated HIV-1 restriction by recruiting A3G into the E3 ubiquitin ligase complex, which is composed of Cullin5, Elongin B/C, and CBFβ, to induce A3G degradation through the ubiquitin-proteasome pathway.<a onclick="showRef(event, 'cit6b cit6c cit6e'); return false;" href="javascript:void(0);" class="ref cit6b cit6c cit6e">(6b,c,e)</a> We examined whether FNC can interact with the E3 ubiquitin ligase complex using a CM5 chip-based Biacore T200 system and found that FNC binds to the Vif–CBFβ–ELOB–ELOC complex very quickly, reaching saturation in about 100 s (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E). This incorporation is stable, 36% of the FNC-containing complex still surviving after dissociation for 150 s, indicating slow dissociation between FNC and the E3 complex. The calculated dissociation equilibrium constant was 87 nM. In a parallel study, the <i>K</i><sub>d</sub> value of 3TC with the Vif complex was 1150 nM, indicating a much weaker affinity between 3TC and the complex (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>E).</div><div class="NLM_p">Having demonstrated the association of FNC with the E3 ubiquitin ligase complex, we next examined whether FNC could inhibit A3G ubiquitination mediated by the complex. HEK293T cells were co-transfected with the A3G-expressing plasmid pcDNA-A3G-Myc, the ubiquitin-expressing plasmid pcDNA-ubiquitin-His, and the Vif-expressing plasmid pcDNA-Vif-HA for 24 h, during which cells were treated with or without FNC. The polyubiquitination of A3G was detected by Western blotting, which revealed a basal polyubiquitination in the presence of exogenous ubiquitin (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F, lane 2). Vif-induced A3G polyubiquitination and degradation were observed and were blocked by the treatment with the proteasome inhibitor MG132 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F, lanes 4 versus lane 3). Notably, the treatment with FNC also reduced Vif-triggered polyubiquitination of A3G (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>F, lanes 5 and 6).</div><div class="NLM_p last">Taken together, these data demonstrate that FNC preserves A3G expression by being incorporated into the Vif/E3 ubiquitin ligase complex, thereby interfering with A3G ubiquitination and Vif-induced A3G degradation.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11">2.6.  Molecular Modeling Studies</h3><div class="NLM_p">As known, molecular simulations can provide detailed structural insights into the molecular interactions. In the present work, molecular docking and molecular dynamics simulations were performed to predict the binding mode of FNC-TP with an HIV-1 reverse transcriptase and elucidate the structural-activity relationship shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. As shown in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>, FNC-TP fits well in the active site, and the complex is stabilized by extensive hydrogen bonding and salt bridge as well as van der Waals interactions. Specifically, the base moiety of FNC-TP forms three hydrogen bonds with the complementary base pair, dGMP, in the template chain. The negatively charged phosphate group of FNC-TP forms strong salt bridge interactions with Lys65, Arg72, and Lys220. Asp110, Asp185, and the carbonyl group of Val111 together with the TP group form a metal-chelating interaction network with the two Mg<sup>2+</sup> ions. The azido group is well positioned and forms extensive van der Waals interactions with the side chains of Tyr115, Phe160, Met184, and the sugar ring from the adjacent DNA base. In addition, the terminal nitrogen atom of the azido group forms N···H–C hydrogen bond interaction with the side chains of Met184. The fluorine atom is involved in N–H···F hydrogen bond interaction with the side chains of Arg72. The hydroxyl group in the sugar ring is hydrogen-bonded with the backbone of Tyr115. The binding mode can help us understand why the other compounds were less potent than FNC. For example, compounds <b>2d</b>, <b>2e</b>, <b>2f</b>, <b>2i</b>, <b>2m</b>, and <b>2n</b> are less potent than FNC since the NR<sub>2</sub> group cannot form hydrogen bond interactions with the oxygen atom in the complementary base pair, dGMP. While for the other compounds with an NHR group, which can be hydrogen-bonded with the oxygen atom, it is energetically unfavorable for the hydrophobic group to be positioned in the polar water environment. Therefore, all the other compounds were less potent than FNC.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative binding complex structure of FNC-TP and an HIV-1 reverse transcriptase derived from MD simulations. The HIV-1 reverse transcriptase is represented as a cartoon, and FNC-TP is shown in a stick form, colored in green. The residues interacting with FNC-TP are shown in stick in purple.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">3.  Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In this study, we examined the mechanisms of action of FNC, a novel NRTI anti-HIV drug. In addition to having much higher anti-HIV activity than conventional NRTIs such as 3TC, FNC also displays a long-lasting effect on HIV-1 infection in our preclinical and phase I and II clinical studies. Although other anti-HIV drugs with RT binding affinity comparable to that of FNC have been reported, none of the drugs exhibited a similar anti-HIV efficacy. Our data reveal the indirect antiviral effect of FNC in augmenting the level of the host antiviral factor A3G, together with the previous demonstration of the direct inhibition in HIV-1 reverse transcription,<a onclick="showRef(event, 'cit3b ref4'); return false;" href="javascript:void(0);" class="ref cit3b ref4">(3b,4)</a> and the dual role of FNC in the prevention of HIV-1 infection can explain its superior anti-HIV potency. Our data also show that FNC selectively penetrates the HIV-1 target cells where it exhibits long-term retention. These properties make FNC a potential drug of choice for a PrEP agent. FNC does not activate uninfected bystander cells and thus has diminished side effects that are commonly observed in other NRTIs and explains its low cytotoxicity. In addition to these advantages, FNC also displays strong synergy with other antiretroviral drugs.</div><div class="NLM_p">An unusual feature of FNC is its ability to target the interactions between host factors and HIV-1 proteins, thus augmenting its efficacy. A3G-induced hypermutation of HIV-1 proviral DNA inactivates the virus but fails to introduce viral mutations and subsequent drug resistance,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> thus making A3G and its interaction with HIV-1 Vif desirable drug targets. Many small molecules directly targeting A3G, blocking Vif-ELOC interaction, or disrupting the assembly of the Vif-containing ubiquitin ligase complex have been reported to possess potent anti-HIV activity.<a onclick="showRef(event, 'cit8b cit8c cit8d cit8e cit8f cit8g cit8h cit8k ref11'); return false;" href="javascript:void(0);" class="ref cit8b cit8c cit8d cit8e cit8f cit8g cit8h cit8k ref11">(8b−h,k,11)</a> Our recent results on the crystal structure of the Vif–CBFβ–CUL5–ELOB–ELOC complex<a onclick="showRef(event, 'cit6c'); return false;" href="javascript:void(0);" class="ref cit6c">(6c)</a> can also facilitate the design of more attractive drugs that target the Vif/A3G interacting complex.</div><div class="NLM_p">Despite the absence of direct evidence, we obtained several lines of indirect evidence that FNC inhibits Vif-induced degradation of the anti-viral host protein A3G. First, FNC substantially promotes accumulation of A3G in CD4<sup>+</sup> T cells from HIV-1-infected individuals; second, FNC but not 3TC directly interacts with the Vif–CBFβ–ELOB–ELOC complex; third, FNC greatly impedes Vif-mediated polyubiquitination and proteasome-mediated degradation of A3G in HEK293T cells. In view of the established mechanisms of A3G-mediated anti-HIV activity, our results suggest that FNC can activate A3G-mediated inhibition of HIV-1 infection by stabilization of A3G. Together with the selective entry into HIV-1 target cells and long-term retention within the cells, the FNC-restored A3G expression further enhances its efficacy. In addition, FNC has an advantage in that it can restore A3G expression more successfully than other clinically used antiretroviral regimens. The long-term (48 weeks) treatment of patients with cenicriviroc (CVC) or efavirenz (EFV) did not upregulate A3G expression, but a slight increase of APOBEC3A, another member of the APOEC3 family, was observed in the CVC treatment.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Although FNC also targets the Vif/A3G interaction, it clearly has mechanisms distinct from those of reported small molecules that stabilize A3G because it interacts with the Vif–CBFβ–ELOB–ELOC complex. In contrast to other known small molecules, FNC binding does not affect the assembly of the complex. Despite a lack of knowledge of the precise site on the complex where FNC binds, FNC appears to function by inhibiting Vif-mediated polyubiquitination of A3G and consequent proteasome-mediated A3G degradation. Collectively, our data suggest that the Vif–CBFβ–ELOB–ELOC complex as a whole may be a valid target and small molecules capable of manipulating its activity could be developed.</div><div class="NLM_p last">In addition to defining a novel mechanism of FNC restoring A3G expression, another interesting finding in this study is the selective entry and the long-term retention of FNC in HIV-1 target cells. The latter provides a mechanistic basis for FNC to be used as a PrEP agent for HIV prevention.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">4.  Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14">4.1.  Compounds</h3><div class="NLM_p last">Compounds <b>1</b> and <b>2</b> were prepared from 1,3,5-<i>O</i>-tribenzoyl-2-deoxy-2-fluoro-<span class="smallcaps smallerCapital">d</span>-arabinofuranoside according to our previously reported procedures.<a onclick="showRef(event, 'cit3b cit5b cit9a'); return false;" href="javascript:void(0);" class="ref cit3b cit5b cit9a">(3b,5b,9a)</a> All the tested compounds possess a purity of at least 95%. Analytical HPLC was run on the Agilent 1260 HPLC instrument, equipped with an Agilent XDB-C18 column and UV detection at 270 nm. The eluent system was 40% MeOH in H<sub>2</sub>O; flow rate = 0.8 mL/min. The compounds were dissolved in dimethyl sulfoxide (DMSO) for stock preparation and further diluted with RPMI-1640 cell culture medium (Gibco) to produce a working solution.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15">4.2.  Cells</h3><div class="NLM_p last">Human embryonic kidney cells HEK293T were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) containing 10% fetal bovine serum (FBS) (Gibco) and 100 U/mL penicillin (Invitrogen) and 100 μg/mL streptomycin (Invitrogen). The human CD4<sup>+</sup> T-lymphocyte cell line Hut/CCR5 was provided by Li Wu (Ohio State University, USA). Human peripheral blood mononuclear cells (PBMCs) were purchased from the Blood Center of Shanghai, China, and PBMCs were isolated from the buffy coats of healthy donors by Ficoll density gradient centrifugation. CD14<sup>+</sup> monocytes and CD4<sup>+</sup> T cells were further isolated from PBMCs using anti-CD14- or CD4-specific antibody-coated magnetic beads (Miltenyi Biotec) according to manufacturer’s instructions. Hut/CCR5, CD4<sup>+</sup> T cells, and CD14<sup>+</sup> monocytes were cultured in RPMI 1640 medium containing 10% fetal bovine serum (FBS)(Hyclone) with 100 U/mL penicillin and 100 μg/mL streptomycin.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16">4.3.  Plasmids</h3><div class="NLM_p last">The plasmid expressing APOBEC3G (pcDNA-APOBEC3G-Myc) was provided by Yong-Hui Zheng (The Michigan State University, USA), and the gene of APOBEC3G was also subcloned into pcDNA-eGFP at the carboxyl-terminus to construct the plasmid pcDNA-APOBEC3G-eGFP; the HIV-1 Vif-expressing plasmid (pcDNA-Vif-HA) was provided by Li Wu (Ohio State University, USA), and pcDNA-ubiquitin-His was a gift from Ke Lan (Wu Han University, China).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17">4.4.  Viral Stocks</h3><div class="NLM_p last">Calcium phosphate-mediated transfection of HEK293T cells was used to generate virus stock. Pseudotyped single-cycle infectious HIV-luc/VSV-G or HIV-luc/JRFL was co-transfected with the luciferase reporter HIV-1 proviral plasmid pLAI-Δ-env-luc and the expression plasmid vesicular stomatitis virus G (VSV-G) protein or HIV-1-JRFL Env. Plasmids were kindly provided as gifts from Li Wu (Ohio State University, USA). Harvested supernatants of transfected cells that contained viral particles were filtered and titrated with p24<sup>gag</sup> capture enzyme-linked immunosorbent assay (ELISA). The HIV-1 p24<sup>gag</sup>-specific monoclonal antibodies were kindly provided as gifts by Yong-Tang Zheng (Kunming Institute of Zoology, Chinese Academy of Sciences, China).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18">4.5.  Anti-HIV Activity Assay</h3><div class="NLM_p">Hut/CCR5 cells (0.5 × 10<sup>5</sup>) were infected with HIV-luc/JRFL (1 ng p24<sup>Gag</sup>), or HEK293T cells (1 × 10<sup>5</sup>) were infected with HIV-luc/VSV-G (1 ng p24<sup>Gag</sup>), in the presence of different concentrations of compounds for 3 h. After washing, the cells were further cultured for an additional 72 h in the presence of the same concentrations of compounds. Cells were harvested and lysed, and viral infection was measured by detecting luciferase activity using the Luciferase assay system (Promega). The concentration of compounds inhibiting 50% of HIV-1 infection (EC<sub>50</sub>) was determined from the dose response curves. The cell viability with compound treatment was measured by MTT colorimetric assay,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and the concentration of compounds inducing 50% cytotoxicity (CC<sub>50</sub>) was calculated from the dose response curves.</div><div class="NLM_p">To test the synergy of anti-HIV-1 activity of combinations of compounds, FNC was combined with either dolutegravir or rilpivirine in different ratios based on the calculated EC<sub>50</sub> value of each compound. The software of Chou and Talalay and CompuSyn (ComboSyn Inc., Paramus, New Jersey, USA) was used for quantification of synergy by calculating the combination index (CI). The CI value offers a quantitative definition of antagonism (CI > 1), additive effect (CI = 1), weak synergism (0.7 < CI < 1), moderate synergism (0.3 < CI < 0.7), and strong synergism (CI < 0.3) with drug combinations.</div><div class="NLM_p last">To detect the long-lasting prevention effect, different concentrations of FNC (0.1, 1, and 10 nM) or 3TC (1,000 and 10,000 nM) were incubated with Hut/CCR5 cells (1 × 10<sup>6</sup>) at 37 °C for 4 h. After washing and removal of cell-free drugs, the cells were further incubated, and at the indicated times, 0.5 × 10<sup>5</sup> cells were used for infection with HIV-luc/JRFL (1 ng p24<sup>Gag</sup>) for an additional 72 h; and viral infection was then determined by detection of luciferase activity. At the same time points, the cell number was counted by microscopy. The inhibition of HIV-1 infection was analyzed, and the time necessary for 50% reduction of HIV-1 prevention (T<sub>50%-prevention</sub>) was calculated based on the regression curve of HIV-1 prevention.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">4.6.  Ethics Statement and Cohort of Patients</h3><div class="NLM_p">Three HIV-1-infected antiretroviral treatment–naïve human individuals were recruited. These recipients have a plasma viral load higher than 1000 copies/mL and a CD4<sup>+</sup> T cell count greater than 200 cells/mm<sup>3</sup>. Informed consent was obtained, and experimental protocols were approved by the Medical Ethics Review Committee of Zhengzhou Sixth People’s Hospital. All experiments were performed in accordance with relevant national guidelines and regulations. CD4<sup>+</sup> T cell counts were analyzed by flow cytometry, and HIV-1 viral loads were measured by a polymerase chain reaction (PCR) (Cobas Amplicor, Roche, Basel, Switzerland).</div><div class="NLM_p last">Each day for six consecutive days, the recipients were administered 4 tablets of azvudine, each containing 1 mg of FNC. At day 0 (immediately before initiation of treatment) and day 7 (1 day after treatment completion), 20 mL of peripheral blood was collected, and the peripheral blood mononuclear cells (PBMCs) were isolated with Ficoll-Paque density gradient centrifugation (GE Healthcare Life Sciences). CD4<sup>+</sup> T cells were further purified from PBMCs using anti-CD4 antibody-coated magnetic beads (Miltenyi Biotec). Cells were lysed with buffer [50 mM HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) pH 7.4, 150 mM NaCl (sodium chloride), 0.5 mM EGTA [ethylene glycol-bis(β-aminoethyl ether)-<i>N</i>,N,<i>N</i>′,<i>N</i>′-tetraacetic acid], 1% protease inhibitor cocktail (Sigma), 1 mM sodium orthovanadate, 1 mM NaF (sodium fluoride), 1% (vol/vol) Triton X-100, and 10% (vol/vol) glycerol] for 1 h on ice. The endogenous expression of APOBEC3G was detected by Western blotting.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20">4.7.  Pharmacokinetic Studies in Rhesus Macaque Monkeys and Sprague–Dawley Rats</h3><div class="NLM_p">Three 7–10 kg adult male rhesus macaques (<i>Macaca mulatta</i>) were provided by Henan Normal University. The study was approved by the Institutional Animal Care and Use Committee of Henan Normal University. Animals were housed in accordance with the Association for Assessment and Accreditation of Laboratory Animal Care International Standards. Animals were treated with a single oral administration of FNC at 1 or 6 mg/kg or lamivudine at 20 mg/kg. Peripheral blood (20 mL) was collected at 1, 6, 24, 72, 120, and 168 h after administration. FNC was dissolved in distilled water at a concentration of 1 or 6 mg/mL. Lamivudine was suspended in 0.5% (w/v) carboxyl methyl cellulose sodium aqueous solution at a concentration of 20 mg/mL. All blood samples were centrifuged at 1000<i>g</i> for 10 min, and the plasma was separated and stored at −80 °C for FNC or 3TC analysis. PBMCs were isolated by Ficoll density gradient centrifugation and used for FNC-TP or 3TC-TP analysis.</div><div class="NLM_p">For quantification of drugs in plasma, a 50 μL aliquot of plasma was pipetted into a 1.5 mL capped polypropylene tube, and then, 50 μL of internal standard solution (50 ng/mL of 3TC) and 200 μL of methanol were added and the mixture was vortexed for 30 s. After centrifuging at 16,000<i>g</i> for 5 min, 250 μL of supernatant was transferred into a 10 mL glass tube and evaporated to dryness under a steam of nitrogen at 50 °C. The residue was reconstituted with 250 μL of the mobile phase and vortexed briefly. After centrifuging again at 16,000<i>g</i> for 5 min at room temperature, the supernatant was analyzed by liquid chromatography-triple quadrupole mass spectrometry (LC–MS/MS) as previously reported.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Quantification of 3TC was performed in the selected-reaction monitoring (SRM) mode with the transitions of <i>m</i>/<i>z</i> of 230.0 → 112.0.</div><div class="NLM_p">For quantification of drugs in PBMCs, these isolated PBMCs from animals were treated with the ultrasonic cell disintegrator and centrifuged at 16,000<i>g</i> for 5 min at 4 °C. The supernatant was mixed with three volumes of acetonitrile by vortexing for 30 s, and then, one volume of water was added and mixed again. After centrifuging at 16,000<i>g</i> for 5 min, the supernatant was evaporated to dryness under a steam of nitrogen at 40 °C. The residue was reconstituted with 500 μL of the mobile phase and briefly vortexed. After centrifuging at 16,000<i>g</i> for 5 min at room temperature, the supernatant was analyzed by LC–MS/MS. The HPLC was a Thermo Fisher ACCELA LC system. Chromatographic separation was performed on a Phenomenex Luna PFP column (100 mm × 2.0 mm; 3 μm; Kyoto, USA). The mobile phase, consisting of a mixed aqueous solution of methanol–ammonia (0.1%, pH 10) (10:90, v/v), was delivered at a flow rate of 0.18 mL/min. The column temperature was maintained at 30 °C. The injection volume was 10 μL. Detection was achieved with a Thermo Fisher TSQ QUANTUM ULTRA triple quadrupole mass spectrometer with an ESI interface in the negative-ion mode. The parameter settings were spray voltage, 2500 V; capillary temperature, 350 °C; sheath gas (nitrogen), 40 arbitrary units; auxiliary gas (nitrogen), 10 arbitrary units; and vaporizer temperature, room temperature. Detection and quantification of the compounds were performed in the selected-reaction monitoring (SRM) mode with the transitions of <i>m</i>/<i>z</i> of 524.7 → 158.7 and <i>m</i>/<i>z</i> of 468.0 → 159.0 for FNC-TP and 3TC-TP, respectively.</div><div class="NLM_p last">For delineation of FNC distribution in tissues or organs, 56 healthy Sprague–Dawley rats, 50% female and 50% male, were randomly divided into seven groups with eight rats in each group. Rats were administered a single dose of 0.5 mg/kg by gavage. The rats were sacrificed at 1, 3, 7, 12, 24, 48, and 72 h post-administration, and the tissues and organs, including the heart, liver, spleen, lung, kidneys, stomach, intestines, thymus, brain, and testicles (or ovaries), were excised to prepare tissue homogenates. Rat tissue homogenates (100 μL) were added with 100 μL of internal standard solution (500 ng/mL 3TC) and 400 μL of methanol; then, the samples were mixed well on vortex for 30 s and centrifuged at 13,000 rpm for 5 min. Supernatants (400 μL) were harvested to 10 mL in a round-bottom glass tube and dried under nitrogen flow at 50 °C. Samples were then dissolved with 100 μL of mobile phase solution, vortexed for 60 s, transferred to a 1.5 mL Eppendorf tube, and centrifuged at 13,000 rpm for 5 min; finally, 10 μL supernatants were collected for LC-MS/MS analysis. A chromatographic column YMC-Pack Pro.C18, 3 μm, 150 mm × 4.6 mm i.d., was used; the mobile phase was methanol (containing 0.3% formic acid) and 10 mM ammonium acetate (containing 0.3% formic acid) in a 25:75 (V/V) ratio; a flow rate of 0.3 mL/min, a column temperature of 30 °C, a volume of injection of 10 μL, electrospray ionization (ESI) in the positive-ion mode, a capillary voltage of 3.5 kV, nitrogen for sheath gas with a pressure of 40 Arb, nitrogen for auxiliary gas with a pressure of 10 Arb, an atomizing chamber at room temperature, and selective monitoring of the mass-to-charge ratio (<i>m</i>/<i>z</i>) were also utilized. The transition for FNC is 287 → 112, and for the 3TC is 230 → 112.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21">4.8.  Assay of Drug Distribution in Human Cell Subsets</h3><div class="NLM_p last">Human PBMCs from healthy donors were isolated and incubated with FNC (350 nM) for 4 h. CD14<sup>+</sup> monocytes and CD4<sup>+</sup> T cells were subsequently isolated by using antibody-coated magnetic beads with positive selection. The intracellular active form FNC-TP from CD14<sup>+</sup> monocytes, CD4<sup>+</sup> T cells, and the remaining cells were quantified by LC–MS/MS assay.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">4.9.  Assay of A3G Expression</h3><div class="NLM_p">A3G expression was detected by both Western blotting and flow cytometry. For Western blotting, HEK293T cells were transfected by lipofectamine 2000 (Life Technologies) with pcDNA-APOBEC3G-Myc and/or pcDNA-Vif-HA for 24 h, and cells were further treated with FNC (10 nM) or 3TC (1000 nM) for an additional 48 h; some cells were treated with the proteasome inhibitor MG132 (10 μM) 16 h prior to harvesting. Cells were harvested and lysed for Western blotting to detect the expression of A3G (Myc) and exogenous Vif (HA), and GAPDH was used for loading normalization. The antibodies below were used: rabbit polyclonal antibodies anti-HA or anti-Myc antibodies (Abcam), mouse anti-His monoclonal antibody (Abmart), and HRP-conjugated secondary antibodies against a mouse or rabbit (Sigma-Aldrich). For detection of the endogenous A3G in patient CD4<sup>+</sup> T cells, the specific mouse monoclonal antibody antihuman A3G (Bio-Rad) was used for Western blotting.</div><div class="NLM_p last">For flow cytometry detecting A3G expression, HEK293T cells were transfected with pcDNA-APOBEC3G-eGFP and/or pcDNA-Vif-HA for 24 h, and cells were further treated with FNC (10 nM) or 3TC (1,000 nM) for an additional 48 h; some cells were treated with the proteasome inhibitor MG132 (10 μM) 16 h prior to harvesting. A3G expression is measured by detecting GFP production with a Fortessa flow cytometer (BD Pharmin-Gen) and analyzed with the FlowJo 7.6.1 software.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23">4.10.  Assay for A3G Ubiquitination</h3><div class="NLM_p last">HEK293T cells were co-transfected by lipofectamine 2000 (Life Technologies) with pcDNA-APOBEC3G-Myc, pcDNA-Vif-HA, and pcDNA-ubiquitin-His for 24 h, and cells were further treated with FNC (3.5 or 35 nM) for an additional 48 h; some cells were treated with the proteasome inhibitor MG132 (10 μM) 16 h prior to harvesting. Cells were harvested and lysed for Western blotting to detect the expression of His-ubiquitin with immunostaining with anti-His antibodies (Abmart).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24">4.11.  Kinetic Analysis of the Association of FNC with the Vif–CBFβ–ELOB–ELOC Complex</h3><div class="NLM_p last">A Biacore T200 system (CM5 chip) was used to detect the kinetic parameters of small molecules binding to proteins. Amino conjugation of the Vif complex to the CM5 chip was performed using GE’s original amino conjugation kit (item no. Br-1000-50). The running buffer used was HBS-T containing 0.01 M HEPES pH 7.4, 0.15 M sodium chloride, and 0.005% Tween-20. The Vif–CBFβ–ELOB–ELOC complex was first diluted to 343 μg/mL with HBS-T solution and then diluted to 40 μg/mL with sodium acetate solution (GE original) at pH 4.5. When coupling, the contact time was 600 s, and the flow rate was 10 μL/min. For kinetic analysis of the FNC with the Vif–CBFβ–ELOB–ELOC complex, FNC was diluted from 200 μM with PBS-T solution to 13 concentration gradients for detection; during detection and analysis, the contact time was 180 s, the flow rate was 20 μL/min, and the dissociation time was 300 s; after detection, five contagious concentrations were selected for dynamic analysis. Since FNC solution contains DMSO as an organic solvent, the solution calibration was carried out, and a reference channel was arranged to minimize errors. All sample solutions with CM5 chips were filtered with a 0.22 μm membrane, and the buffer was degassed.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25">4.12.  Detection of Non-specific Activation of Human Cells</h3><div class="NLM_p last">Isolated PBMCs from healthy human individuals were incubated with FNC (100 nM) or phytohemagglutinin-P (PHA-P) (Sigma-Aldrich) (5 μg/mL) for 48 h, in the presence of recombinant interleukin (IL)-2 (20 IU/mL). Cells were harvested and immunostained with anti-CD3, anti-CD4, anti-CD14, anti-CD25, anti-CD69, and anti-HLA-DR antibodies (eBioscience) and detected using a Fortessa flow cytometer (BD Pharmingen) and analyzed with the assistance of the FlowJo 7.6.1 software.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26">4.13.  Statistical Analysis</h3><div class="NLM_p last">Statistical analysis was performed using a paired <i>t</i>-test with SigmaStat 2.0 (Systat Software, San Jose, CA, USA).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27">4.14.  Computational Details</h3><div class="NLM_p last">Molecular docking and molecular dynamics (MD) simulations were performed to construct and optimize the binding complex structure of FNC-TP with an HIV-I reverse transcriptase (PDB ID <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J2M">5J2M</a><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a>). In order to simulate appropriate base pair interactions (A-T, G-C), the original base T paired with EFdA in the crystal structure of <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J2M">5J2M</a> was modified to G. Then, the bioactive form of nucleoside analogs, i.e., FNC-TP, was docked into the possible active site of the enzyme by using the AutoDock 4.2 program.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> After the initial model was prepared, the ionizable residues were set to the standard protonated or deprotonated states at the physiological conditions (pH = ∼7.4). Then, the complex structure was solvated in a rectangular box of TIP3P water molecules with a minimum solute–wall distance of 15 Å. Additional Na<sup>+</sup> was added in the solvent as counter ions to neutralize the whole system. In the following, a series of energy minimizations were carried out by using the Sander module of the Amber 16 program<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> with a non-bonded cutoff of 10 Å and a conjugate gradient energy minimization method. Subsequently, the two systems were gradually heated from 10 to 298.15 K by a weak-coupling method with a constraint force constant of 5 kcal mol<sup>–1</sup> Å<sup>–2</sup> on the solute. The constraint force constant was gradually decreased during a period of 600 ps equilibration and finally removed for the production MD simulation. To obtain a stable MD trajectory, the production MD simulation was kept running 5.0 ns in the NTP ensemble, at <i>T</i> = 298.15 K. Afterward, the representative snapshots of the complex structure were extracted from the production MD.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i28"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00940" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34226" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34226" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00940?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00940</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Assay for non-specific activation of human cells (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_001.pdf">jm0c00940_si_001.pdf (186.56 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_002.csv">jm0c00940_si_002.csv (1.67 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c00940" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23212" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23212" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jijie Chai</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecule and Drug Innovation,
College of Life Science, Henan Normal University, Xinxiang 453007, China</span>; 
    <span class="hlFld-Affiliation affiliation">Tsinghua-Peking
Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a2c1cac3cbc8c8e2cfc3cbce8cd6d1cbccc5cad7c38cc7c6d78cc1cc"><span class="__cf_email__" data-cfemail="4f2c272e2625250f222e2623613b3c262128273a2e612a2b3a612c21">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jian-Hua Wang</span> - <span class="hlFld-Affiliation affiliation">Guangzhou
Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f483959a93ab9e9d959a9c8195b4939d969cda9597da979a"><span class="__cf_email__" data-cfemail="2354424d447c494a424d4b564263444a414b0d42400d404d">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junbiao Chang</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecule and Drug Innovation,
College of Life Science, Henan Normal University, Xinxiang 453007, China</span>; 
    <span class="hlFld-Affiliation affiliation">College
of Chemistry, Zhengzhou University, Zhengzhou 450001, China</span>; 
    <span class="hlFld-Affiliation affiliation">College
of Chemistry and Chemical Engineering, Henan
Normal University, Xinxiang 453007, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6236-1256" title="Orcid link">http://orcid.org/0000-0001-6236-1256</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#beddd6dfd0d9d4cbd0dcd7dfd1fec4c4cb90dbdacb90ddd0"><span class="__cf_email__" data-cfemail="1b78737a757c716e7579727a745b61616e357e7f6e357875">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Sun</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecule and Drug Innovation,
College of Life Science, Henan Normal University, Xinxiang 453007, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Youmei Peng</span> - <span class="hlFld-Affiliation affiliation">Henan
Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wenquan Yu</span> - <span class="hlFld-Affiliation affiliation">College
of Chemistry, Zhengzhou University, Zhengzhou 450001, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-3711-0006" title="Orcid link">http://orcid.org/0000-0002-3711-0006</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Zhang</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecule and Drug Innovation,
College of Life Science, Henan Normal University, Xinxiang 453007, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lan Liang</span> - <span class="hlFld-Affiliation affiliation">College
of Chemistry and Chemical Engineering, Henan
Normal University, Xinxiang 453007, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chuanjun Song</span> - <span class="hlFld-Affiliation affiliation">College
of Chemistry, Zhengzhou University, Zhengzhou 450001, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7733-578X" title="Orcid link">http://orcid.org/0000-0001-7733-578X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiao Hou</span> - <span class="hlFld-Affiliation affiliation">College
of Chemistry, Zhengzhou University, Zhengzhou 450001, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yan Qiao</span> - <span class="hlFld-Affiliation affiliation">College
of Chemistry, Zhengzhou University, Zhengzhou 450001, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-6357-8203" title="Orcid link">http://orcid.org/0000-0001-6357-8203</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingduan Wang</span> - <span class="hlFld-Affiliation affiliation">Henan
Institute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jingyu Chen</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecule and Drug Innovation,
College of Life Science, Henan Normal University, Xinxiang 453007, China</span>; 
    <span class="hlFld-Affiliation affiliation">Guangzhou
Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mengli Wu</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecule and Drug Innovation,
College of Life Science, Henan Normal University, Xinxiang 453007, China</span>; 
    <span class="hlFld-Affiliation affiliation">Guangzhou
Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dongwei Zhang</span> - <span class="hlFld-Affiliation affiliation">Henan
Key Laboratory of Organic Functional Molecule and Drug Innovation,
College of Life Science, Henan Normal University, Xinxiang 453007, China</span>; 
    <span class="hlFld-Affiliation affiliation">Guangzhou
Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ertong Li</span> - <span class="hlFld-Affiliation affiliation">Tsinghua-Peking
Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhifu Han</span> - <span class="hlFld-Affiliation affiliation">Tsinghua-Peking
Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing 100084, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qingxia Zhao</span> - <span class="hlFld-Affiliation affiliation">Department
of Infection, Zhengzhou Sixth People’s
Hospital, Zhengzhou 450000, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xia Jin</span> - <span class="hlFld-Affiliation affiliation">Shanghai
Public Health Clinical Center Affiliated to Fudan University, Shanghai 201508, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bailing Zhang</span> - <span class="hlFld-Affiliation affiliation">HIT
Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiwei Huang</span> - <span class="hlFld-Affiliation affiliation">HIT
Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin 150080, China</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>L.S., Y.P., and W.Y. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Li Wu, Yong-Hui Zheng, Ke Lan, and Yong-Tang Zheng for cells and plasmids. The work was supported by the National Natural Science Foundation of China (U1804283, 81873965, 81773570) and the key project from Chinese Academy of Sciences (QYZDB-SSW-SMC059). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">ABBREVIATIONS</td></tr><tr><td class="NLM_term">FNC</td><td class="NLM_def"><p class="first last">2′-deoxy-2′-β-fluoro-4′-azidocytidine</p></td></tr><tr><td class="NLM_term">3TC</td><td class="NLM_def"><p class="first last">lamivudine</p></td></tr><tr><td class="NLM_term">HIV</td><td class="NLM_def"><p class="first last">human immunodeficiency virus</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">NRTI</td><td class="NLM_def"><p class="first last">nucleoside reverse transcriptase inhibitor</p></td></tr><tr><td class="NLM_term">cART</td><td class="NLM_def"><p class="first last">combination antiretroviral therapy</p></td></tr><tr><td class="NLM_term">dS</td><td class="NLM_def"><p class="first last">2′,3′-dideoxynucleosides</p></td></tr><tr><td class="NLM_term">dN</td><td class="NLM_def"><p class="first last">2′-deoxynucleosides</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">reverse transcriptase</p></td></tr><tr><td class="NLM_term">4′sdN</td><td class="NLM_def"><p class="first last">4′-<i>C</i>-substituted-2′-deoxynucleoside</p></td></tr><tr><td class="NLM_term">DNA</td><td class="NLM_def"><p class="first last">deoxyribonucleic acid</p></td></tr><tr><td class="NLM_term">A3G</td><td class="NLM_def"><p class="first last">APOBEC3G</p></td></tr><tr><td class="NLM_term">CBFβ</td><td class="NLM_def"><p class="first last">core binding factor subunit beta</p></td></tr><tr><td class="NLM_term">PBMC</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">PrEP</td><td class="NLM_def"><p class="first last">pre-exposure prophylaxis</p></td></tr><tr><td class="NLM_term">VSVG</td><td class="NLM_def"><p class="first last">vesicular stomatitis virus glycoprotein</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% effective concentration</p></td></tr><tr><td class="NLM_term">CC<sub>50</sub></td><td class="NLM_def"><p class="first last">50% cytotoxic concentration</p></td></tr><tr><td class="NLM_term">MTT</td><td class="NLM_def"><p class="first last">3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide</p></td></tr><tr><td class="NLM_term">NNRTI</td><td class="NLM_def"><p class="first last">non-nucleoside reverse transcriptase inhibitor</p></td></tr><tr><td class="NLM_term">CI</td><td class="NLM_def"><p class="first last">combination index</p></td></tr><tr><td class="NLM_term">TP</td><td class="NLM_def"><p class="first last">triphosphate</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviations</p></td></tr><tr><td class="NLM_term">NA</td><td class="NLM_def"><p class="first last">not acquired</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">Vif</td><td class="NLM_def"><p class="first last">virion infectivity factor</p></td></tr><tr><td class="NLM_term">MD</td><td class="NLM_def"><p class="first last">molecular dynamics</p></td></tr><tr><td class="NLM_term">CVC</td><td class="NLM_def"><p class="first last">cenicriviroc</p></td></tr><tr><td class="NLM_term">EFV</td><td class="NLM_def"><p class="first last">efavirenz</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s modified Eagle’s medium</p></td></tr><tr><td class="NLM_term">FBS</td><td class="NLM_def"><p class="first last">fetal bovine serum</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24571" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24571" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 16 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Punekar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ruiter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhart, C.</span></span> <span> </span><span class="NLM_article-title">A review of long-term toxicity of antiretroviral treatment regimens and implications for an aging population</span>. <i>Infect. Dis. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1007/s40121-018-0201-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1007%2Fs40121-018-0201-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=29761330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A280%3ADC%252BC1Mfjt1OrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=183-195&author=A.+Chawlaauthor=C.+Wangauthor=C.+Pattonauthor=M.+Murrayauthor=Y.+Punekarauthor=A.+de+Ruiterauthor=C.+Steinhart&title=A+review+of+long-term+toxicity+of+antiretroviral+treatment+regimens+and+implications+for+an+aging+population&doi=10.1007%2Fs40121-018-0201-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population</span></div><div class="casAuthors">Chawla Anita; Wang Christina; Patton Cody; Murray Miranda; Punekar Yogesh; de Ruiter Annemiek; Steinhart Corklin</div><div class="citationInfo"><span class="NLM_cas:title">Infectious diseases and therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-195</span>
        ISSN:<span class="NLM_cas:issn">2193-8229</span>.
    </div><div class="casAbstract">Human immunodeficiency virus (HIV) is a chronic infectious disease currently requiring lifelong antiretroviral therapy (ART).  People living with HIV (PLWH) face an increased risk of comorbidities associated with aging, chronic HIV, and the toxicity arising from long-term ART.  A literature review was conducted to identify the most recent evidence documenting toxicities associated with long-term ART, particularly among aging PLWH.  In general, PLWH are at a greater risk of developing fractures, osteoporosis, renal and metabolic disorders, central nervous system disorders, cardiovascular disease, and liver disease.  There remains limited evidence describing the economic burden of long-term ART.  Overall, an aging HIV population treated with long-term ART presents a scenario in which the clinical, humanistic, and economic burden for healthcare systems will demand thoughtful policy solutions that preserve access to treatment.  Newer treatment regimens with fewer drugs may mitigate some of the cumulative toxicity burden of long-term ART.Funding: ViiV Healthcare.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6Mo5eNHhG0zEC-75aqa5AfW6udTcc2eYudost24hG37ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mfjt1OrsA%253D%253D&md5=8d18a486d49c1cb39ee6f94fc40020e6</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1007%2Fs40121-018-0201-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40121-018-0201-6%26sid%3Dliteratum%253Aachs%26aulast%3DChawla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DPatton%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DM.%26aulast%3DPunekar%26aufirst%3DY.%26aulast%3Dde%2BRuiter%26aufirst%3DA.%26aulast%3DSteinhart%26aufirst%3DC.%26atitle%3DA%2520review%2520of%2520long-term%2520toxicity%2520of%2520antiretroviral%2520treatment%2520regimens%2520and%2520implications%2520for%2520an%2520aging%2520population%26jtitle%3DInfect.%2520Dis.%2520Ther.%26date%3D2018%26volume%3D7%26spage%3D183%26epage%3D195%26doi%3D10.1007%2Fs40121-018-0201-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. K.</span></span> <span> </span><span class="NLM_article-title">The impact of HIV-1 drug escape on the global treatment landscape</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2019.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.chom.2019.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=31295424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=48-60&author=D.+A.+Collierauthor=C.+Monitauthor=R.+K.+Gupta&title=The+impact+of+HIV-1+drug+escape+on+the+global+treatment+landscape&doi=10.1016%2Fj.chom.2019.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The Impact of HIV-1 Drug Escape on the Global Treatment Landscape</span></div><div class="casAuthors">Collier, D. A.; Monit, C.; Gupta, R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-60</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The rising prevalence of HIV drug resistance (HIVDR) could threaten gains made in combating the HIV epidemic and compromise the 90-90-90 target proposed by United Nations Program on HIV/AIDS (UNAIDS) to have achieved virol. suppression in 90% of all persons receiving antiretroviral therapy (ART) by the year 2020.  HIVDR has implications for the persistence of HIV, the selection of current and future ART drug regimens, and strategies of vaccine and cure development.  Focusing on drug classes that are in clin. use, this Review critically summarizes what is known about the mechanisms the virus utilizes to escape drug control.  Armed with this knowledge, strategies to limit the expansion of HIVDR are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_HuvocDGDR7Vg90H21EOLACvtfcHk0lhMJ4-FK2Yr6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsr%252FN&md5=cf776f99e1f4f748c66862d0da15db7e</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2019.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2019.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DCollier%26aufirst%3DD.%2BA.%26aulast%3DMonit%26aufirst%3DC.%26aulast%3DGupta%26aufirst%3DR.%2BK.%26atitle%3DThe%2520impact%2520of%2520HIV-1%2520drug%2520escape%2520on%2520the%2520global%2520treatment%2520landscape%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2019%26volume%3D26%26spage%3D48%26epage%3D60%26doi%3D10.1016%2Fj.chom.2019.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohrui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohgo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Syntheses of 4’-C-ethynyl-beta-D-arabino- and 4’-C-ethynyl-2′-deoxy-beta-D-ribo-pentofuranosylpyrimidines and -purines and evaluation of their anti-HIV activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4516</span>– <span class="NLM_lpage">4525</span>, <span class="refDoi"> DOI: 10.1021/jm000209n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000209n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1OisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4516-4525&author=H.+Ohruiauthor=S.+Kohgoauthor=K.+Kitanoauthor=S.+Sakataauthor=E.+Kodamaauthor=K.+Yoshimuraauthor=M.+Matsuokaauthor=S.+Shigetaauthor=H.+Mitsuya&title=Syntheses+of+4%E2%80%99-C-ethynyl-beta-D-arabino-+and+4%E2%80%99-C-ethynyl-2%E2%80%B2-deoxy-beta-D-ribo-pentofuranosylpyrimidines+and+-purines+and+evaluation+of+their+anti-HIV+activity&doi=10.1021%2Fjm000209n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of 4'-C-Ethynyl-β-D-arabino- and 4'-C-Ethynyl-2'-deoxy-β-D-ribo-pentofuranosylpyrimidines and -purines and Evaluation of Their Anti-HIV Activity</span></div><div class="casAuthors">Ohrui, Hiroshi; Kohgo, Satoru; Kitano, Kenji; Sakata, Shinji; Kodama, Eiichi; Yoshimura, Kazuhisa; Matsuoka, Masao; Shigeta, Shiro; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4516-4525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4'-C-Ethynyl-β-D-arabino- and 4'-C-ethynyl-2'-deoxy-β-D-ribo-pentofuranosylpyrimidine and -purine nucleosides were synthesized and evaluated for their in vitro anti-HIV activity.  The key intermediate, 4-C-ethynyl- or 4-C-triethylsilylethynyl-D-ribo-pentofuranose, was prepd. from D-glucose and glycosidated with various pyrimidine or purine bases.  The arabino pyrimidine derivs. were prepd. from the corresponding ribo derivs. via O2,2'-anhydro nucleosides.  The 2'-deoxy-ribo derivs. were synthesized by radical redn. of 2'-bromo or 2'- phenoxythiocarbonyloxy nucleosides.  Among these 4'-C-ethynyl nucleosides, seven analogs proved to be potent against HIV-1 in vitro with EC50 values ranging from 0.0003 to 0.03 μM.  These compds. also exerted activity against clin. and multi-dideoxy-nucleoside-resistant HIV-1 strains with comparable EC50 values.  Three such 4'-C-ethynyl-2'-deoxypurine analogs including 4'-C-ethynyl-2'-deoxyadenosine and 4'-C-ethynyl-2,6-diamino-2'-deoxypurine were less cytotoxic [selectivity indexes (SIs): 975-2733] than three 4'-C-ethynyl-2'-deoxycytidine analogs (SIs: 63-363).  4'-C-Ethynyl-5-fluoro-2'-deoxycytidine was least toxic (SI: >3333) and potent against all HIV strains tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_ZOZ0AOXN8LVg90H21EOLACvtfcHk0ljWSfvThfSRfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1OisL4%253D&md5=b87278f85ea7d883cacdfadbfab3ff15</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm000209n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000209n%26sid%3Dliteratum%253Aachs%26aulast%3DOhrui%26aufirst%3DH.%26aulast%3DKohgo%26aufirst%3DS.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DSakata%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DE.%26aulast%3DYoshimura%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DM.%26aulast%3DShigeta%26aufirst%3DS.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DSyntheses%2520of%25204%25E2%2580%2599-C-ethynyl-beta-D-arabino-%2520and%25204%25E2%2580%2599-C-ethynyl-2%25E2%2580%25B2-deoxy-beta-D-ribo-pentofuranosylpyrimidines%2520and%2520-purines%2520and%2520evaluation%2520of%2520their%2520anti-HIV%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4516%26epage%3D4525%26doi%3D10.1021%2Fjm000209n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ohrui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">4 -C-Substituted-2 -Deoxynucleosides A Family of Antiretroviral Agents Which are Potent Against Drug-Resistant HIV Variants</span>. <i>Curr. Drug Targets Infect. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.2174/1568005013343218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.2174%2F1568005013343218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=12455229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslCrsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=1-10&author=H.+Ohruiauthor=H.+Mitsuya&title=4+-C-Substituted-2+-Deoxynucleosides+A+Family+of+Antiretroviral+Agents+Which+are+Potent+Against+Drug-Resistant+HIV+Variants&doi=10.2174%2F1568005013343218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">4'-C-substituted-2'-deoxynucleosides: a family of antiretroviral agents which are potent against drug-resistant HIV variants</span></div><div class="casAuthors">Ohrui, Hiroshi; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Infectious Disorders</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">CDTIAS</span>;
        ISSN:<span class="NLM_cas:issn">1568-0053</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 25 refs.  In the past years, a variety of 4'-C-substituted-2'-deoxynucleosides (4'SdNs) were designed, synthesized, and examd. as potential therapeutics against human immunodeficiency virus (HIV) infection and certain such analogs proved to exert potent activity against HIV-1 in vitro.  Unlike currently available nucleoside reverse transcriptase (RT) inhibitors such as 3'-azido-3'-deoxythymidine (AZT), which have the 2',3'-dideoxy configuration and thereby cause DNA chain termination in the elongating proviral DNA, 4'SdNs do retain the 3'-α-OH moiety but also appear to work against retrovirus as proviral DNA chain terminators.  Several 4'SdNs have been shown to be active against various lab. and clin. HIV-1 strains including known drug-resistant HIV-1 variants.  Among such 4'SdNs is 4'-azido-2'-deoxythymidine (4'-AZT) which exerts potent antiviral activity against wild type and AZT-resistant clin. HIV strains.  More anti-HIV 4'SdNs have recently been reported including 4'-ethynylthymidine, 4'-ethynyl-2'-deoxy-D-ribofuranosyl-2,6-diaminopurine (4'-E-dDAP), 4'-ethynyl-2'-deoxyguanosine (4'-E-dG) and 4'-ethynyl-2'-deoxyadenosine (4'-E-dA).  The latter three analogs are highly potent against HIV-1 and HIV-2 with EC50 values ranging from 0.0003 to 0.01 μM and have favorable cytotoxicity profiles with selective index (SI) values ranging from 975 to 2600.  These 4'-ethynyl-2'-deoxynucleosides also exert potent activity against all known drug-resistant HIV-1 variants including the multi-dideoxynucleoside-resistant HIV and the variants with the 6-base pair inserts.  Some of these compds. have favorable pharmacol. properties and further development as potential therapeutics against HIV-1 infection is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM1mEtWgugVrVg90H21EOLACvtfcHk0ljWSfvThfSRfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslCrsbw%253D&md5=fa439842fb091d8632edaafab8d5537f</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.2174%2F1568005013343218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568005013343218%26sid%3Dliteratum%253Aachs%26aulast%3DOhrui%26aufirst%3DH.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3D4%2520-C-Substituted-2%2520-Deoxynucleosides%2520A%2520Family%2520of%2520Antiretroviral%2520Agents%2520Which%2520are%2520Potent%2520Against%2520Drug-Resistant%2520HIV%2520Variants%26jtitle%3DCurr.%2520Drug%2520Targets%2520Infect.%2520Disord.%26date%3D2001%26volume%3D1%26spage%3D1%26epage%3D10%26doi%3D10.2174%2F1568005013343218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of new 2′-deoxy-2′-fluoro-4′-azido nucleoside analogues as potent anti-HIV agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4178</span>– <span class="NLM_lpage">4183</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.ejmech.2011.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=21745701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2rtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=4178-4183&author=Q.+Wangauthor=W.+Huauthor=S.+Wangauthor=Z.+Panauthor=L.+Taoauthor=X.+Guoauthor=K.+Qianauthor=C.-H.+Chenauthor=K.-H.+Leeauthor=J.+Chang&title=Synthesis+of+new+2%E2%80%B2-deoxy-2%E2%80%B2-fluoro-4%E2%80%B2-azido+nucleoside+analogues+as+potent+anti-HIV+agents&doi=10.1016%2Fj.ejmech.2011.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of new 2'-deoxy-2'-fluoro-4'-azido nucleoside analogs as potent anti-HIV agents</span></div><div class="casAuthors">Wang, Qiang; Hu, Weidong; Wang, Shuyang; Pan, Zhenliang; Tao, Le; Guo, Xiaohe; Qian, Keduo; Chen, Chin-Ho; Lee, Kuo-Hsiung; Chang, Junbiao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4178-4183</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We prepd. 1-(4'-azido-2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)cytosine (I) and its hydrochloride salt (II) as potential antiviral agents based on the favorable antiviral profiles of 4'-substituted nucleosides.  Compds. I and II were synthesized from 1,3,5-O-tribenzoyl-2-deoxy-2-fluoro-D-arabinofuranoside in multiple steps, and their structures were unequivocally established by IR, 1H NMR, 13C NMR, and 19F NMR spectroscopy, HRMS, and X-ray crystallog.  Compds. I and II exhibited potent anti-HIV-1 activity (EC50: 0.3 and 0.13 nM, resp.) without significant cytotoxicity in concns. up to 100 μM.  Compd. II exhibited extremely potent anti-HIV activity against NL4-3 (wild-type), NL4-3 (K101E), and RTMDR viral strains, with EC50 values of 0.086, 0.15, and 0.11 nM, resp.  Due to the high potency of II, it was also screened against an NIH Reagent Program NRTI-resistant virus panel contg. eleven mutated viral strains and for cytotoxicity against six different human cell lines.  The results of this screening indicated that II is a novel NRTI that could be developed as an anti-AIDS clin. trial candidate to overcome drug-resistance issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-NQktrJjnQLVg90H21EOLACvtfcHk0ljWSfvThfSRfg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2rtL%252FO&md5=72f2a93a502eb99225c843c88ede16db</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520new%25202%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluoro-4%25E2%2580%25B2-azido%2520nucleoside%2520analogues%2520as%2520potent%2520anti-HIV%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D4178%26epage%3D4183%26doi%3D10.1016%2Fj.ejmech.2011.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span> <span> </span><span class="NLM_article-title">Quantification of 2′-deoxy-2′-β-fluoro-4′-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2014.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.jpba.2014.06.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=24999865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OjtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2014&pages=379-386&author=Y.+Pengauthor=T.+Chengauthor=L.+Dongauthor=Y.+Zhangauthor=X.+Chenauthor=J.+Jiangauthor=J.+Zhangauthor=X.+Guoauthor=M.+Guoauthor=J.+Changauthor=Q.+Wang&title=Quantification+of+2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B2-fluoro-4%E2%80%B2-azidocytidine+in+rat+and+dog+plasma+using+liquid+chromatography-quadrupole+time-of-flight+and+liquid+chromatography-triple+quadrupole+mass+spectrometry%3A+Application+to+bioavailability+and+pharmacokinetic+studies&doi=10.1016%2Fj.jpba.2014.06.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of 2'-deoxy-2'-β-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies</span></div><div class="casAuthors">Peng, Youmei; Cheng, Tiefeng; Dong, Lihong; Zhang, Yuhai; Chen, Xiaojing; Jiang, Jinhua; Zhang, Jingmin; Guo, Xiaohe; Guo, Mintong; Chang, Junbiao; Wang, Qingduan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">379-386</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2'-Deoxy-2'-β-fluoro-4'-azidocytidine (FNC) is a novel pyrimidine analog that inhibits not only the replication of the hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV but also the replication of lamivudine-resistant HBV, 4'-azidocytidine or 2'-β-methylcytidine-resistant HCV, and nucleoside reverse-transcriptase inhibitor-resistant HIV variants.  The present study was undertaken to evaluate the abs. oral bioavailability of FNC in rats and the pharmacokinetic properties of FNC after intragastric administration of single and multiple doses in rats and dogs.  A sensitive high-performance liq. chromatog. tandem quadrupole time-of-flight mass spectrometry (HPLC/Q-TOF MS) method and a reliable high-performance liq. chromatog. tandem triple quadrupole mass spectrometry (HPLC/QqQ MS/MS) method were established for the detn. of FNC in the rat and dog plasmas, resp.  The sample prepn. involved a protein-pptn. method with methanol after the addn. of lamivudine as an internal std.  FNC was analyzed by LC using a YMC-Pack Pro C18 column (150 mm × 4.6 mm, 3 μm) with methanol (contg. 0.3% formic acid): 10 mM ammonium acetate (contg. 0.3% formic acid, pH 2.8) (35:65, vol./vol.) as the mobile phase.  Both mass spectrometers were equipped with an electrospray ionization interface in the pos.-ion mode.  The linear range was from 2.00 to 2000.00 ng mL-1 in rat plasma and 0.50 to 400.00 ng mL-1 in dog plasma.  The intraday and interday precision were less than 10.55%, and the accuracy was in the range of -5.86 to 5.13%.  The mean recoveries were greater than 82.70% and 82.97% for FNC and IS, resp.  The HPLC/Q-TOF MS and HPLC/QqQ MS/MS methods were both successfully applied in the pharmacokinetic studies of FNC in rats and dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4LIrQ22KTXLVg90H21EOLACvtfcHk0ljwh99RddAs6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OjtrbM&md5=0aa39c2b9dbf9610eadf5b067152596c</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2014.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2014.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DQuantification%2520of%25202%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B2-fluoro-4%25E2%2580%25B2-azidocytidine%2520in%2520rat%2520and%2520dog%2520plasma%2520using%2520liquid%2520chromatography-quadrupole%2520time-of-flight%2520and%2520liquid%2520chromatography-triple%2520quadrupole%2520mass%2520spectrometry%253A%2520Application%2520to%2520bioavailability%2520and%2520pharmacokinetic%2520studies%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2014%26volume%3D98%26spage%3D379%26epage%3D386%26doi%3D10.1016%2Fj.jpba.2014.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span> <span> </span><span class="NLM_article-title">Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e105617</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0105617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1371%2Fjournal.pone.0105617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=25144636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CisLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105617&author=R.+R.+Wangauthor=Q.+H.+Yangauthor=R.+H.+Luoauthor=Y.+M.+Pengauthor=S.+X.+Daiauthor=X.+J.+Zhangauthor=H.+Chenauthor=X.+Q.+Cuiauthor=Y.+J.+Liuauthor=J.+F.+Huangauthor=J.+B.+Changauthor=Y.+T.+Zheng&title=Azvudine%2C+a+novel+nucleoside+reverse+transcriptase+inhibitor+showed+good+drug+combination+features+and+better+inhibition+on+drug-resistant+strains+than+lamivudine+in+vitro&doi=10.1371%2Fjournal.pone.0105617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro</span></div><div class="casAuthors">Wang, Rui-Rui; Yang, Qing-Hua; Luo, Rong-Hua; Peng, You-Mei; Dai, Shao-Xing; Zhang, Xing-Jie; Chen, Huan; Cui, Xue-Qing; Liu, Ya-Juan; Huang, Jing-Fei; Chang, Jun-Biao; Zheng, Yong-Tang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e105617/1-e105617/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus.  Here we reported the in vitro activity of azvudine against HIV-1 and HIV-2 when used alone or in combination with other antiretroviral drugs and its drug resistance features.  Azvudine exerted highly potent inhibition on HIV-1 (EC50s ranging from 0.03 to 6.92 nM) and HIV-2 (EC50s ranging from 0.018 to 0.025 nM).  It also showed synergism in combination with six approved anti-HIV drugs on both C8166 and PBMC.  In combination assay, the concns. of azvudine used were 1000 or 500 fold lower than other drugs.  Azvudine also showed potent inhibition on NRTI-resistant strains (L74V and T69N).  Although M184V caused 250 fold redn. in susceptibility, azvudine remained active at nanomolar range.  In in vitro induced resistant assay, the frequency of M184I mutation increased with induction time which suggests M184I as the key mutation in azvudine treatment.  As control, lamivudine treatment resulted in a higher frequency of M184I/V given the same induction time and higher occurrence of M184V was found.  Mol. modeling anal. suggests that steric hindrance is more pronounced in mutant M184I than M184V due to the azido group of azvudine.  The present data demonstrates the potential of azvudine as a complementary drug to current anti-HIV drugs.  M184I should be the key mutation, however, azvudine still remains active on HIV-1LAI-M184V at nanomolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohMi_dHAZKtLVg90H21EOLACvtfcHk0ljwh99RddAs6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CisLzJ&md5=50ebf3198554ff4a35814f18d892cceb</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105617%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%2BR.%26aulast%3DYang%26aufirst%3DQ.%2BH.%26aulast%3DLuo%26aufirst%3DR.%2BH.%26aulast%3DPeng%26aufirst%3DY.%2BM.%26aulast%3DDai%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCui%26aufirst%3DX.%2BQ.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26aulast%3DHuang%26aufirst%3DJ.%2BF.%26aulast%3DChang%26aufirst%3DJ.%2BB.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26atitle%3DAzvudine%252C%2520a%2520novel%2520nucleoside%2520reverse%2520transcriptase%2520inhibitor%2520showed%2520good%2520drug%2520combination%2520features%2520and%2520better%2520inhibition%2520on%2520drug-resistant%2520strains%2520than%2520lamivudine%2520in%2520vitro%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105617%26doi%3D10.1371%2Fjournal.pone.0105617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wójtowicz-Rajchel, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and applications of fluorinated nucleoside analogues</span>. <i>J. Fluorine Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.jfluchem.2012.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.jfluchem.2012.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVyktrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2012&pages=11-48&author=H.+W%C3%B3jtowicz-Rajchel&title=Synthesis+and+applications+of+fluorinated+nucleoside+analogues&doi=10.1016%2Fj.jfluchem.2012.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and applications of fluorinated nucleoside analogues</span></div><div class="casAuthors">Wojtowicz-Rajchel, Hanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-48</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The review presents the synthesis of fluorinated highly modified nucleoside analogs-carbanucleosides, arom. nucleosides, acyclic nucleosides and related derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoszEDibYWln7Vg90H21EOLACvtfcHk0ljwh99RddAs6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVyktrjE&md5=df4a032247b009439fcc6b2cab92116b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2012.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2012.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B3jtowicz-Rajchel%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520fluorinated%2520nucleoside%2520analogues%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2012%26volume%3D143%26spage%3D11%26epage%3D48%26doi%3D10.1016%2Fj.jfluchem.2012.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-substituted fluoronucleoside analogs for the treatment of hepatitis B virus infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3693</span>– <span class="NLM_lpage">3703</span>, <span class="refDoi"> DOI: 10.1021/jm5012963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3693-3703&author=Q.+Yangauthor=J.+Kangauthor=L.+Zhengauthor=X.+J.+Wangauthor=N.+Wanauthor=J.+Wuauthor=Y.+Qiaoauthor=P.+Niuauthor=S.+Q.+Wangauthor=Y.+Pengauthor=Q.+Wangauthor=W.+Yuauthor=J.+Chang&title=Synthesis+and+biological+evaluation+of+4-substituted+fluoronucleoside+analogs+for+the+treatment+of+hepatitis+B+virus+infection&doi=10.1021%2Fjm5012963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of 4-Substituted Fluoronucleoside Analogs for the Treatment of Hepatitis B Virus Infection</span></div><div class="casAuthors">Yang, Qinghua; Kang, Jinfeng; Zheng, Liyun; Wang, Xue-Jun; Wan, Na; Wu, Jie; Qiao, Yan; Niu, Pengfei; Wang, Sheng-Qi; Peng, Youmei; Wang, Qingduan; Yu, Wenquan; Chang, Junbiao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3693-3703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 4-substituted fluoronucleosides have been synthesized in order to address the toxicity issue of the parent nucleoside I (R = H), and after in vitro evaluation, the cyclopropylamino analog 1f was selected for in vivo study.  In mice, this compd. exhibited a significantly improved toxicity profile.  Administered orally, nucleoside I (R = cyclopropyl) was well-tolerated at a dose up to 3 g/kg and showed insignificant toxicity on white blood cells and a low mutagenic effect at dosages up to 80 mg/kg (single) or 20 mg/kg/day (5 days).  In duck HBV (DHBV)-infected duck models, both the serum and liver DHBV DNA levels (74.2 and 82.1%, resp.) were markedly reduced by the treatment of I (R = cyclopropyl) at a dose of 1 mg/kg/day for 10 days.  In addn., both the viral DNA levels had a lower degree of recovery after withdrawal of the test compd. for 3 days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpLHHBv3qosbVg90H21EOLACvtfcHk0lgidjNKXRVqCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWns7k%253D&md5=af8c2d92f70e50105518ce2b88c05ceb</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm5012963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012963%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DWan%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-substituted%2520fluoronucleoside%2520analogs%2520for%2520the%2520treatment%2520of%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3693%26epage%3D3703%26doi%3D10.1021%2Fjm5012963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehy, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaddis, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malim, M. H.</span></span> <span> </span><span class="NLM_article-title">Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>418</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">650</span>, <span class="refDoi"> DOI: 10.1038/nature00939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnature00939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=12167863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVyltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2002&pages=646-650&author=A.+M.+Sheehyauthor=N.+C.+Gaddisauthor=J.+D.+Choiauthor=M.+H.+Malim&title=Isolation+of+a+human+gene+that+inhibits+HIV-1+infection+and+is+suppressed+by+the+viral+Vif+protein&doi=10.1038%2Fnature00939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein</span></div><div class="casAuthors">Sheehy, Ann M.; Gaddis, Nathan C.; Choi, Jonathan D.; Malim, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">418</span>
        (<span class="NLM_cas:issue">6898</span>),
    <span class="NLM_cas:pages">646-650</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Viruses have developed diverse non-immune strategies to counteract host-mediated mechanisms that confer resistance to infection.  The Vif (virion infectivity factor) proteins are encoded by primate immunodeficiency viruses, most notably human immunodeficiency virus-1 (HIV-1).  These proteins are potent regulators of virus infection and replication and are consequently essential for pathogenic infections in vivo.  HIV-1 Vif seems to be required during the late stages of virus prodn. for the suppression of an innate antiviral phenotype that resides in human T lymphocytes.  Thus, in the absence of Vif, expression of this phenotype renders progeny virions non-infectious.  Here, the authors describe a unique cellular gene, CEM15, whose transient or stable expression in cells that do not normally express CEM15 recreates this phenotype, but whose antiviral action is overcome by the presence of Vif.  Because the Vif:CEM15 regulatory circuit is crit. for HIV-1 replication, perturbing the circuit may be a promising target for future HIV/AIDS therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXIBE3wFqXQLVg90H21EOLACvtfcHk0lgidjNKXRVqCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVyltLs%253D&md5=a4793b246832bce94dbf88f2604cc6b5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnature00939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature00939%26sid%3Dliteratum%253Aachs%26aulast%3DSheehy%26aufirst%3DA.%2BM.%26aulast%3DGaddis%26aufirst%3DN.%2BC.%26aulast%3DChoi%26aufirst%3DJ.%2BD.%26aulast%3DMalim%26aufirst%3DM.%2BH.%26atitle%3DIsolation%2520of%2520a%2520human%2520gene%2520that%2520inhibits%2520HIV-1%2520infection%2520and%2520is%2520suppressed%2520by%2520the%2520viral%2520Vif%2520protein%26jtitle%3DNature%26date%3D2002%26volume%3D418%26spage%3D646%26epage%3D650%26doi%3D10.1038%2Fnature00939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippa, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belashov, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedekind, J. E.</span></span> <span> </span><span class="NLM_article-title">Core-binding factor β increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">8702</span>– <span class="NLM_lpage">8704</span>, <span class="refDoi"> DOI: 10.1021/bi301244z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi301244z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKmtb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8702-8704&author=J.+D.+Salterauthor=G.+M.+Lippaauthor=I.+A.+Belashovauthor=J.+E.+Wedekind&title=Core-binding+factor+%CE%B2+increases+the+affinity+between+human+Cullin+5+and+HIV-1+Vif+within+an+E3+ligase+complex&doi=10.1021%2Fbi301244z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Core-Binding Factor β Increases the Affinity between Human Cullin 5 and HIV-1 Vif within an E3 Ligase Complex</span></div><div class="casAuthors">Salter, Jason D.; Lippa, Geoffrey M.; Belashov, Ivan A.; Wedekind, Joseph E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">8702-8704</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIV-1 Vif masquerades as a receptor for a cellular E3 ligase harboring Elongin B, Elongin C, and Cullin 5 (EloB/C/Cul5) proteins that facilitate degrdn. of the antiretroviral factor APOBEC3G (A3G).  This Vif-mediated activity requires human core-binding factor β (CBFβ) in contrast to cellular substrate receptors.  We obsd. calorimetrically that Cul5 binds tighter to full-length Vif(1-192)/EloB/C/CBFβ (Kd = 5±2 nM) than to Vif(95-192)/EloB/C (Kd = 327±40 nM), which cannot bind CBFβ.  A comparison of heat capacity changes supports a model in which CBFβ prestabilizes Vif(1-192) relative to Vif(95-192), consistent with a stronger interaction of Cul5 with Vif's C-terminal Zn2+-binding motif.  An addnl. interface between Cul5 and an N-terminal region of Vif appears to be plausible, which has therapeutic design implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokY2KFD9TX6bVg90H21EOLACvtfcHk0lgidjNKXRVqCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKmtb3P&md5=c2f5a3ef5472271f24b3c84390954735</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fbi301244z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi301244z%26sid%3Dliteratum%253Aachs%26aulast%3DSalter%26aufirst%3DJ.%2BD.%26aulast%3DLippa%26aufirst%3DG.%2BM.%26aulast%3DBelashov%26aufirst%3DI.%2BA.%26aulast%3DWedekind%26aufirst%3DJ.%2BE.%26atitle%3DCore-binding%2520factor%2520%25CE%25B2%2520increases%2520the%2520affinity%2520between%2520human%2520Cullin%25205%2520and%2520HIV-1%2520Vif%2520within%2520an%2520E3%2520ligase%2520complex%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D8702%26epage%3D8704%26doi%3D10.1021%2Fbi301244z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>505</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/nature12884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnature12884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=24402281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltVOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=229-233&author=Y.+Guoauthor=L.+Dongauthor=X.+Qiuauthor=Y.+Wangauthor=B.+Zhangauthor=H.+Liuauthor=Y.+Yuauthor=Y.+Zangauthor=M.+Yangauthor=Z.+Huang&title=Structural+basis+for+hijacking+CBF-%CE%B2+and+CUL5+E3+ligase+complex+by+HIV-1+Vif&doi=10.1038%2Fnature12884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif</span></div><div class="casAuthors">Guo, Yingying; Dong, Liyong; Qiu, Xiaolin; Wang, Yishu; Zhang, Bailing; Liu, Hongnan; Yu, You; Zang, Yi; Yang, Maojun; Huang, Zhiwei</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7482</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human immunodeficiency virus (HIV)-1 protein Vif has a central role in the neutralization of host innate defences by hijacking cellular proteasomal degrdn. pathways to subvert the antiviral activity of host restriction factors; however, the underlying mechanism by which Vif achieves this remains unclear.  Here we report a crystal structure of the Vif-CBF-β-CUL5-ELOB-ELOC complex.  The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-β, CUL5 and ELOC.  The larger domain (α/β domain) of Vif binds to the same side of CBF-β as RUNX1, indicating that Vif and RUNX1 are exclusive for CBF-β binding.  Interactions of the smaller domain (α-domain) of Vif with ELOC and CUL5 are cooperative and mimic those of SOCS2 with the latter two proteins.  A unique zinc-finger motif of Vif, which is located between the two Vif domains, makes no contacts with the other proteins but stabilizes the conformation of the α-domain, which may be important for Vif-CUL5 interaction.  Together, our data reveal the structural basis for Vif hijacking of the CBF-β and CUL5 E3 ligase complex, laying a foundation for rational design of novel anti-HIV drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE0_bPXlE0z7Vg90H21EOLACvtfcHk0lhyUscAd4r15w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltVOjuw%253D%253D&md5=2022c24fcc896db3e4bd280688af10a5</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1038%2Fnature12884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12884%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DStructural%2520basis%2520for%2520hijacking%2520CBF-%25CE%25B2%2520and%2520CUL5%2520E3%2520ligase%2520complex%2520by%2520HIV-1%2520Vif%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D229%26epage%3D233%26doi%3D10.1038%2Fnature12884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomerantz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span> <span> </span><span class="NLM_article-title">The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1038/nature01707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnature01707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=12808465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVelsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2003&pages=94-98&author=H.+Zhangauthor=B.+Yangauthor=R.+J.+Pomerantzauthor=C.+Zhangauthor=S.+C.+Arunachalamauthor=L.+Gao&title=The+cytidine+deaminase+CEM15+induces+hypermutation+in+newly+synthesized+HIV-1+DNA&doi=10.1038%2Fnature01707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA</span></div><div class="casAuthors">Zhang, Hui; Yang, Bin; Pomerantz, Roger J.; Zhang, Chune; Arunachalam, Shyamala C.; Gao, Ling</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">424</span>
        (<span class="NLM_cas:issue">6944</span>),
    <span class="NLM_cas:pages">94-98</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">High mutation frequency during reverse transcription has a principal role in the genetic variation of primate lentiviral populations.  It is the main driving force for the generation of drug resistance and the escape from immune surveillance.  G to A hypermutation is one of the characteristics of primate lentiviruses, as well as other retroviruses, during replication in vivo and in cell culture.  The mol. mechanisms of this process, however, remain to be clarified.  Here, we demonstrate that CEM15 (also known as apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G; APOBEC3G), an endogenous inhibitor of human immunodeficiency virus type 1 (HIV-1) replication, is a cytidine deaminase and is able to induce G to A hypermutation in newly synthesized viral DNA.  This effect can be counteracted by the HIV-1 virion infectivity factor (Vif).  It seems that this viral DNA mutator is a viral defense mechanism in host cells that may induce either lethal hypermutation or instability of the incoming nascent viral reverse transcripts, which could account for the Vif-defective phenotype.  Importantly, the accumulation of CEM15-mediated non-lethal hypermutation in the replicating viral genome could potently contribute to the genetic variation of primate lentiviral populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG9B1FKCT5prVg90H21EOLACvtfcHk0lhyUscAd4r15w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVelsL4%253D&md5=0e21f73e84dcf215f0a4efc2e7292a63</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1038%2Fnature01707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01707%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DPomerantz%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DArunachalam%26aufirst%3DS.%2BC.%26aulast%3DGao%26aufirst%3DL.%26atitle%3DThe%2520cytidine%2520deaminase%2520CEM15%2520induces%2520hypermutation%2520in%2520newly%2520synthesized%2520HIV-1%2520DNA%26jtitle%3DNature%26date%3D2003%26volume%3D424%26spage%3D94%26epage%3D98%26doi%3D10.1038%2Fnature01707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.-F.</span></span> <span> </span><span class="NLM_article-title">Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2867</span>– <span class="NLM_lpage">2872</span>, <span class="refDoi"> DOI: 10.1101/gad.1250204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1101%2Fgad.1250204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=15574593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFShu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=2867-2872&author=Y.+Yuauthor=Z.+Xiaoauthor=E.+S.+Ehrlichauthor=X.+Yuauthor=X.-F.+Yu&title=Selective+assembly+of+HIV-1+Vif-Cul5-ElonginB-ElonginC+E3+ubiquitin+ligase+complex+through+a+novel+SOCS+box+and+upstream+cysteines&doi=10.1101%2Fgad.1250204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective assembly of HIV-1 Vif-Cul5-elonginB-elonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines</span></div><div class="casAuthors">Yu, Yunkai; Xiao, Zuoxiang; Ehrlich, Elana S.; Yu, Xianghui; Yu, Xiao-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2867-2872</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">APOBEC3G, which induces hypermutations in newly synthesized viral DNA, is suppressed by HIV-1 Vif, acting through Cul5-ElonginB-ElonginC E3 ubiquitin ligase.  We have now characterized a novel SOCS box in HIV-1 Vif that mediates its interaction with ElonginC.  In this SOCS box, alanine replaces the consensus cysteine in the previously identified SOCS box.  This new motif was necessary but insufficient for interaction with Cul5-ElonginB-ElonginC, as two highly conserved Cys residues outside the SOCS box were required to interact with Cul5 but not ElonginC.  Therefore, selective assembly with Cul5 vs. Cul2 E3 may require protein interfaces besides the SOCS-box-ElonginC interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Mszl5z9PqLVg90H21EOLACvtfcHk0lhyUscAd4r15w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFShu7nM&md5=a87ebea2600296a10eca42bcd0940e19</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1101%2Fgad.1250204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1250204%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DEhrlich%26aufirst%3DE.%2BS.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DX.-F.%26atitle%3DSelective%2520assembly%2520of%2520HIV-1%2520Vif-Cul5-ElonginB-ElonginC%2520E3%2520ubiquitin%2520ligase%2520complex%2520through%2520a%2520novel%2520SOCS%2520box%2520and%2520upstream%2520cysteines%26jtitle%3DGenes%2520Dev.%26date%3D2004%26volume%3D18%26spage%3D2867%26epage%3D2872%26doi%3D10.1101%2Fgad.1250204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.-F.</span></span> <span> </span><span class="NLM_article-title">Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">1056</span>– <span class="NLM_lpage">1060</span>, <span class="refDoi"> DOI: 10.1126/science.1089591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1126%2Fscience.1089591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=14564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1056-1060&author=X.+Yuauthor=Y.+Yuauthor=B.+Liuauthor=K.+Luoauthor=W.+Kongauthor=P.+Maoauthor=X.-F.+Yu&title=Induction+of+APOBEC3G+ubiquitination+and+degradation+by+an+HIV-1+Vif-Cul5-SCF+complex&doi=10.1126%2Fscience.1089591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6f</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex</span></div><div class="casAuthors">Yu, Xianghui; Yu, Yunkai; Liu, Bindong; Luo, Kun; Kong, Wei; Mao, Panyong; Yu, Xiao-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5647</span>),
    <span class="NLM_cas:pages">1056-1060</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Human immunodeficiency virus-1 (HIV-1) Vif is essential for viral evasion of host antiviral factor CEM15/APOBEC3G.  We report that Vif interacts with cellular proteins Cul5, elongins B and C, and Rbx1 to form an Skp1-cullin-F-box (SCF)-like complex.  The ability of Vif to suppress antiviral activity of APOBEC3G was specifically dependent on Cul5-SCF function, allowing Vif to interact with APOBEC3G and induce its ubiquitination and degrdn.  A Vif mutant that interacted with APOBEC3G but not with Cul5-SCF was functionally inactive.  The Cul5-SCF was also required for Vif function in distantly related simian immunodeficiency virus mac.  These results indicate that the conserved Cul5-SCF pathway used by Vif is a potential target for antiviral development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGf6QtjED_krVg90H21EOLACvtfcHk0lgZBIm7Yr1ANw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmsbo%253D&md5=0cb1c6691663653b228151fa32006ffa</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1126%2Fscience.1089591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1089591%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLuo%26aufirst%3DK.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DMao%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DX.-F.%26atitle%3DInduction%2520of%2520APOBEC3G%2520ubiquitination%2520and%2520degradation%2520by%2520an%2520HIV-1%2520Vif-Cul5-SCF%2520complex%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D1056%26epage%3D1060%26doi%3D10.1126%2Fscience.1089591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mangeat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trono, D.</span></span> <span> </span><span class="NLM_article-title">Broad antiretroviral defence by human apobec3g through lethal editing of nascent reverse transcripts</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1038/nature01709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnature01709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=12808466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVelsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2003&pages=99-103&author=B.+Mangeatauthor=P.+Turelliauthor=G.+Caronauthor=M.+Friedliauthor=L.+Perrinauthor=D.+Trono&title=Broad+antiretroviral+defence+by+human+apobec3g+through+lethal+editing+of+nascent+reverse+transcripts&doi=10.1038%2Fnature01709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6g</span><div class="casTitle"><span class="NLM_cas:atitle">Broad antiretroviral defense by human APOBEC3G through lethal editing of nascent reverse transcripts</span></div><div class="casAuthors">Mangeat, Bastien; Turelli, Priscilla; Caron, Gersende; Friedli, Marc; Perrin, Luc; Trono, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">424</span>
        (<span class="NLM_cas:issue">6944</span>),
    <span class="NLM_cas:pages">99-103</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Viral replication usually requires that innate intracellular lines of defense be overcome, a task usually accomplished by specialized viral gene products.  The virion infectivity factor (Vif) protein of human immunodeficiency virus (HIV) is required during the late stages of viral prodn. to counter the antiviral activity of APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G; also known as CEM15), a protein expressed notably in human T lymphocytes.  When produced in the presence of APOBEC3G, vif-defective virus is non-infectious.  APOBEC3G is closely related to APOBEC1, the central component of an RNA-editing complex that deaminates a cytosine residue in apoB mRNA.  APOBEC family members also have potent DNA mutator activity through dC deamination; however, whether the editing potential of APOBEC3G has any relevance to HIV inhibition is unknown.  Here, we demonstrate that it does, as APOBEC3G exerts its antiviral effect during reverse transcription to trigger G-to-A hypermutation in the nascent retroviral DNA.  We also find that APOBEC3G can act on a broad range of retroviruses in addn. to HIV, suggesting that hypermutation by editing is a general innate defense mechanism against this important group of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvBB6bv6N02rVg90H21EOLACvtfcHk0lgZBIm7Yr1ANw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVelsL8%253D&md5=357bb5bf3bf2b94d9054323e91a9856e</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1038%2Fnature01709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01709%26sid%3Dliteratum%253Aachs%26aulast%3DMangeat%26aufirst%3DB.%26aulast%3DTurelli%26aufirst%3DP.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DFriedli%26aufirst%3DM.%26aulast%3DPerrin%26aufirst%3DL.%26aulast%3DTrono%26aufirst%3DD.%26atitle%3DBroad%2520antiretroviral%2520defence%2520by%2520human%2520apobec3g%2520through%2520lethal%2520editing%2520of%2520nascent%2520reverse%2520transcripts%26jtitle%3DNature%26date%3D2003%26volume%3D424%26spage%3D99%26epage%3D103%26doi%3D10.1038%2Fnature01709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelico, L.</span></span> <span> </span><span class="NLM_article-title">Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e1004024</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1004024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1371%2Fjournal.ppat.1004024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=24651717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVWmsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&author=A.+Araauthor=R.+P.+Loveauthor=L.+Chelico&title=Different+mutagenic+potential+of+HIV-1+restriction+factors+APOBEC3G+and+APOBEC3F+is+determined+by+distinct+single-stranded+DNA+scanning+mechanisms&doi=10.1371%2Fjournal.ppat.1004024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms</span></div><div class="casAuthors">Ara, Anjuman; Love, Robin P.; Chelico, Linda</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1004024/1-e1004024/21, 21 pp.</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The APOBEC3 deoxycytidine deaminase family functions as host restriction factors that can block replication of Vif (virus infectivity factor) deficient HIV-1 virions to differing degrees by deaminating cytosines to uracils in single-stranded (-)HIV-1 DNA.  Upon replication of the (-)DNA to (+)DNA, the HIV-1 reverse transcriptase incorporates adenines opposite the uracils, thereby inducing C/G→T/A mutations that can functionally inactivate HIV-1.  Although both APOBEC3F and APOBEC3G are expressed in cell types HIV-1 infects and are suppressed by Vif, there has been no prior biochem. anal. of APOBEC3F, in contrast to APOBEC3G.  Using synthetic DNA substrates, we characterized APOBEC3F and found that similar to APOBEC3G; it is a processive enzyme and can deaminate at least two cytosines in a single enzyme-substrate encounter.  However, APOBEC3F scanning movement is distinct from APOBEC3G, and relies on jumping rather than both jumping and sliding.  APOBEC3F jumping movements were also different from APOBEC3G.  The lack of sliding movement from APOBEC3F is due to an 190NPM192 motif, since insertion of this motif into APOBEC3G decreases its sliding movements.  The APOBEC3G NPM mutant induced significantly less mutations in comparison to wild-type APOBEC3G in an in vitro model HIV-1 replication assay and single-cycle infectivity assay, indicating that differences in DNA scanning were relevant to restriction of HIV-1.  Conversely, mutation of the APOBEC3F 191Pro to 191Gly enables APOBEC3F sliding movements to occur.  Although APOBEC3F 190NGM192 could slide, the enzyme did not induce more mutagenesis than wild-type APOBEC3F, demonstrating that the unique jumping mechanism of APOBEC3F abrogates the influence of sliding on mutagenesis.  Overall, we demonstrate key differences in the impact of APOBEC3F- and APOBEC3G-induced mutagenesis on HIV-1 that supports a model in which both the processive DNA scanning mechanism and preferred deamination motif (APOBEC3F, 5'TTC; APOBEC3G 5'CCC) influences the mutagenic and gene inactivation potential of an APOBEC3 enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGribF9Fh6pYjLVg90H21EOLACvtfcHk0lgZBIm7Yr1ANw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVWmsrrF&md5=80c1b9c2985417973a5d57de76501f48</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004024%26sid%3Dliteratum%253Aachs%26aulast%3DAra%26aufirst%3DA.%26aulast%3DLove%26aufirst%3DR.%2BP.%26aulast%3DChelico%26aufirst%3DL.%26atitle%3DDifferent%2520mutagenic%2520potential%2520of%2520HIV-1%2520restriction%2520factors%2520APOBEC3G%2520and%2520APOBEC3F%2520is%2520determined%2520by%2520distinct%2520single-stranded%2520DNA%2520scanning%2520mechanisms%26jtitle%3DPLoS%2520Pathog.%26date%3D2014%26volume%3D10%26doi%3D10.1371%2Fjournal.ppat.1004024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bélanger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, M. A.</span></span> <span> </span><span class="NLM_article-title">Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2878</span>– <span class="NLM_lpage">2887</span>, <span class="refDoi"> DOI: 10.1099/vir.0.000214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1099%2Fvir.0.000214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=26048885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XislCkur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=2878-2887&author=K.+B%C3%A9langerauthor=M.+A.+Langlois&title=Comparative+analysis+of+the+gene-inactivating+potential+of+retroviral+restriction+factors+APOBEC3F+and+APOBEC3G&doi=10.1099%2Fvir.0.000214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G</span></div><div class="casAuthors">Belanger, Kasandra; Langlois, Marc-Andre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2878-2887</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">APOBEC3 (A3) proteins are host-encoded restriction factors that inhibit retrovirus infection by mutagenic deamination of cytosines in minus-strand DNA replication intermediates.  APOBEC3F (A3F) and APOBEC3G (A3G) are two of the most potent A3 enzymes in humans with each having a different target DNA specificity.  A3G prefers to deaminate cytosines preceded by a cytosine (5'-CC), whereas A3F preferentially targets cytosines preceded by a thymine (5'-TC).  Here we performed a detailed comparative anal. of retrovirus-encoded gene sequences edited by A3F and A3G, with the aim of correlating the context and intensity of the mutations with their effects on gene function.  Our results revealed that, when there are few (TGG) tryptophan codons in the sequence, both enzymes alter gene function with a similar efficiency when given equal opportunities to deaminate in their preferred target DNA context.  In contrast, tryptophan-rich genes are efficiently inactivated in the presence of a low mutational burden, through termination codon generation by A3G but not A3F.  Overall, our results clearly demonstrated that the target DNA specificity of an A3 enzyme along with the intensity of the mutational burden and the tryptophan content of the gene being targeted are the factors that have the most forceful influence on whether A3-induced mutations will favor either terminal inactivation or genetic diversification of a retrovirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobOrYNLw3KWLVg90H21EOLACvtfcHk0lgZBIm7Yr1ANw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislCkur4%253D&md5=73821f92c456482e45b49f667dc3b63d</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.000214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.000214%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9langer%26aufirst%3DK.%26aulast%3DLanglois%26aufirst%3DM.%2BA.%26atitle%3DComparative%2520analysis%2520of%2520the%2520gene-inactivating%2520potential%2520of%2520retroviral%2520restriction%2520factors%2520APOBEC3F%2520and%2520APOBEC3G%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2015%26volume%3D96%26spage%3D2878%26epage%3D2887%26doi%3D10.1099%2Fvir.0.000214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follack, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolph, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelico, L.</span></span> <span> </span><span class="NLM_article-title">Mechanism of enhanced HIV restriction by virion coencapsidated cytidine deaminases APOBEC3F and APOBEC3G</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">e02230</span>– <span class="NLM_lpage">e02216</span>, <span class="refDoi"> DOI: 10.1128/jvi.02230-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1128%2FJVI.02230-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=27881650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptFGqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&pages=e02230-e02216&author=A.+Araauthor=R.+P.+Loveauthor=T.+B.+Follackauthor=K.+A.+Ahmedauthor=M.+B.+Adolphauthor=L.+Chelico&title=Mechanism+of+enhanced+HIV+restriction+by+virion+coencapsidated+cytidine+deaminases+APOBEC3F+and+APOBEC3G&doi=10.1128%2Fjvi.02230-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of enhanced HIV restriction by virion coencapsidated cytidine deaminases APOBEC3F and APOBEC3G</span></div><div class="casAuthors">Ara, Anjuman; Love, Robin P.; Follack, Tyson B.; Ahmed, Khawaja A.; Adolph, Madison B.; Chelico, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e02230-16/1-e02230-16/19</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The APOBEC3 (A3) enzymes, A3G and A3F, are coordinately expressed in CD4+ T cells and can become coencapsidated into HIV-1 virions, primarily in the absence of the viral infectivity factor (Vif).  A3F and A3G are deoxycytidine deaminases that inhibit HIV-1 replication by inducing guanine-to-adenine hypermutation through deamination of cytosine to form uracil in minus-strand DNA.  The effect of the simultaneous presence of both A3G and A3F on HIV-1 restriction ability is not clear.  Here, we used a single-cycle infectivity assay and biochem. analyses to det. if coencapsidated A3G and A3F differ in their restriction capacity from A3G or A3F alone.  Proviral DNA sequencing demonstrated that compared to each A3 enzyme alone, A3G and A3F, when combined, had a coordinate effect on hypermutation.  Using size exclusion chromatog., rotational anisotropy, and in vitro deamination assays, we demonstrate that A3F promotes A3G deamination activity by forming an A3F/G hetero-oligomer in the absence of RNA which is more efficient at deaminating cytosines.  Further, A3F caused the accumulation of shorter reverse transcripts due to decreasing reverse transcriptase efficiency, which would leave single-stranded minus-strand DNA exposed for longer periods of time, enabling more deamination events to occur.  Although A3G and A3F are known to function alongside each other, these data provide evidence for an A3F/G hetero-oligomeric A3 with unique properties compared to each individual counterpart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm96mEFTqOwLVg90H21EOLACvtfcHk0lj2fbRE3bt_5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptFGqtbY%253D&md5=af6a4f0108d6037c0597bcea9e397aee</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1128%2FJVI.02230-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02230-16%26sid%3Dliteratum%253Aachs%26aulast%3DAra%26aufirst%3DA.%26aulast%3DLove%26aufirst%3DR.%2BP.%26aulast%3DFollack%26aufirst%3DT.%2BB.%26aulast%3DAhmed%26aufirst%3DK.%2BA.%26aulast%3DAdolph%26aufirst%3DM.%2BB.%26aulast%3DChelico%26aufirst%3DL.%26atitle%3DMechanism%2520of%2520enhanced%2520HIV%2520restriction%2520by%2520virion%2520coencapsidated%2520cytidine%2520deaminases%2520APOBEC3F%2520and%2520APOBEC3G%26jtitle%3DJ.%2520Virol.%26date%3D2017%26volume%3D91%26spage%3De02230%26epage%3De02216%26doi%3D10.1128%2Fjvi.02230-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zennou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieniasz, P. D.</span></span> <span> </span><span class="NLM_article-title">Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2005.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.virol.2005.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=16460778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Onu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2006&pages=31-40&author=V.+Zennouauthor=P.+D.+Bieniasz&title=Comparative+analysis+of+the+antiretroviral+activity+of+APOBEC3G+and+APOBEC3F+from+primates&doi=10.1016%2Fj.virol.2005.12.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates</span></div><div class="casAuthors">Zennou, Veronique; Bieniasz, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">APOBEC3G and APOBEC3F exhibit antiretroviral activity primarily as a consequence of their ability to deaminate cytidines in retroviral DNA.  Here, the authors compare the properties of APOBEC3F and APOBEC3G from human, macaque, and African green monkey (AGM).  While all APOBEC proteins tested exhibited anti-HIV-1 activity, human APOBEC3F was, surprisingly, 10- to 50-fold less potent than human APOBEC3G.  However, similar discrepancies in antiviral potency were not found when pairs of proteins from macaque and AGM were compared.  Intrinsic differences in the ability of each APOBEC protein to induce hypermutation, rather than differences in packaging efficiency, partially accounted for variable antiretroviral activity.  Each of four primate lentivirus Vif proteins reduced human and AGM APOBEC3F expression and antiviral activity, but all were only partially effective and species-specific effects were relatively minor.  Overall, highly efficient and species-specific neutralization of APOBEC3G, and less efficient neutralization of APOBEC3F, appears to be a general property of Vif proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC7k4S0qIV9rVg90H21EOLACvtfcHk0lj2fbRE3bt_5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Onu78%253D&md5=403096fd2264f644cac4f456513b577f</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2005.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2005.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DZennou%26aufirst%3DV.%26aulast%3DBieniasz%26aufirst%3DP.%2BD.%26atitle%3DComparative%2520analysis%2520of%2520the%2520antiretroviral%2520activity%2520of%2520APOBEC3G%2520and%2520APOBEC3F%2520from%2520primates%26jtitle%3DVirology%26date%3D2006%26volume%3D349%26spage%3D31%26epage%3D40%26doi%3D10.1016%2Fj.virol.2005.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chaipan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, V. K.</span></span> <span> </span><span class="NLM_article-title">APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1128/JVI.00676-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1128%2FJVI.00676-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=23097438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2jsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=444-453&author=C.+Chaipanauthor=J.+L.+Smithauthor=W.+S.+Huauthor=V.+K.+Pathak&title=APOBEC3G+restricts+HIV-1+to+a+greater+extent+than+APOBEC3F+and+APOBEC3DE+in+human+primary+CD4%2B+T+cells+and+macrophages&doi=10.1128%2FJVI.00676-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages</span></div><div class="casAuthors">Chaipan, Chawaree; Smith, Jessica L.; Hu, Wei-Shau; Pathak, Vinay K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">444-453</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">APOBEC3 proteins inhibit HIV-1 replication in exptl. systems and induce hypermutation in infected patients; however, the relative contributions of several APOBEC3 proteins to restriction of HIV-1 replication in the absence of the viral Vif protein in human primary CD4+ T cells and macrophages are unknown.  We obsd. significant inhibition of HIV-1Δvif produced in 293T cells in the presence of APOBEC3DE (A3DE), APOBEC3F (A3F), APOBEC3G (A3G), and APOBEC3H haplotype II (A3H HapII) but not APOBEC3B (A3B), APOBEC3C (A3C), or APOBEC3H haplotype I (A3H HapI).  Our previous studies showed that Vif amino acids Y40RHHY44 are important for inducing proteasomal degrdn. of A3G, whereas amino acids 14DRMR17 are important for degrdn. of A3F and A3DE.  Here, we introduced substitution mutations of 40YRHHY44 and 14DRMR17 in replication-competent HIV-1 to generate vif mutants NL4-3 YRHHY>A5 and NL4-3 DRMR>A4 to compare the antiviral activity of A3G to the combined antiviral activity of A3F and A3DE in activated CD4+ T cells and macrophages.  During the first 15 days (round 1), in which multiple cycles of viral replication occurred, both the NL4-3 YRHHY>A5 and NL4-3 DRMR>A4 mutants replicated in activated CD4+ T cells and macrophages, and only the NL4-3 YRHHY>A5 mutant showed a 2- to 4-day delay in replication compared to the wild type.  During the subsequent 27 days (round 2) of cultures initiated with peak virus obtained from round 1, the NL4-3 YRHHY>A5 mutant exhibited a longer, 8- to 10-day delay and the NL4-3 DRMR>A4 mutant exhibited a 2- to 6-day delay in replication compared to the wild type.  The NL4-3 YRHHY>A5 and NL4-3 DRMR>A4 mutant proviruses displayed G-to-A hypermutations primarily in GG and GA dinucleotides as expected of A3G- and A3F- or A3DE-mediated deamination, resp.  We conclude that A3G exerts a greater restriction effect on HIV-1 than A3F and A3DE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOpC2WNMKisLVg90H21EOLACvtfcHk0lj2fbRE3bt_5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2jsb4%253D&md5=f08c6c8fd28710b680985881f9951565</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1128%2FJVI.00676-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00676-12%26sid%3Dliteratum%253Aachs%26aulast%3DChaipan%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DHu%26aufirst%3DW.%2BS.%26aulast%3DPathak%26aufirst%3DV.%2BK.%26atitle%3DAPOBEC3G%2520restricts%2520HIV-1%2520to%2520a%2520greater%2520extent%2520than%2520APOBEC3F%2520and%2520APOBEC3DE%2520in%2520human%2520primary%2520CD4%252B%2520T%2520cells%2520and%2520macrophages%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26spage%3D444%26epage%3D453%26doi%3D10.1128%2FJVI.00676-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaori-Kondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyanagi, Y.</span></span> <span> </span><span class="NLM_article-title">APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e1004453</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1004453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1371%2Fjournal.ppat.1004453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=25330146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyisbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&author=K.+Satoauthor=J.+S.+Takeuchiauthor=N.+Misawaauthor=T.+Izumiauthor=T.+Kobayashiauthor=Y.+Kimuraauthor=S.+Iwamiauthor=A.+Takaori-Kondoauthor=W.+S.+Huauthor=K.+Aiharaauthor=M.+Itoauthor=D.+S.+Anauthor=V.+K.+Pathakauthor=Y.+Koyanagi&title=APOBEC3D+and+APOBEC3F+potently+promote+HIV-1+diversification+and+evolution+in+humanized+mouse+model&doi=10.1371%2Fjournal.ppat.1004453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model</span></div><div class="casAuthors">Sato, Kei; Takeuchi, Junko S.; Misawa, Naoko; Izumi, Taisuke; Kobayashi, Tomoko; Kimura, Yuichi; Iwami, Shingo; Takaori-Kondo, Akifumi; Hu, Wei-shau; Aihara, Kazuyuki; Ito, Mamoru; An, Dong Sung; Pathak, Vinay K.; Koyanagi, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1004453/1-e1004453/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Several APOBEC3 proteins, particularly APOBEC3D, APOBEC3F and APOBEC3G, induce G-to-A hypermutations in HIV-1 genome and abrogate viral replication in exptl. systems, but their relative contributions to controlling viral replication and viral genetic variation in vivo have not been elucidated.  On the other hand, an HIV-1-encoded protein, Vif, can degrade these APOBEC3 proteins via a ubiquitin/proteasome pathway.  Although APOBEC3 proteins have been widely considered as potent restriction factors against HIV-1, it remains unclear which endogenous APOBEC3 protein(s) affect HIV-1 propagation in vivo.  Here we use a humanized mouse model and HIV-1 with mutations in Vif motifs that are responsible for specific APOBEC3 interactions, DRMR/AAAA (4A) or YRHHY/AAAAA (5A) and demonstrate that endogenous APOBEC3D/F and APOBEC3G exert strong anti-HIV-1 activity in vivo.  We also show that the growth kinetics of 4A HIV-1 neg. correlated with the expression level of APOBEC3F.  Moreover, single genome sequencing analyses of viral RNA in plasma of infected mice reveal that 4A HIV-1 is specifically and significantly diversified.  Furthermore, a mutated virus that is capable of using both CCR5 and CXCR4 as entry coreceptor is specifically detected in 4A HIV-1-infected mice.  Taken together, our results demonstrate that APOBEC3D/F and APOBEC3G fundamentally work as restriction factors against HIV-1 in vivo, but at the same time, that APOBEC3D and APOBEC3F are capable of promoting viral diversification and evolution in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1aUjxdqezorVg90H21EOLACvtfcHk0li-Od3U7e8TdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyisbjF&md5=715df81dcd53223dcd95325063630324</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004453%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DJ.%2BS.%26aulast%3DMisawa%26aufirst%3DN.%26aulast%3DIzumi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DIwami%26aufirst%3DS.%26aulast%3DTakaori-Kondo%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DW.%2BS.%26aulast%3DAihara%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DAn%26aufirst%3DD.%2BS.%26aulast%3DPathak%26aufirst%3DV.%2BK.%26aulast%3DKoyanagi%26aufirst%3DY.%26atitle%3DAPOBEC3D%2520and%2520APOBEC3F%2520potently%2520promote%2520HIV-1%2520diversification%2520and%2520evolution%2520in%2520humanized%2520mouse%2520model%26jtitle%3DPLoS%2520Pathog.%26date%3D2014%26volume%3D10%26doi%3D10.1371%2Fjournal.ppat.1004453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit7g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammadzadeh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arts, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, A. F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelico, L.</span></span> <span> </span><span class="NLM_article-title">Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance</span>. <i>Heliyon</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e01498</span> <span class="refDoi"> DOI: 10.1016/j.heliyon.2019.e01498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.heliyon.2019.e01498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=31025011" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&author=N.+Mohammadzadehauthor=R.+P.+Loveauthor=R.+Gibsonauthor=E.+J.+Artsauthor=A.+F.+Y.+Poonauthor=L.+Chelico&title=Role+of+co-expressed+APOBEC3F+and+APOBEC3G+in+inducing+HIV-1+drug+resistance&doi=10.1016%2Fj.heliyon.2019.e01498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1016%2Fj.heliyon.2019.e01498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.heliyon.2019.e01498%26sid%3Dliteratum%253Aachs%26aulast%3DMohammadzadeh%26aufirst%3DN.%26aulast%3DLove%26aufirst%3DR.%2BP.%26aulast%3DGibson%26aufirst%3DR.%26aulast%3DArts%26aufirst%3DE.%2BJ.%26aulast%3DPoon%26aufirst%3DA.%2BF.%2BY.%26aulast%3DChelico%26aufirst%3DL.%26atitle%3DRole%2520of%2520co-expressed%2520APOBEC3F%2520and%2520APOBEC3G%2520in%2520inducing%2520HIV-1%2520drug%2520resistance%26jtitle%3DHeliyon%26date%3D2019%26volume%3D5%26doi%3D10.1016%2Fj.heliyon.2019.e01498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. C.</span></span> <span> </span><span class="NLM_article-title">A new class of antiretroviral enabling innate immunity by protecting APOBEC3 from HIV Vif-dependent degradation</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2018.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.molmed.2018.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=29609878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlslKntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=507-520&author=R.+P.+Bennettauthor=J.+D.+Salterauthor=H.+C.+Smith&title=A+new+class+of+antiretroviral+enabling+innate+immunity+by+protecting+APOBEC3+from+HIV+Vif-dependent+degradation&doi=10.1016%2Fj.molmed.2018.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation</span></div><div class="casAuthors">Bennett, Ryan P.; Salter, Jason D.; Smith, Harold C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-520</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The infectivity of HIV depends on overcoming APOBEC3 (A3) innate immunity, predominantly through the expression of the viral protein Vif, which induces A3 degrdn. in the proteasome.  Disruption of the functional interactions of Vif enables A3 mutagenesis of the HIV genome during viral replication, which can result in a broadly neutralizing antiviral effect.  Vif function requires self-assocn. along with interactions with A3 proteins, protein chaperones, and factors of the ubiquitination machinery and these are described here as a potential platform for novel antiviral drug discovery.  This Review will examine the current state of development of Vif inhibitors that we believe to have therapeutic and functional cure potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFlHx5NZHQbVg90H21EOLACvtfcHk0li-Od3U7e8TdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlslKntbs%253D&md5=926251d193e3fa81d373248c00103b91</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2018.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2018.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DR.%2BP.%26aulast%3DSalter%26aufirst%3DJ.%2BD.%26aulast%3DSmith%26aufirst%3DH.%2BC.%26atitle%3DA%2520new%2520class%2520of%2520antiretroviral%2520enabling%2520innate%2520immunity%2520by%2520protecting%2520APOBEC3%2520from%2520HIV%2520Vif-dependent%2520degradation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D507%26epage%3D520%26doi%3D10.1016%2Fj.molmed.2018.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Reingewertz, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britan-Rosich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotem-Bamberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenthal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedler, A.</span></span> <span> </span><span class="NLM_article-title">Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3523</span>– <span class="NLM_lpage">3532</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.bmc.2013.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=23545135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVGis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3523-3532&author=T.+H.+Reingewertzauthor=E.+Britan-Rosichauthor=S.+Rotem-Bambergerauthor=M.+Viardauthor=A.+Jacobsauthor=A.+Millerauthor=J.+Y.+Leeauthor=J.+Hwangauthor=R.+Blumenthalauthor=M.+Kotlerauthor=A.+Friedler&title=Mapping+the+Vif-A3G+interaction+using+peptide+arrays%3A+a+basis+for+anti-HIV+lead+peptides&doi=10.1016%2Fj.bmc.2013.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the Vif-A3G interaction using peptide arrays: A basis for anti-HIV lead peptides</span></div><div class="casAuthors">Reingewertz, Tali H.; Britan-Rosich, Elena; Rotem-Bamberger, Shahar; Viard, Mathias; Jacobs, Amy; Miller, Abigail; Lee, Ji Youn; Hwang, Jeeseong; Blumenthal, Robert; Kotler, Moshe; Friedler, Assaf</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3523-3532</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human apolipoprotein-B mRNA-editing catalytic polypeptide-like 3G (A3G) is a cytidine deaminase that restricts retroviruses, endogenous retro-elements and DNA viruses.  A3G plays a key role in the anti-HIV-1 innate cellular immunity.  The HIV-1 Vif protein counteracts A3G mainly by leading A3G towards the proteosomal machinery and by direct inhibition of its enzymic activity.  Both activities involve direct interaction between Vif and A3G.  Disrupting the interaction between A3G and Vif may rescue A3G antiviral activity and inhibit HIV-1 propagation.  Here, mapping the interaction sites between A3G and Vif by peptide array screening revealed distinct regions in Vif important for A3G binding, including the N-terminal domain (NTD), C-terminal domain (CTD) and residues 83-99.  The Vif-binding sites in A3G included 12 different peptides that showed strong binding to either full-length Vif, Vif CTD or both.  Sequence similarity was found between Vif-binding peptides from the A3G CTD and NTD.  A3G peptides were synthesized and tested for their ability to counteract Vif action.  A3G 211-225 inhibited HIV-1 replication in cell culture and impaired Vif dependent A3G degrdn.  In vivo co-localization of full-length Vif with A3G 211-225 was demonstrated by use of FRET.  This peptide has the potential to serve as an anti-HIV-1 lead compd.  Our results suggest a complex interaction between Vif and A3G that is mediated by discontinuous binding regions with different affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8G3Ff-movXrVg90H21EOLACvtfcHk0li-Od3U7e8TdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVGis74%253D&md5=7eb43d623b55b2d0cbbae7758afd3b28</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DReingewertz%26aufirst%3DT.%2BH.%26aulast%3DBritan-Rosich%26aufirst%3DE.%26aulast%3DRotem-Bamberger%26aufirst%3DS.%26aulast%3DViard%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DHwang%26aufirst%3DJ.%26aulast%3DBlumenthal%26aufirst%3DR.%26aulast%3DKotler%26aufirst%3DM.%26aulast%3DFriedler%26aufirst%3DA.%26atitle%3DMapping%2520the%2520Vif-A3G%2520interaction%2520using%2520peptide%2520arrays%253A%2520a%2520basis%2520for%2520anti-HIV%2520lead%2520peptides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3523%26epage%3D3532%26doi%3D10.1016%2Fj.bmc.2013.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pery, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebane, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazier, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendran, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabuzda, D.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">10504</span>– <span class="NLM_lpage">10517</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.626903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1074%2Fjbc.M114.626903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=25724652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsF2lu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=10504-10517&author=E.+Peryauthor=A.+Sheehyauthor=N.+M.+Nebaneauthor=A.+J.+Brazierauthor=V.+Misraauthor=K.+S.+Rajendranauthor=S.+J.+Buhrlageauthor=M.+K.+Mankowskiauthor=L.+Rasmussenauthor=E.+L.+Whiteauthor=R.+G.+Ptakauthor=D.+Gabuzda&title=Identification+of+a+novel+HIV-1+inhibitor+targeting+Vif-dependent+degradation+of+human+APOBEC3G+protein&doi=10.1074%2Fjbc.M114.626903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel HIV-1 Inhibitor Targeting Vif-dependent Degradation of Human APOBEC3G Protein</span></div><div class="casAuthors">Pery, Erez; Sheehy, Ann; Nebane, N. Miranda; Brazier, Andrew Jay; Misra, Vikas; Rajendran, Kottampatty S.; Buhrlage, Sara J.; Mankowski, Marie K.; Rasmussen, Lynn; White, E. Lucile; Ptak, Roger G.; Gabuzda, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10504-10517</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">APOBEC3G (A3G) is a cellular cytidine deaminase that restricts HIV-1 replication by inducing G-to-A hypermutation in viral DNA and by deamination-independent mechanisms.  HIV-1 Vif binds to A3G, resulting in its degrdn. via the 26 S proteasome.  Therefore, this interaction represents a potential therapeutic target.  To identify compds. that inhibit interaction between A3G and HIV-1 Vif in a high throughput format, the authors developed a homogeneous time-resolved fluorescence resonance energy transfer assay.  A 307,520 compd. library from the NIH Mol. Libraries Small Mol. Repository was screened.  Secondary screens to evaluate dose-response performance and off-target effects, cell-based assays to identify compds. that attenuate Vif-dependent degrdn. of A3G, and assays testing antiviral activity in peripheral blood mononuclear cells and T cells were employed.  One compd., N.41, showed potent antiviral activity in A3G(+) but not in A3G(-) T cells and had an IC50 as low as 8.4 μm and a TC50 of >100 μm when tested against HIV-1Ba-L replication in peripheral blood mononuclear cells.  N.41 inhibited the Vif-A3G interaction and increased cellular A3G levels and incorporation of A3G into virions, thereby attenuating virus infectivity in a Vif-dependent manner.  N.41 activity was also species- and Vif-dependent.  Preliminary structure-activity relation studies suggest that a hydroxyl moiety located at a phenylamino group is crit. for N.41 anti-HIV activity and identified N.41 analogs with better potency (IC50 as low as 4.2 μm).  These findings identify a new lead compd. that attenuates HIV replication by liberating A3G from Vif regulation and increasing its innate antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDZALKQSjuVrVg90H21EOLACvtfcHk0liZcvmw4w76Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsF2lu7c%253D&md5=f14381987a1d698f975ba516b001a652</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.626903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.626903%26sid%3Dliteratum%253Aachs%26aulast%3DPery%26aufirst%3DE.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DNebane%26aufirst%3DN.%2BM.%26aulast%3DBrazier%26aufirst%3DA.%2BJ.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DRajendran%26aufirst%3DK.%2BS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DRasmussen%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DE.%2BL.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DGabuzda%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520a%2520novel%2520HIV-1%2520inhibitor%2520targeting%2520Vif-dependent%2520degradation%2520of%2520human%2520APOBEC3G%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D10504%26epage%3D10517%26doi%3D10.1074%2Fjbc.M114.626903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span> <span> </span><span class="NLM_article-title">Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">16546</span>– <span class="NLM_lpage">16552</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.085308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1074%2Fjbc.M109.085308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=20363737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlygs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=16546-16552&author=S.+Cenauthor=Z.+G.+Pengauthor=X.+Y.+Liauthor=Z.+R.+Liauthor=J.+Maauthor=Y.+M.+Wangauthor=B.+Fanauthor=X.+F.+Youauthor=Y.+P.+Wangauthor=F.+Liuauthor=R.+G.+Shaoauthor=L.+X.+Zhaoauthor=L.+Yuauthor=J.+D.+Jiang&title=Small+molecular+compounds+inhibit+HIV-1+replication+through+specifically+stabilizing+APOBEC3G&doi=10.1074%2Fjbc.M109.085308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G</span></div><div class="casAuthors">Cen, Shan; Peng, Zong-Gen; Li, Xiao-Yu; Li, Zhuo-Rong; Ma, Jing; Wang, Yue-Ming; Fan, Bo; You, Xue-Fu; Wang, Yu-Ping; Liu, Fei; Shao, Rong-Guang; Zhao, Li-Xun; Yu, Liyan; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">16546-16552</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">APOBEC3G (hA3G) is a host inhibitor for human immunodeficiency virus, type 1 (HIV-1).  However, HIV-1 Vif binds hA3G and induces its degrdn.  We have established a screening system to discover inhibitors that protect hA3G from Vif-mediated degrdn.  Through screening, compds. IMB-26 and IMB-35 were identified to be specific inhibitors for the degrdn. of hA3G by Vif.  The inhibitors suppressed HIV-1 replication in hA3G-contg. cells but not in those without hA3G.  The anti-HIV effect correlated with the endogenous hA3G level.  HIV-1 particles from hA3G(+) cells treated with IMB-26/35 contained a hA3G level higher than that from those without IMB-26/35 treatment and showed decreased infectivity.  IMB-26/35 bound directly to the hA3G protein, suppressed Vif/hA3G interaction, and therefore protected hA3G from Vif-mediated degrdn.  The compds. were safe with an anti-HIV therapeutic index >200 in vitro.  LD50 of IMB-26 in mice was >1000 mg/kg (i.p.).  Therefore, IMB-26 and IMB-35 are novel anti-HIV leads working through specific stabilization of hA3G.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6S5ic-i8s_bVg90H21EOLACvtfcHk0liZcvmw4w76Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlygs7k%253D&md5=dc861b059d80cd5da86af1dd4e3874d3</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.085308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.085308%26sid%3Dliteratum%253Aachs%26aulast%3DCen%26aufirst%3DS.%26aulast%3DPeng%26aufirst%3DZ.%2BG.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DZ.%2BR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%2BM.%26aulast%3DFan%26aufirst%3DB.%26aulast%3DYou%26aufirst%3DX.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BP.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DR.%2BG.%26aulast%3DZhao%26aufirst%3DL.%2BX.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26atitle%3DSmall%2520molecular%2520compounds%2520inhibit%2520HIV-1%2520replication%2520through%2520specifically%2520stabilizing%2520APOBEC3G%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D16546%26epage%3D16552%26doi%3D10.1074%2Fjbc.M109.085308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyakawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudoh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaori-Kondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryo, A.</span></span> <span> </span><span class="NLM_article-title">ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">6945</span>, <span class="refDoi"> DOI: 10.1038/ncomms7945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fncomms7945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=25901786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2it7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6945&author=K.+Miyakawaauthor=S.+Matsunagaauthor=K.+Kanouauthor=A.+Matsuzawaauthor=R.+Morishitaauthor=A.+Kudohauthor=K.+Shindoauthor=M.+Yokoyamaauthor=H.+Satoauthor=H.+Kimuraauthor=T.+Tamuraauthor=N.+Yamamotoauthor=H.+Ichijoauthor=A.+Takaori-Kondoauthor=A.+Ryo&title=ASK1+restores+the+antiviral+activity+of+APOBEC3G+by+disrupting+HIV-1+Vif-mediated+counteraction&doi=10.1038%2Fncomms7945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction</span></div><div class="casAuthors">Miyakawa, Kei; Matsunaga, Satoko; Kanou, Kazuhiko; Matsuzawa, Atsushi; Morishita, Ryo; Kudoh, Ayumi; Shindo, Keisuke; Yokoyama, Masaru; Sato, Hironori; Kimura, Hirokazu; Tamura, Tomohiko; Yamamoto, Naoki; Ichijo, Hidenori; Takaori-Kondo, Akifumi; Ryo, Akihide</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6945</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">APOBEC3G (A3G) is an innate antiviral restriction factor that strongly inhibits the replication of human immunodeficiency virus type 1 (HIV-1).  An HIV-1 accessory protein, Vif, hijacks the host ubiquitin-proteasome system to execute A3G degrdn.  Identification of the host pathways that obstruct the action of Vif could provide a new strategy for blocking viral replication.  We demonstrate here that the host protein ASK1 (apoptosis signal-regulating kinase 1) interferes with the counteraction by Vif and revitalizes A3G-mediated viral restriction.  ASK1 binds the BC-box of Vif, thereby disrupting the assembly of the Vif-ubiquitin ligase complex.  Consequently, ASK1 stabilizes A3G and promotes its incorporation into viral particles, ultimately reducing viral infectivity.  Furthermore, treatment with the antiretroviral drug AZT (zidovudine) induces ASK1 expression and restores the antiviral activity of A3G in HIV-1-infected cells.  This study thus demonstrates a distinct function of ASK1 in restoring the host antiviral system that can be enhanced by AZT treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrTJnh6PZVvbVg90H21EOLACvtfcHk0liZcvmw4w76Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2it7nF&md5=9d90f44c773556be3478b80e1ab46eaf</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1038%2Fncomms7945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7945%26sid%3Dliteratum%253Aachs%26aulast%3DMiyakawa%26aufirst%3DK.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DKanou%26aufirst%3DK.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DMorishita%26aufirst%3DR.%26aulast%3DKudoh%26aufirst%3DA.%26aulast%3DShindo%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DTakaori-Kondo%26aufirst%3DA.%26aulast%3DRyo%26aufirst%3DA.%26atitle%3DASK1%2520restores%2520the%2520antiviral%2520activity%2520of%2520APOBEC3G%2520by%2520disrupting%2520HIV-1%2520Vif-mediated%2520counteraction%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6945%26doi%3D10.1038%2Fncomms7945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, C.</span></span> <span> </span><span class="NLM_article-title">Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2015.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.antiviral.2015.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=26241003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OqtLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2015&pages=20-27&author=S.+Zhangauthor=L.+Zhongauthor=B.+Chenauthor=T.+Panauthor=X.+Zhangauthor=L.+Liangauthor=Q.+Liauthor=Z.+Zhangauthor=H.+Chenauthor=J.+Zhouauthor=H.+Luoauthor=H.+Zhangauthor=C.+Bai&title=Identification+of+an+HIV-1+replication+inhibitor+which+rescues+host+restriction+factor+APOBEC3G+in+Vif-APOBEC3G+complex&doi=10.1016%2Fj.antiviral.2015.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex</span></div><div class="casAuthors">Zhang, Shaoyang; Zhong, Limei; Chen, Bing; Pan, Ting; Zhang, Xue; Liang, Liting; Li, Qianwen; Zhang, Ziying; Chen, Hui; Zhou, Jie; Luo, Haihua; Zhang, Hui; Bai, Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20-27</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HIV-1 Vif protein is one of the most crucial accessory proteins for viral replication.  It efficiently counteracts the important host restriction factor APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G, A3G) which is lethal to HIV-1 by causing G to A mutation of viral genome.  Vif protein mediates degrdn. of APOBEC3G via the complicated protein-protein interactions of Vif, APOBEC3G, Elongin C/B and Cullin 5.  The importance of Vif-APOBEC3G complex makes it a good potential target to develop new therapeutics of HIV-1.  We identified a potent HIV-1 replication inhibitor (ZBMA-1, IC50 = 1.01 μM) that efficiently protected APOBEC3G protein by targeting Vif-APOBEC3G complex.  The co-immunopptn. and docking studies indicated that compd. ZBMA-1 affected the binding of Elongin C with Vif protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxlGmCtQl7WbVg90H21EOLACvtfcHk0ljfP4qx80poAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OqtLvM&md5=9dfaaa95c21ce7ca270f2597bc94a082</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBai%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520an%2520HIV-1%2520replication%2520inhibitor%2520which%2520rescues%2520host%2520restriction%2520factor%2520APOBEC3G%2520in%2520Vif-APOBEC3G%2520complex%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D122%26spage%3D20%26epage%3D27%26doi%3D10.1016%2Fj.antiviral.2015.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">5497</span>– <span class="NLM_lpage">5507</span>, <span class="refDoi"> DOI: 10.1128/JVI.06957-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1128%2FJVI.06957-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=22379088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslOisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=5497-5507&author=T.+Zuoauthor=D.+Liuauthor=W.+Lvauthor=X.+Wangauthor=J.+Wangauthor=M.+Lvauthor=W.+Huangauthor=J.+Wuauthor=H.+Zhangauthor=H.+Jinauthor=L.+Zhangauthor=W.+Kongauthor=X.+Yu&title=Small-molecule+inhibition+of+human+immunodeficiency+virus+type+1+replication+by+targeting+the+interaction+between+Vif+and+ElonginC&doi=10.1128%2FJVI.06957-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8gR"><div class="casContent"><span class="casTitleNuber">8g</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC</span></div><div class="casAuthors">Zuo, Tao; Liu, Donglai; Lv, Wei; Wang, Xiaodan; Wang, Jiawen; Lv, Mingyu; Huang, Wenlin; Wu, Jiaxin; Zhang, Haihong; Jin, Hongwei; Zhang, Liangren; Kong, Wei; Yu, Xianghui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5497-5507</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The HIV-1 viral infectivity factor (Vif) protein is essential for viral replication.  Vif recruits cellular ElonginB/C-Cullin5 E3 ubiquitin ligase to target the host antiviral protein APOBEC3G (A3G) for proteasomal degrdn.  In the absence of Vif, A3G is packaged into budding HIV-1 virions and introduces multiple mutations in the newly synthesized minus-strand viral DNA to restrict virus replication.  Thus, the A3G-Vif-E3 complex represents an attractive target for development of novel anti-HIV drugs.  In this study, we identified a potent small mol. compd. (VEC-5) by virtual screening and validated its anti-Vif activity through biochem. anal.  We show that VEC-5 inhibits virus replication only in A3G-pos. cells.  Treatment with VEC-5 increased cellular A3G levels when Vif was coexpressed and enhanced A3G incorporation into HIV-1 virions to reduce viral infectivity.  Coimmunopptn. and computational anal. further attributed the anti-Vif activity of VEC-5 to the inhibition of Vif from direct binding to the ElonginC protein.  These findings support the notion that suppressing Vif function can liberate A3G to carry out its antiviral activity and demonstrate that regulation of the Vif-ElonginC interaction is a novel target for small-mol. inhibitors of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorkfZuyomFT7Vg90H21EOLACvtfcHk0ljfP4qx80poAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslOisb8%253D&md5=f155f1f4dd5ea631d7baaba9c1c4b7ea</span></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.1128%2FJVI.06957-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.06957-11%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLv%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLv%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DX.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520by%2520targeting%2520the%2520interaction%2520between%2520Vif%2520and%2520ElonginC%26jtitle%3DJ.%2520Virol.%26date%3D2012%26volume%3D86%26spage%3D5497%26epage%3D5507%26doi%3D10.1128%2FJVI.06957-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, S.</span></span> <span> </span><span class="NLM_article-title">Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">8067</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-26318-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fs41598-018-26318-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=29795228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A280%3ADC%252BC1Mfms1Wruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=8067&author=L.+Maauthor=Z.+Zhangauthor=Z.+Liuauthor=Q.+Panauthor=J.+Wangauthor=X.+Liauthor=F.+Guoauthor=C.+Liangauthor=L.+Huauthor=J.+Zhouauthor=S.+Cen&title=Identification+of+small+molecule+compounds+targeting+the+interaction+of+HIV-1+Vif+and+human+APOBEC3G+by+virtual+screening+and+biological+evaluation&doi=10.1038%2Fs41598-018-26318-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8h</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation</span></div><div class="casAuthors">Ma Ling; Zhang Zhixin; Wang Jing; Li Xiaoyu; Hu Laixing; Zhou Jinming; Cen Shan; Liu Zhenlong; Pan Qinghua; Liang Chen; Guo Fei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8067</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human APOBEC3G (hA3G) is a restriction factor that inhibits human immunodeficiency 1 virus (HIV-1) replication.  The virally encoded protein Vif binds to hA3G and induces its degradation, thereby counteracting the antiviral activity of hA3G.  Vif-mediated hA3G degradation clearly represents a potential target for anti-HIV drug development.  Herein, we have performed virtual screening to discover small molecule inhibitors that target the binding interface of the Vif/hA3G complex.  Subsequent biochemical studies have led to the identification of a small molecule inhibitor, IMB-301 that binds to hA3G, interrupts the hA3G-Vif interaction and inhibits Vif-mediated degradation of hA3G.  As a result, IMB-301 strongly inhibits HIV-1 replication in a hA3G-dependent manner.  Our study further demonstrates the feasibility of inhibiting HIV replication by abrogating the Vif-hA3G interaction with small molecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmhRizwKUbL91QT_1O5WBYfW6udTcc2ebjtKsIJCRkDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mfms1Wruw%253D%253D&md5=6abc264787e99c1a0cc46b8063f766ad</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-26318-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-26318-3%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCen%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520small%2520molecule%2520compounds%2520targeting%2520the%2520interaction%2520of%2520HIV-1%2520Vif%2520and%2520human%2520APOBEC3G%2520by%2520virtual%2520screening%2520and%2520biological%2520evaluation%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D8067%26doi%3D10.1038%2Fs41598-018-26318-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harki, D. A.</span></span> <span> </span><span class="NLM_article-title">APOBEC enzymes as targets for virus and cancer therapy</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.chembiol.2017.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=29153851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVartb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=36-49&author=M.+E.+Olsonauthor=R.+S.+Harrisauthor=D.+A.+Harki&title=APOBEC+enzymes+as+targets+for+virus+and+cancer+therapy&doi=10.1016%2Fj.chembiol.2017.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8iR"><div class="casContent"><span class="casTitleNuber">8i</span><div class="casTitle"><span class="NLM_cas:atitle">APOBEC Enzymes as Targets for Virus and Cancer Therapy</span></div><div class="casAuthors">Olson, Margaret E.; Harris, Reuben S.; Harki, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-49</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Human DNA cytosine-to-uracil deaminases catalyze mutations in both pathogen and cellular genomes.  APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H restrict human immunodeficiency virus 1 (HIV-1) infection in cells deficient in the viral infectivity factor (Vif), and have the potential to catalyze sublethal levels of mutation in viral genomes in Vif-proficient cells.  At least two APOBEC3 enzymes, and in particular APOBEC3B, are sources of somatic mutagenesis in cancer cells that drive tumor evolution and may manifest clin. as recurrence, metastasis, and/or therapy resistance.  Consequently, APOBEC3 enzymes are tantalizing targets for developing chem. probes and therapeutic mols. to harness mutational processes in human disease.  This review highlights recent efforts to chem. manipulate APOBEC3 activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgDIHc8ehwMrVg90H21EOLACvtfcHk0ljQL_GFgZcNRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVartb%252FE&md5=b30784e7e7d5b22ce1cd2b19c08e927e</span></div><a href="/servlet/linkout?suffix=cit8i&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DM.%2BE.%26aulast%3DHarris%26aufirst%3DR.%2BS.%26aulast%3DHarki%26aufirst%3DD.%2BA.%26atitle%3DAPOBEC%2520enzymes%2520as%2520targets%2520for%2520virus%2520and%2520cancer%2520therapy%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D36%26epage%3D49%26doi%3D10.1016%2Fj.chembiol.2017.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8j"><span><span class="NLM_label">(j) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8j&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.ejmech.2017.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8j&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=28235704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=310-324&author=M.+Zhouauthor=R.+H.+Luoauthor=X.+Y.+Houauthor=R.+R.+Wangauthor=G.+Y.+Yanauthor=H.+Chenauthor=R.+H.+Zhangauthor=J.+Y.+Shiauthor=Y.+T.+Zhengauthor=R.+Liauthor=Y.+Q.+Wei&title=Synthesis%2C+biological+evaluation+and+molecular+docking+study+of+N-%282-methoxyphenyl%29-6-%28%284-nitrophenyl%29sulfonyl%29benzamide+derivatives+as+potent+HIV-1+Vif+antagonists&doi=10.1016%2Fj.ejmech.2017.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8jR"><div class="casContent"><span class="casTitleNuber">8j</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists</span></div><div class="casAuthors">Zhou, Meng; Luo, Rong-Hua; Hou, Xue-Yan; Wang, Rui-Rui; Yan, Guo-Yi; Chen, Huan; Zhang, Rong-Hong; Shi, Jian-You; Zheng, Yong-Tang; Li, Rui; Wei, Yu-Quan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">310-324</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Design, synthesis, antiviral evaluation and mol. docking study of N-(methoxyphenyl)((nitrophenyl)sulfonyl)benzamide derivs. e.g., I [R = H (II), C(O)CH2NH2 (III)] as potent HIV-1 Vif antagonists was reported.  Among the synthesized compds., compd. II was found to be a potent with EC50 value of 1.54 μM, enhancing the antiviral activity more than 150-fold compared with N-(2-methoxyphenyl)-2-((4-nitrophenyl)thio)benzamide (Vif antagonists) in nonpermissive H9 cells.  Further, II protected A3G from degrdn. by inhibiting Vif function.  Besides, II suppressed different HIV-1 clin. strains (HIV-1KM018, HIV-1TC-1 and HIV-1WAN) and drug-resistant strains (NRTI, NNRTI, PI, and FI) with relatively high activities.  Amidation of II with glycine gave a prodrug III, improving the water soly. about 2600-fold compared with II.  Moreover, III inhibited the virus replication efficiently with an EC50 value of 0.228 μM.  These results suggested that the prodrug III was a promising candidate agent for the treatment of AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdAYSD5KNLYbVg90H21EOLACvtfcHk0ljQL_GFgZcNRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGgs7s%253D&md5=298b94a5c4018b9622f14d558e278ddd</span></div><a href="/servlet/linkout?suffix=cit8j&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DR.%2BH.%26aulast%3DHou%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DR.%2BR.%26aulast%3DYan%26aufirst%3DG.%2BY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%2BH.%26aulast%3DShi%26aufirst%3DJ.%2BY.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DY.%2BQ.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520molecular%2520docking%2520study%2520of%2520N-%25282-methoxyphenyl%2529-6-%2528%25284-nitrophenyl%2529sulfonyl%2529benzamide%2520derivatives%2520as%2520potent%2520HIV-1%2520Vif%2520antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D129%26spage%3D310%26epage%3D324%26doi%3D10.1016%2Fj.ejmech.2017.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8k"><span><span class="NLM_label">(k) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckheit, R. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. C.</span></span> <span> </span><span class="NLM_article-title">An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2016.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.antiviral.2016.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=27825797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGqtLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2016&pages=51-59&author=R.+P.+Bennettauthor=R.+A.+Stewartauthor=P.+A.+Hoganauthor=R.+G.+Ptakauthor=M.+K.+Mankowskiauthor=T.+L.+Hartmanauthor=R.+W.+Buckheitauthor=B.+A.+Snyderauthor=J.+D.+Salterauthor=G.+A.+Moralesauthor=H.+C.+Smith&title=An+analog+of+camptothecin+inactive+against+Topoisomerase+I+is+broadly+neutralizing+of+HIV-1+through+inhibition+of+Vif-dependent+APOBEC3G+degradation&doi=10.1016%2Fj.antiviral.2016.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8kR"><div class="casContent"><span class="casTitleNuber">8k</span><div class="casTitle"><span class="NLM_cas:atitle">An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation</span></div><div class="casAuthors">Bennett, Ryan P.; Stewart, Ryan A.; Hogan, Priscilla A.; Ptak, Roger G.; Mankowski, Marie K.; Hartman, Tracy L.; Buckheit, Robert W., Jr.; Snyder, Beth A.; Salter, Jason D.; Morales, Guillermo A.; Smith, Harold C.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-59</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Camptothecin (CPT) is a natural product discovered to be active against various cancers through its ability to inhibit Topoisomerase I (TOP1).  CPT analogs also have anti-HIV-1 (HIV) activity that was previously shown to be independent of TOP1 inhibition.  We show that a cancer inactive CPT analog (O2-16) inhibits HIV infection by disrupting multimerization of the HIV protein Vif.  Antiviral activity depended on the expression of the cellular viral restriction factor APOBEC3G (A3G) that, in the absence of functional Vif, has the ability to hypermutate HIV proviral DNA during reverse transcription.  Our studies demonstrate that O2-16 has low cytotoxicity and inhibits Vif-dependent A3G degrdn., enabling A3G packaging into HIV viral particles that results in A3G signature hypermutations in viral genomes.  This antiviral activity was A3G-dependent and broadly neutralizing against sixteen HIV clin. isolates from groups M (subtypes A-G), N, and O as well as seven single and multi-drug resistant strains of HIV.  Mol. modeling predicted binding near the PPLP motif crucial for Vif multimerization and activity.  O2-16 also was active in blocking Vif degrdn. of APOBEC3F (A3F).  We propose that CPT analogs not active against TOP1 have novel therapeutic potential as Vif antagonists that enable A3G-dependent hypermutation of HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqATlWSwY5_5rVg90H21EOLACvtfcHk0linMgC2NiGWQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGqtLfJ&md5=d894832d96cf6e3061405ddd83915fde</span></div><a href="/servlet/linkout?suffix=cit8k&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2016.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2016.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DR.%2BP.%26aulast%3DStewart%26aufirst%3DR.%2BA.%26aulast%3DHogan%26aufirst%3DP.%2BA.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DHartman%26aufirst%3DT.%2BL.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DSnyder%26aufirst%3DB.%2BA.%26aulast%3DSalter%26aufirst%3DJ.%2BD.%26aulast%3DMorales%26aufirst%3DG.%2BA.%26aulast%3DSmith%26aufirst%3DH.%2BC.%26atitle%3DAn%2520analog%2520of%2520camptothecin%2520inactive%2520against%2520Topoisomerase%2520I%2520is%2520broadly%2520neutralizing%2520of%2520HIV-1%2520through%2520inhibition%2520of%2520Vif-dependent%2520APOBEC3G%2520degradation%26jtitle%3DAntiviral%2520Res.%26date%3D2016%26volume%3D136%26spage%3D51%26epage%3D59%26doi%3D10.1016%2Fj.antiviral.2016.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit8l"><span><span class="NLM_label">(l) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummetha, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, M.</span></span> <span> </span><span class="NLM_article-title">HIV-1 escape from small-molecule antagonism of Vif</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e00144</span>– <span class="NLM_lpage">e00119</span>, <span class="refDoi"> DOI: 10.1128/mbio.00144-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8l&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1128%2FmBio.00144-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8l&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=30808702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8l&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKgsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=e00144-e00119&author=M.+Sharkeyauthor=N.+Sharovaauthor=I.+Mohammedauthor=S.+E.+Huffauthor=I.+R.+Kummethaauthor=G.+Singhauthor=T.+M.+Ranaauthor=M.+Stevenson&title=HIV-1+escape+from+small-molecule+antagonism+of+Vif&doi=10.1128%2Fmbio.00144-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8lR"><div class="casContent"><span class="casTitleNuber">8l</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 escape from small-molecule antagonism of Vif</span></div><div class="casAuthors">Sharkey, Mark; Sharova, Natalia; Mohammed, Idrees; Huff, Sarah E.; Kummetha, Indrasena Reddy; Singh, Gatikrushna; Rana, Tariq M.; Stevenson, Mario</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e00144-19</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The HIV-1 accessory protein Vif, which counteracts the antiviral action of the DNA-editing cytidine deaminase APOBEC3G (A3G), is an attractive and yet unexploited therapeutic target.  Vif reduces the virion incorporation of A3G by targeting the restriction factor for proteasomal degrdn. in the virus-producing cell.  Compds. that inhibit Vif-mediated degrdn. of A3G in cells targeted by HIV-1 would represent a novel antiviral therapeutic.  We previously described small mols. with activity consistent with Vif antagonism.  In this study, we derived inhibitor escape HIV-1 variants to characterize the mechanism by which these novel agents inhibit virus replication.  Here we show that resistance to these agents is dependent on an amino acid substitution in Vif (V142I) and on a point mutation that likely upregulates transcription by modifying the lymphocyte enhancing factor 1 (LEF-1) binding site.  Mol. modeling demonstrated a docking site in the Vif-Elongin C complex that is disrupted by these inhibitors.  This docking site is lost when Vif acquires the V142I mutation that leads to inhibitor resistance.  Competitive fitness expts. indicated that the V142I Vif and LEF-1 binding site mutations created a virus that is better adapted to growing in the presence of A3G than the wild-type virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJd1Lul1f887Vg90H21EOLACvtfcHk0linMgC2NiGWQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlKgsbfI&md5=442b9c797eaf12015754323a0b6ec8c6</span></div><a href="/servlet/linkout?suffix=cit8l&amp;dbid=16384&amp;doi=10.1128%2FmBio.00144-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00144-19%26sid%3Dliteratum%253Aachs%26aulast%3DSharkey%26aufirst%3DM.%26aulast%3DSharova%26aufirst%3DN.%26aulast%3DMohammed%26aufirst%3DI.%26aulast%3DHuff%26aufirst%3DS.%2BE.%26aulast%3DKummetha%26aufirst%3DI.%2BR.%26aulast%3DSingh%26aufirst%3DG.%26aulast%3DRana%26aufirst%3DT.%2BM.%26aulast%3DStevenson%26aufirst%3DM.%26atitle%3DHIV-1%2520escape%2520from%2520small-molecule%2520antagonism%2520of%2520Vif%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26spage%3De00144%26epage%3De00119%26doi%3D10.1128%2Fmbio.00144-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of new N(4)-Substituted 2′-deoxy-2′-fluoro-4′-azido cytidine derivatives as potent anti-HBV agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.06.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.ejmech.2015.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=26119991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=103-110&author=Z.+Lvauthor=W.+Heauthor=X.+Tianauthor=J.+Kangauthor=Y.+Liuauthor=Y.+Pengauthor=L.+Zhengauthor=Q.+Wangauthor=W.+Yuauthor=J.+Chang&title=Design%2C+synthesis%2C+and+biological+evaluation+of+new+N%284%29-Substituted+2%E2%80%B2-deoxy-2%E2%80%B2-fluoro-4%E2%80%B2-azido+cytidine+derivatives+as+potent+anti-HBV+agents&doi=10.1016%2Fj.ejmech.2015.06.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of new N4-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents</span></div><div class="casAuthors">Lv, Zhigang; He, Wu; Tian, Xianhai; Kang, Jinfeng; Liu, Yangxue; Peng, Youmei; Zheng, Liyun; Wang, Qingduan; Yu, Wenquan; Chang, Junbiao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-110</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of new 2'-deoxy-2'-β-fluoro-4'-azido-β-D-arabinofuranosyl cytidine derivs. bearing heteroatom-contg. N4-substituents were designed and synthesized.  Antiviral screening in HepG2.2.15 cells identified three analogs (1a, 1d & 1g) with good anti-HBV activity and low cytotoxicty.  Of them, compd. 1g exhibited significant inhibitory activity on both HBV antigens secretion (EC50, HBsAg = 9 nM, EC50, HBeAg = 0.25 μM) and viral DNA replication (intracellular, EC50 = 0.099 μM; extracellular, EC50 < 0.01 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0gLpgiRfy_bVg90H21EOLACvtfcHk0linMgC2NiGWQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsbnP&md5=5c6d89c17897a2fe42a0c4604ec9ce23</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520new%2520N%25284%2529-Substituted%25202%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluoro-4%25E2%2580%25B2-azido%2520cytidine%2520derivatives%2520as%2520potent%2520anti-HBV%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D103%26epage%3D110%26doi%3D10.1016%2Fj.ejmech.2015.06.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span>; <span class="NLM_string-name">Bao, X.</span>; <span class="NLM_string-name">Wang, Q.</span>; <span class="NLM_string-name">Guo, X.</span>; <span class="NLM_string-name">Wang, W.</span>; <span class="NLM_string-name">Qi, X.</span></span> <span> </span><span class="NLM_article-title">2’-Fluoro-4’-Substituted Nucleosides, the Preparation and Use</span>. CN Patent <span class="NLM_patent">ZL200710137548.0</span>, August 26, <span class="NLM_year">2009</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+Chang&author=X.+Bao&author=Q.+Wang&author=X.+Guo&author=W.+Wang&author=X.+Qi&title=2%E2%80%99-Fluoro-4%E2%80%99-Substituted+Nucleosides%2C+the+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%26atitle%3D2%25E2%2580%2599-Fluoro-4%25E2%2580%2599-Substituted%2520Nucleosides%252C%2520the%2520Preparation%2520and%2520Use%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span> <span> </span><span class="NLM_article-title">2’-Fluoro-4’-Substituted Nucleosides, the Preparation and Use</span>. Eur. Patent <span class="NLM_patent">EP2177527B</span>, December 18, <span class="NLM_year">2013</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+Chang&title=2%E2%80%99-Fluoro-4%E2%80%99-Substituted+Nucleosides%2C+the+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%26atitle%3D2%25E2%2580%2599-Fluoro-4%25E2%2580%2599-Substituted%2520Nucleosides%252C%2520the%2520Preparation%2520and%2520Use%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9d"><span>US Patent <span class="NLM_patent">US8835615B2</span>, September
16, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=US+Patent+US8835615B2%2C+September%0A16%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span> <span> </span><span class="NLM_article-title">Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">104555</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2019.104555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.antiviral.2019.104555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=31295520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsValsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2019&pages=104555&author=H.+Yangauthor=X.+Liauthor=X.+Yangauthor=P.+Luauthor=Y.+Wangauthor=Z.+Jiangauthor=H.+Panauthor=L.+Zhaoauthor=Y.+Zhuauthor=I.+U.+Khanauthor=Y.+Shenauthor=H.+Luauthor=T.+Zhangauthor=G.+Jiangauthor=Z.+Maauthor=H.+Wuauthor=H.+Zhu&title=Dual+effects+of+the+novel+ingenol+derivatives+on+the+acute+and+latent+HIV-1+infections&doi=10.1016%2Fj.antiviral.2019.104555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections</span></div><div class="casAuthors">Yang, He; Li, Xian; Yang, Xinyi; Lu, Panpan; Wang, Yanan; Jiang, Zhengtao; Pan, Hanyu; Zhao, Lin; Zhu, Yuqi; Khan, InamUllah; Shen, Yinzhong; Lu, Hongzhou; Zhang, Tong; Jiang, Guochun; Ma, Zhongjun; Wu, Hao; Zhu, Huanzhang</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104555</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The latent reservoir of HIV-1 in resting memory CD4+ T cells serves as a major barrier to curing HIV-1 infection.  Reactivation of latent HIV-1 is proposed as a promising strategy for the clearance of the viral reservoirs.  Because of the limitations of current latency reversal agents (LRAs), identification of new LRAs is urgently required.  Here, we analyzed Euphorbia kansui exts. and obtained three ingenol deriv. compds. named EK-1A, EK-5A and EK-15A.  We found that ingenol derivs. can effectively reactivate latent HIV-1 at very low (nanomolar) concns. in HIV latency model in vitro.  Furthermore, ingenol derivs. exhibited synergy with other LRAs in reactivating latent HIV-1.  We verified that EK-15A can promote latent HIV-1 reactivation in the ex vivo resting CD4+ T cells isolated from the peripheral blood of HIV-infected individuals on suppressive antiretroviral therapy.  In addn., ingenol derivs. down-regulated the expression of cell surface HIV co-receptors CCR5 and CXCR4, therefore potentially preventing new infection of HIV-1.  Our results indicated that the ingenol derivs. extd. from Euphorbia kansui have dual functions: reactivation of latent HIV-1 and inhibition of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLw_ixuFPywLVg90H21EOLACvtfcHk0lhZ1XuUN0EJOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsValsLzM&md5=aa5f3c4ded7c0b19a1e650620d9ca76e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2019.104555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2019.104555%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DI.%2BU.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DDual%2520effects%2520of%2520the%2520novel%2520ingenol%2520derivatives%2520on%2520the%2520acute%2520and%2520latent%2520HIV-1%2520infections%26jtitle%3DAntiviral%2520Res.%26date%3D2019%26volume%3D169%26spage%3D104555%26doi%3D10.1016%2Fj.antiviral.2019.104555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pery, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda
Nebane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucile White, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabuzda, D.</span></span> <span> </span><span class="NLM_article-title">Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>484</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2015.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.virol.2015.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=26141568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVygtL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=484&publication_year=2015&pages=276-287&author=E.+Peryauthor=A.+Sheehyauthor=N.+Miranda%0ANebaneauthor=V.+Misraauthor=M.+K.+Mankowskiauthor=L.+Rasmussenauthor=E.+Lucile+Whiteauthor=R.+G.+Ptakauthor=D.+Gabuzda&title=Redoxal%2C+an+inhibitor+of+de+novo+pyrimidine+biosynthesis%2C+augments+APOBEC3G+antiviral+activity+against+human+immunodeficiency+virus+type+1&doi=10.1016%2Fj.virol.2015.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1</span></div><div class="casAuthors">Pery, Erez; Sheehy, Ann; Miranda Nebane, N.; Misra, Vikas; Mankowski, Marie K.; Rasmussen, Lynn; Lucile White, E.; Ptak, Roger G.; Gabuzda, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">484</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">276-287</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">APOBEC3G (A3G) is a cytidine deaminase that restricts HIV-1 replication by inducing G-to-A hypermutation in viral DNA; deamination-independent mechanisms are also implicated.  HIV-1 Vif protein counteracts A3G by inducing its proteasomal degrdn.  Thus, the Vif-A3G axis is a potential therapeutic target.  To identify compds. that inhibit Vif:A3G interaction, a 307,520 compd. library was tested in a TR-FRET screen.  Two identified compds., redoxal and lomofungin, inhibited HIV-1 replication in peripheral blood mononuclear cells.  Lomofungin activity was linked to A3G, but not pursued further due to cytotoxicity.  Redoxal displayed A3G-dependent restriction, inhibiting viral replication by stabilizing A3G protein levels and increasing A3G in virions.  A3G-independent activity was also detected.  Treatment with uridine or orotate, intermediates of pyrimidine synthesis, diminished redoxal-induced stabilization of A3G and antiviral activity.  These results identify redoxal as an inhibitor of HIV-1 replication and suggest its ability to inhibit pyrimidine biosynthesis suppresses viral replication by augmenting A3G antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7PpA3KmqMxLVg90H21EOLACvtfcHk0lhZ1XuUN0EJOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVygtL3P&md5=7a8e8f0cae803db53b0700d5e36057e3</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2015.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2015.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DPery%26aufirst%3DE.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DMiranda%2BNebane%26aufirst%3DN.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DRasmussen%26aufirst%3DL.%26aulast%3DLucile%2BWhite%26aufirst%3DE.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DGabuzda%26aufirst%3DD.%26atitle%3DRedoxal%252C%2520an%2520inhibitor%2520of%2520de%2520novo%2520pyrimidine%2520biosynthesis%252C%2520augments%2520APOBEC3G%2520antiviral%2520activity%2520against%2520human%2520immunodeficiency%2520virus%2520type%25201%26jtitle%3DVirology%26date%3D2015%26volume%3D484%26spage%3D276%26epage%3D287%26doi%3D10.1016%2Fj.virol.2015.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nathans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stranska, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, T. M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of HIV-1 Vif</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1192</span>, <span class="refDoi"> DOI: 10.1038/nbt.1496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnbt.1496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=18806783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1aisr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=1187-1192&author=R.+Nathansauthor=H.+Caoauthor=N.+Sharovaauthor=A.+Aliauthor=M.+Sharkeyauthor=R.+Stranskaauthor=M.+Stevensonauthor=T.+M.+Rana&title=Small-molecule+inhibition+of+HIV-1+Vif&doi=10.1038%2Fnbt.1496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of HIV-1 Vif</span></div><div class="casAuthors">Nathans, Robin; Cao, Hong; Sharova, Natalia; Ali, Akbar; Sharkey, Mark; Stranska, Ruzena; Stevenson, Mario; Rana, Tariq M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1187-1192</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The HIV-1 protein Vif, essential for in vivo viral replication, targets the human DNA-editing enzyme, APOBEC3G (A3G), which inhibits replication of retroviruses and hepatitis B virus.  As Vif has no known cellular homologs, it is an attractive, yet unrealized, target for antiviral intervention.  Although zinc chelation inhibits Vif and enhances viral sensitivity to A3G, this effect is unrelated to the interaction of Vif with A3G.  We identify a small mol., RN-18, that antagonizes Vif function and inhibits HIV-1 replication only in the presence of A3G.  RN-18 increases cellular A3G levels in a Vif-dependent manner and increases A3G incorporation into virions without inhibiting general proteasome-mediated protein degrdn.  RN-18 enhances Vif degrdn. only in the presence of A3G, reduces viral infectivity by increasing A3G incorporation into virions and enhances cytidine deamination of the viral genome.  These results demonstrate that the HIV-1 Vif-A3G axis is a valid target for developing small mol.-based new therapies for HIV infection or for enhancing innate immunity against viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWRpTfp6uVArVg90H21EOLACvtfcHk0lieVi0j0AP4SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1aisr3K&md5=f80228275d0e19e40e049ea715c11895</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1496%26sid%3Dliteratum%253Aachs%26aulast%3DNathans%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DSharova%26aufirst%3DN.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DSharkey%26aufirst%3DM.%26aulast%3DStranska%26aufirst%3DR.%26aulast%3DStevenson%26aufirst%3DM.%26aulast%3DRana%26aufirst%3DT.%2BM.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520HIV-1%2520Vif%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D1187%26epage%3D1192%26doi%3D10.1038%2Fnbt.1496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of indole derivatives as Vif inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4150</span>– <span class="NLM_lpage">4155</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.bmcl.2017.07.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=28754362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GktLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4150-4155&author=C.+Puauthor=R.+H.+Luoauthor=M.+Zhangauthor=X.+Houauthor=G.+Yanauthor=J.+Luoauthor=Y.+T.+Zhengauthor=R.+Li&title=Design%2C+synthesis+and+biological+evaluation+of+indole+derivatives+as+Vif+inhibitors&doi=10.1016%2Fj.bmcl.2017.07.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of indole derivatives as Vif inhibitors</span></div><div class="casAuthors">Pu, Chunlan; Luo, Rong-Hua; Zhang, Mengqi; Hou, Xueyan; Yan, Guoyi; Luo, Jiang; Zheng, Yong-Tang; Li, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4150-4155</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this article, design, synthesis and biol. evaluation of indole derivs. as viral infectivity factor (Vif) inhibitors is reported.  Fragment-based virtual screening (FBVS) was conducted and a series of fragments was obtained, among which, 5-(pyridin-2-yl)-1H-indole can form H-bonds with Tyr148 and Ile155 and based on this fragment other indole derivs. were synthesized.  Through the immune-fluorescence staining and Western blot assays, 3-(1H-indol-5-yl)pyridin-6-amine (I) shows potent activity in inhibiting Vif-mediated A3G degrdn.  Further docking expt. shows that compd. I form H-bond interactions with residues His139, Tyr148 and Ile155.  Therefore, I is a promising lead compd. against Vif that can be used to treat AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXEEv18bl3rrVg90H21EOLACvtfcHk0lieVi0j0AP4SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GktLjL&md5=57510f6ea51163fd75d7a405560dff35</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DPu%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DR.%2BH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520indole%2520derivatives%2520as%2520Vif%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4150%26epage%3D4155%26doi%3D10.1016%2Fj.bmcl.2017.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit11d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span> <span> </span><span class="NLM_article-title">Anti-HIV activities and mechanism of 12-O-tricosanoylphorbol-20-acetate, a novel phorbol ester from ostodes katharinae</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1498</span>, <span class="refDoi"> DOI: 10.3390/molecules22091498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.3390%2Fmolecules22091498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWgs7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1498&author=H.+Chenauthor=R.+Zhangauthor=R.+H.+Luoauthor=L.+M.+Yangauthor=R.+R.+Wangauthor=X.+J.+Haoauthor=Y.+T.+Zheng&title=Anti-HIV+activities+and+mechanism+of+12-O-tricosanoylphorbol-20-acetate%2C+a+novel+phorbol+ester+from+ostodes+katharinae&doi=10.3390%2Fmolecules22091498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HIV activities and mechanism of 12-O-tricosanoylphorbol-20-acetate, a novel phorbol ester from Ostodes katharinae</span></div><div class="casAuthors">Chen, Huan; Zhang, Rong; Luo, Rong-Hua; Yang, Liu-Meng; Wang, Rui-Rui; Hao, Xiao-Jiang; Zheng, Yong-Tang</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1498/1-1498/18</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">APOBEC3G is a member of the human cytidine deaminase family that restricts Vif-deficient viruses by being packaged with progeny virions and inducing the G to A mutation during the synthesis of HIV-1 viral DNA when the progeny virus infects new cells.  HIV-1 Vif protein resists the activity of A3G by mediating A3G degrdn.  Phorbol esters are plant-derived org. compds. belonging to the tigliane family of diterpenes and could activate the PKC pathway.  In this study, we identified an inhibitor 12-O-tricosanoylphorbol-20-acetate (hop-8), a novel ester of phorbol which was isolated from Ostodes katharinae of the family Euphorbiaceae, that inhibited the replication of wild-type HIV-1 and HIV-2 strains and drug-resistant strains broadly both in C8166 cells and PBMCs with low cytotoxicity and the EC50 values ranged from 0.106 μM to 7.987 μM.  One of the main mechanisms of hop-8 is to stimulate A3G expressing in HIV-1 producing cells and upregulate the A3G level in progeny virions, which results in reducing the infectivity of the progeny virus.  This novel mechanism of hop-8 inhibition of HIV replication might represents a promising approach for developing new therapeutics for HIV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnLNnmLSNXrLVg90H21EOLACvtfcHk0lieVi0j0AP4SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWgs7fO&md5=140d4150f28b7cbb9dd6ce9810f01221</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22091498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22091498%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DR.%2BH.%26aulast%3DYang%26aufirst%3DL.%2BM.%26aulast%3DWang%26aufirst%3DR.%2BR.%26aulast%3DHao%26aufirst%3DX.%2BJ.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26atitle%3DAnti-HIV%2520activities%2520and%2520mechanism%2520of%252012-O-tricosanoylphorbol-20-acetate%252C%2520a%2520novel%2520phorbol%2520ester%2520from%2520ostodes%2520katharinae%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1498%26doi%3D10.3390%2Fmolecules22091498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Covino, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purificato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzo, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauzzi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyedkazemi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantuzzi, L.</span></span> <span> </span><span class="NLM_article-title">APOBEC3G/3A Expression in human immunodeficiency virus type 1-infected individuals following initiation of antiretroviral therapy containing cenicriviroc or efavirenz</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1839</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2018.01839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.3389%2Ffimmu.2018.01839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=30135687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlWmu7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1839&author=D.+A.+Covinoauthor=C.+Purificatoauthor=L.+Catapanoauthor=C.+M.+Galluzzoauthor=M.+C.+Gauzziauthor=S.+Vellaauthor=E.+Lefebvreauthor=S.+Seyedkazemiauthor=M.+Andreottiauthor=L.+Fantuzzi&title=APOBEC3G%2F3A+Expression+in+human+immunodeficiency+virus+type+1-infected+individuals+following+initiation+of+antiretroviral+therapy+containing+cenicriviroc+or+efavirenz&doi=10.3389%2Ffimmu.2018.01839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">APOBEC3G/3A expression in human immunodeficiency virus type 1-infected individuals following initiation of antiretroviral therapy containing cenicriviroc or efavirenz</span></div><div class="casAuthors">Covino, Daniela A.; Purificato, Cristina; Catapano, Laura; Galluzzo, Clementina M.; Gauzzi, Maria Cristina; Vella, Stefano; Lefebvre, Eric; Seyedkazemi, Star; Andreotti, Mauro; Fantuzzi, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1839/1-1839/8</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3) family members are cytidine deaminases that play crucial roles in innate responses to retrovirus infection.  The mechanisms by which some of these enzymes restrict human immunodeficiency virus type 1 (HIV-1) replication have been extensively investigated in vitro.  However, little is known regarding how APOBEC3 proteins affect the pathogenesis of HIV-1 infection in vivo and how antiretroviral therapy influences their expression.  In this work, a longitudinal anal. was performed to evaluate APOBEC3G/3A expression in peripheral blood mononuclear cells of antiretroviral-naive HIV-1-infected individuals treated with cenicriviroc (CVC) or efavirenz (EFV) at baseline and 4, 12, 24, and 48 wk post-treatment follow-up.  While APOBEC3G expression was unaffected by therapy, APOBEC3A levels increased in CVC but not EFV arm at week 48 of treatment.  APOBEC3G expression correlated directly with CD4+ cell count and CD4+/CD8+ cell ratio, whereas APOBEC3A levels inversely correlated with plasma sol. CD14.  These findings suggest that higher APOBEC3G/3A levels may be assocd. with protective effects against HIV-1 disease progression and chronic inflammation and warrant further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW1mAXKsY6CLVg90H21EOLACvtfcHk0lieVi0j0AP4SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlWmu7vP&md5=747c08523fdeebcfa94148358b95ab20</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2018.01839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2018.01839%26sid%3Dliteratum%253Aachs%26aulast%3DCovino%26aufirst%3DD.%2BA.%26aulast%3DPurificato%26aufirst%3DC.%26aulast%3DCatapano%26aufirst%3DL.%26aulast%3DGalluzzo%26aufirst%3DC.%2BM.%26aulast%3DGauzzi%26aufirst%3DM.%2BC.%26aulast%3DVella%26aufirst%3DS.%26aulast%3DLefebvre%26aufirst%3DE.%26aulast%3DSeyedkazemi%26aufirst%3DS.%26aulast%3DAndreotti%26aufirst%3DM.%26aulast%3DFantuzzi%26aufirst%3DL.%26atitle%3DAPOBEC3G%252F3A%2520Expression%2520in%2520human%2520immunodeficiency%2520virus%2520type%25201-infected%2520individuals%2520following%2520initiation%2520of%2520antiretroviral%2520therapy%2520containing%2520cenicriviroc%2520or%2520efavirenz%26jtitle%3DFront.%2520Immunol.%26date%3D2018%26volume%3D9%26spage%3D1839%26doi%3D10.3389%2Ffimmu.2018.01839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span> <span> </span><span class="NLM_article-title">Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">971</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.03.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.bbrc.2004.03.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=15094363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1ams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=965-971&author=J.+H.+Wangauthor=S.+C.+Tamauthor=H.+Huangauthor=D.+Y.+Ouyangauthor=Y.+Y.+Wangauthor=Y.+T.+Zheng&title=Site-directed+PEGylation+of+trichosanthin+retained+its+anti-HIV+activity+with+reduced+potency+in+vitro&doi=10.1016%2Fj.bbrc.2004.03.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro</span></div><div class="casAuthors">Wang, Jian-Hua; Tam, Siu-Cheung; Huang, Hai; Ouyang, Dong-Yun; Wang, Yuan-Yuan; Zheng, Yong-Tang</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">965-971</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Trichosanthin (TCS) was the first ribosome inactivating protein found to possess anti-HIV-1 activity.  Phase I/II clin. trial of this compd. had been done.  Antigenicity and short plasma half-life were the major side effects preventing further clin. trial.  Modification of TCS is therefore necessary to revive the interest to develop this compd. as an anti-HIV agent.  Three potential antigenic sites (Ser-7, Lys-173, and Gln-219) were identified by computer modeling.  Through site-directed mutagenesis, these three antigenic amino acids were mutated to a cysteine residue resulting in 3 TCS mutants, namely S7C, K173C, and Q219C.  These mutants were further coupled to polyethylene glycol with a mol. size of 20 kDa (PEG) via the cysteine residue.  This produced another three TCS derivs., namely PEG20k-S7C, PEG20k-K173C, and PEG20k-Q219C.  PEGylation had been widely used recently to decrease immunogenicity by masking the antigenic sites and prolong plasma half-life by expanding the mol. size.  The in vitro anti-HIV-1 activity of these mutants and derivs. was tested.  Results showed that the anti-HIV-1 activity of S7C, K173C, and Q219C was decreased by about 1.5- to 5.5-fold with slightly lower cytotoxicity.  PEGylation produced larger decrease (20- to 30-fold) in anti-HIV activity.  Cytotoxicity was, however, weakened only slightly by about 3-fold.  The in vitro study showed that the anti-HIV activity of PEGylated TCS was retained with reduced potency.  The in vivo activity is expected to have only slightly changed due to other beneficial effects like prolonged half-life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppgNjt-zk_QLVg90H21EOLACvtfcHk0ljRFh6L1OdyFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1ams7k%253D&md5=a694d4a1a275132431272c7bc9bdbe95</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.03.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.03.139%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DTam%26aufirst%3DS.%2BC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DOuyang%26aufirst%3DD.%2BY.%26aulast%3DWang%26aufirst%3DY.%2BY.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26atitle%3DSite-directed%2520PEGylation%2520of%2520trichosanthin%2520retained%2520its%2520anti-HIV%2520activity%2520with%2520reduced%2520potency%2520in%2520vitro%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D965%26epage%3D971%26doi%3D10.1016%2Fj.bbrc.2004.03.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salie, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michailidis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA)</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">9274</span>– <span class="NLM_lpage">9279</span>, <span class="refDoi"> DOI: 10.1073/pnas.1605223113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1073%2Fpnas.1605223113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=27489345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=9274-9279&author=Z.+L.+Salieauthor=K.+A.+Kirbyauthor=E.+Michailidisauthor=B.+Marchandauthor=K.+Singhauthor=L.+C.+Rohanauthor=E.+N.+Kodamaauthor=H.+Mitsuyaauthor=M.+A.+Parniakauthor=S.+G.+Sarafianos&title=Structural+basis+of+HIV+inhibition+by+translocation-defective+RT+inhibitor+4%E2%80%B2-ethynyl-2-fluoro-2%E2%80%B2-deoxyadenosine+%28EFdA%29&doi=10.1073%2Fpnas.1605223113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)</span></div><div class="casAuthors">Salie, Zhe Li; Kirby, Karen A.; Michailidis, Eleftherios; Marchand, Bruno; Singh, Kamalendra; Rohan, Lisa C.; Kodama, Eiichi N.; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">9274-9279</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) is the most potent nucleoside analog inhibitor of HIV reverse transcriptase (RT).  It retains a 3'-OH yet acts as a chain-terminating agent by diminishing translocation from the pretranslocation nucleotide-binding site (N site) to the posttranslocation primer-binding site (P site).  Also, facile misincorporation of EFdA-monophosphate (MP) results in difficult-to-extend mismatched primers.  To understand the high potency and unusual inhibition mechanism of EFdA, we solved RT crystal structures (resolns. from 2.4 to 2.9 Å) that include inhibition intermediates (i) before inhibitor incorporation (catalytic complex, RT/DNA/EFdA-triphosphate), (ii) after incorporation of EFdA-MP followed by dT-MP (RT/DNAEFdA-MPSUP°P/SUP°buldT-MPSUP°N/SUP°), or (iii) after incorporation of two EFdA-MPs (RT/DNAEFdA-MPSUP°P/SUP°bulEFdA-MPSUP°N/SUP°); (iv) the latter was also solved with EFdA-MP mismatched at the N site (RT/DNAEFdA-MPSUP°P/SUP°bulEFdA-MPtSUP°N/SUP°).  We report that the inhibition mechanism and potency of EFdA stem from interactions of its 4'-ethynyl at a previously unexploited conserved hydrophobic pocket in the polymerase active site.  The high resoln. of the catalytic complex structure revealed a network of ordered water mols. at the polymerase active site that stabilize enzyme interactions with nucleotide and DNA substrates.  Finally, decreased translocation results from favorable interactions of primer-terminating EFdA-MP at the pretranslocation site and unfavorable posttranslocation interactions that lead to obsd. localized primer distortions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-6y_9SBl-hbVg90H21EOLACvtfcHk0ljRFh6L1OdyFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygt73K&md5=f3668fe0d312877907006a44549d1520</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1605223113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1605223113%26sid%3Dliteratum%253Aachs%26aulast%3DSalie%26aufirst%3DZ.%2BL.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DRohan%26aufirst%3DL.%2BC.%26aulast%3DKodama%26aufirst%3DE.%2BN.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520basis%2520of%2520HIV%2520inhibition%2520by%2520translocation-defective%2520RT%2520inhibitor%25204%25E2%2580%25B2-ethynyl-2-fluoro-2%25E2%2580%25B2-deoxyadenosine%2520%2528EFdA%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D9274%26epage%3D9279%26doi%3D10.1073%2Fpnas.1605223113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0ljRFh6L1OdyFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Betz, R. M.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham, T. E. I.</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Giese, T. J.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A. W.</span>; <span class="NLM_string-name">Homeyer, N.</span>; <span class="NLM_string-name">Izadi, S.</span>; <span class="NLM_string-name">Janowski, P.</span>; <span class="NLM_string-name">Kaus, J.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Lin, C.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Madej, B.</span>; <span class="NLM_string-name">Mermelstein, D.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Monard, G.</span>; <span class="NLM_string-name">Nguyen, H.</span>; <span class="NLM_string-name">Nguyen, H. T.</span>; <span class="NLM_string-name">Omelyan, I.</span>; <span class="NLM_string-name">Onufriev, A.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Sagui, C.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Botello-Smith, W. M.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wolf, R. M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Xiao, L.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> <i>AMBER 2016</i>, <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+A.+Case&author=R.+M.+Betz&author=D.+S.+Cerutti&author=T.+E.+I.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=T.+J.+Giese&author=H.+Gohlke&author=A.+W.+Goetz&author=N.+Homeyer&author=S.+Izadi&author=P.+Janowski&author=J.+Kaus&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=P.+Li&author=C.+Lin&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=D.+Mermelstein&author=K.+M.+Merz&author=G.+Monard&author=H.+Nguyen&author=H.+T.+Nguyen&author=I.+Omelyan&author=A.+Onufriev&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=C.+L.+Simmerling&author=W.+M.+Botello-Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=L.+Xiao&author=P.+A.+Kollman&title=AMBER+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26jtitle%3DAMBER%25202016%26pub%3DUniversity%2520of%2520California%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b'],'ref4':['cit4a','cit4b'],'ref5':['cit5a','cit5b'],'ref6':['cit6a','cit6b','cit6c','cit6d','cit6e','cit6f','cit6g'],'ref7':['cit7a','cit7b','cit7c','cit7d','cit7e','cit7f','cit7g'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f','cit8g','cit8h','cit8i','cit8j','cit8k','cit8l'],'ref9':['cit9a','cit9b','cit9c','cit9d'],'ref10':['cit10'],'ref11':['cit11a','cit11b','cit11c','cit11d'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 3 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Paramasivam Sivaguru, Yongquan Ning, <span class="NLM_string-name hlFld-ContribAuthor">Xihe Bi</span>. </span><span class="cited-content_cbyCitation_article-title">New Strategies for the Synthesis of Aliphatic Azides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (7)
                                     , 4253-4307. <a href="https://doi.org/10.1021/acs.chemrev.0c01124" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c01124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c01124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c01124%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DNew%252BStrategies%252Bfor%252Bthe%252BSynthesis%252Bof%252BAliphatic%252BAzides%26aulast%3DSivaguru%26aufirst%3DParamasivam%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D14102020%26date%3D26022021%26volume%3D121%26issue%3D7%26spage%3D4253%26epage%3D4307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Junbiao  Chang</span>. </span><span class="cited-content_cbyCitation_article-title">Azvudine (FNC): a promising clinical candidate for COVID-19 treatment. </span><span class="cited-content_cbyCitation_journal-name">Signal Transduction and Targeted Therapy</span><span> <strong>2020,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41392-020-00351-z" title="DOI URL">https://doi.org/10.1038/s41392-020-00351-z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41392-020-00351-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41392-020-00351-z%26sid%3Dliteratum%253Aachs%26jtitle%3DSignal%2520Transduction%2520and%2520Targeted%2520Therapy%26atitle%3DAzvudine%252B%252528FNC%252529%25253A%252Ba%252Bpromising%252Bclinical%252Bcandidate%252Bfor%252BCOVID-19%252Btreatment%26aulast%3DYu%26aufirst%3DBin%26date%3D2020%26date%3D2020%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Xia  Wang</span>, <span class="hlFld-ContribAuthor ">Wen-Peng  Li</span>, <span class="hlFld-ContribAuthor ">Mi-Mi  Zhang</span>, <span class="hlFld-ContribAuthor ">Ming-Sheng  Xie</span>, <span class="hlFld-ContribAuthor ">Gui-Rong  Qu</span>, <span class="hlFld-ContribAuthor ">Hai-Ming  Guo</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of chiral pyrimidine-substituted diester D–A cyclopropanes
              via
              asymmetric cyclopropanation of phenyliodonium ylides. </span><span class="cited-content_cbyCitation_journal-name">Chemical Communications</span><span> <strong>2020,</strong> <em>56 </em>
                                    (78)
                                     , 11649-11652. <a href="https://doi.org/10.1039/D0CC04536E" title="DOI URL">https://doi.org/10.1039/D0CC04536E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CC04536E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CC04536E%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Communications%26atitle%3DSynthesis%252Bof%252Bchiral%252Bpyrimidine-substituted%252Bdiester%252BD%2525E2%252580%252593A%252Bcyclopropanes%252Bvia%252Basymmetric%252Bcyclopropanation%252Bof%252Bphenyliodonium%252Bylides%26aulast%3DWang%26aufirst%3DHai-Xia%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D78%26spage%3D11649%26epage%3D11652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0007.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potent anti-HIV activity of FNC and its synergistic effect with other antiretroviral drugs. (A) Anti-HIV activity<b>.</b> Hut/CCR5 cells (0.5 × 10<sup>5</sup>) were infected with HIV-luc/JRFL (1 ng p24<sup>Gag</sup>) in the presence of different concentrations of FNC for 3 h; after washing, cells were further cultured in the presence of the same concentrations of FNC for additional 72 h. Cells were harvested and lysed, and viral infection was measured by detection of luciferase activity. EC<sub>50</sub> was calculated. (B) Cytotoxicity. Hut/CCR5 cells (0.5 × 10<sup>5</sup>) were treated with different concentrations of FNC for 72 h, and cell viability was analyzed with an MTT colorimetric assay. CC<sub>50</sub> was calculated. (C, D) Synergy assay. Hut/CCR5 cells (0.5 × 10<sup>5</sup>) were infected with HIV-luc/JRFL (1 ng p24<sup>Gag</sup>) in the presence of different combinations of FNC/dolutegravir (C) or FNC/ rilpivirine (D). CI values were calculated with the Chou and Talalay method, and the CI values for the combinations at 50, 75, 90, and 95% inhibition of infection are shown; where the <i>y</i>-axis represents the log of infection inhibited (Fa)/fraction virus uninhibited (Fu), and the <i>x</i>-axis represents the log of the drug dose [Log(D)] (nM) tested; concentrations plotted for the combination curve represent the concentrations of the total drug amount for the median effect plots. For dose–response plots, data points represent the concentration of each drug. Data are presented as mean ± standard deviations (SD); one representative result from four independent experiments is shown (A–D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Pharmacokinetic studies of FNC. (A, B) Concentration–time profiles of FNC (3TC) in plasma and FNC-TP (3TC-TP) in PBMCs of rhesus macaques. Three 7–10 kg adult male rhesus macaques were treated with a single oral administration of FNC at 1 and 6 mg/kg or lamivudine at 20 mg/kg. At the indicated times post-administration, the LC–MS/MS method was used to monitor the presence of FNC or 3TC in plasma (A), and the active form of FNC-TP or 3TC-TP in PBMCs (B). (C) FNC distribution in tissues or organs of rats. The Sprague–Dawley rats were administered a single oral dose of 0.5 mg/kg by gavage, and the tissues and organs were excised at the different times post-administration and used to monitor the FNC concentration with LC–MS/MS methods.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selective entry of FNC into target cells providing a long-lasting prevention of HIV-1 infection. (A) Cell distribution of FNC. Human PBMCs from healthy donors were isolated and further incubated with FNC (350 nM) for 4 h. CD14<sup>+</sup> monocytes and CD4<sup>+</sup> T cells were subsequently isolated using antibody-coated magnetic beads with a positive selection. The intracellular active forms of FNC-TP from CD14<sup>+</sup> monocytes, CD4<sup>+</sup> T cells, and the remaining cells were quantified by LC–MS/MS assay. Results from three donors are shown. (B–D) Long-lasting prevention of HIV-1 infection. Hut/CCR5 cells (1 × 10<sup>6</sup>) were incubated with different concentrations of FNC (0.1, 1, and 10 nM) or 3TC (1000 and 10,000 nM) at 37 °C for 4 h. After washing and removal of cell-free drugs, the cells were further incubated. At the indicated times, 0.5 × 10<sup>5</sup> cells were collected for infection with HIV-luc/JRFL (1 ng p24<sup>Gag</sup>) for an additional 72 h, and viral infection was measured by detecting luciferase activity. The inhibition of HIV-1 infection was analyzed (B), the time needed to reach 50% reduction of HIV-1 infection was calculated based on a regression cure of HIV-1 inhibition (C), and at each time-point, the cell number was counted by microscopy (D). Data were presented as mean ± SD. One representative result from at least three independent experiments is shown (B–D). *<i>p</i> < 0.05 and **<i>p</i> < 0.01 denote significant difference levels as determined by a paired <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. FNC restoring A3G expression. (A, B) FNC restoring A3G expression in HIV-infected patients. Three HIV-1-infected, treatment-naïve individuals were recruited and administered daily azvudine tablets containing 4 mg of FNC for 6 consecutive days. At day 0, immediately before initiation of treatment, and day 7, 1 day after completion of treatment, 20 mL of peripheral blood was collected for isolation of PBMCs and CD4<sup>+</sup> T cells. A3G expression in CD4<sup>+</sup> T cells was detected by Western blotting (A). Plasma viremia was measured by (RT-)qPCR quantification, and the peripheral CD4<sup>+</sup> T cell count was detected by flow cytometry (B). (C, D) FNC protecting A3G from Vif-induced degradation. A3G-expressing plasmids and/or pcDNA-Vif-HA were co-transfected into HEK293T cells, and cells were further treated with FNC (10 nM) or 3TC (1000 nM) for 24 h. MG132 (10 μM) was added 16 h prior to sample collection. A3G expression was detected by Western blotting with immunostaining with antibodies against Myc-tag, and Vif expression was indicated with antibodies against HA-tag (C); alternatively, A3G expression was detected by measuring the GFP intensity by flow cytometry (D). (E) Kinetic analysis of FNC or 3TC incorporation with the E3 ubiquitin ligase complex. A CM5 chip-based Biacore T200 system was used to measure the FNC incorporation with the Vif–CBFβ–ELOB–ELOC complex, and the dynamics of association was analyzed for different concentrations of FNC or 3TC. The binding phase of FNC or 3TC with the Vif complex was between 0 and 180 s, and the dissociation phase was between 180 and 330 s. (F) FNC inhibiting A3G polyubiquitination. The plasmids of pcDNA-APOBEC3G-Myc, pcDNA-ubiquitin-His, and/or pcDNA-Vif-HA were co-transfected into HEK293T cells, and cells were further treated with FNC (3.5 or 35 nM) for 24 h. MG132 (10 μM) was added 16 h prior to sample collection. Cells were harvested and lysed for Western blotting to detect the expression of His-ubiquitin with immunostaining with anti-His antibodies. Data were presented as mean ± SD. **<i>p</i> < 0.01 denotes significant difference levels as determined by a paired <i>t</i>-test.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/medium/jm0c00940_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Representative binding complex structure of FNC-TP and an HIV-1 reverse transcriptase derived from MD simulations. The HIV-1 reverse transcriptase is represented as a cartoon, and FNC-TP is shown in a stick form, colored in green. The residues interacting with FNC-TP are shown in stick in purple.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00940/20200806/images/large/jm0c00940_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00940&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15846" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15846" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 16 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Punekar, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Ruiter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhart, C.</span></span> <span> </span><span class="NLM_article-title">A review of long-term toxicity of antiretroviral treatment regimens and implications for an aging population</span>. <i>Infect. Dis. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">183</span>– <span class="NLM_lpage">195</span>, <span class="refDoi"> DOI: 10.1007/s40121-018-0201-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1007%2Fs40121-018-0201-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=29761330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A280%3ADC%252BC1Mfjt1OrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2018&pages=183-195&author=A.+Chawlaauthor=C.+Wangauthor=C.+Pattonauthor=M.+Murrayauthor=Y.+Punekarauthor=A.+de+Ruiterauthor=C.+Steinhart&title=A+review+of+long-term+toxicity+of+antiretroviral+treatment+regimens+and+implications+for+an+aging+population&doi=10.1007%2Fs40121-018-0201-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1aR"><div class="casContent"><span class="casTitleNuber">1a</span><div class="casTitle"><span class="NLM_cas:atitle">A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population</span></div><div class="casAuthors">Chawla Anita; Wang Christina; Patton Cody; Murray Miranda; Punekar Yogesh; de Ruiter Annemiek; Steinhart Corklin</div><div class="citationInfo"><span class="NLM_cas:title">Infectious diseases and therapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">183-195</span>
        ISSN:<span class="NLM_cas:issn">2193-8229</span>.
    </div><div class="casAbstract">Human immunodeficiency virus (HIV) is a chronic infectious disease currently requiring lifelong antiretroviral therapy (ART).  People living with HIV (PLWH) face an increased risk of comorbidities associated with aging, chronic HIV, and the toxicity arising from long-term ART.  A literature review was conducted to identify the most recent evidence documenting toxicities associated with long-term ART, particularly among aging PLWH.  In general, PLWH are at a greater risk of developing fractures, osteoporosis, renal and metabolic disorders, central nervous system disorders, cardiovascular disease, and liver disease.  There remains limited evidence describing the economic burden of long-term ART.  Overall, an aging HIV population treated with long-term ART presents a scenario in which the clinical, humanistic, and economic burden for healthcare systems will demand thoughtful policy solutions that preserve access to treatment.  Newer treatment regimens with fewer drugs may mitigate some of the cumulative toxicity burden of long-term ART.Funding: ViiV Healthcare.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6Mo5eNHhG0zEC-75aqa5AfW6udTcc2eYhktx5DPq0fbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mfjt1OrsA%253D%253D&md5=8d18a486d49c1cb39ee6f94fc40020e6</span></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1007%2Fs40121-018-0201-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40121-018-0201-6%26sid%3Dliteratum%253Aachs%26aulast%3DChawla%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DPatton%26aufirst%3DC.%26aulast%3DMurray%26aufirst%3DM.%26aulast%3DPunekar%26aufirst%3DY.%26aulast%3Dde%2BRuiter%26aufirst%3DA.%26aulast%3DSteinhart%26aufirst%3DC.%26atitle%3DA%2520review%2520of%2520long-term%2520toxicity%2520of%2520antiretroviral%2520treatment%2520regimens%2520and%2520implications%2520for%2520an%2520aging%2520population%26jtitle%3DInfect.%2520Dis.%2520Ther.%26date%3D2018%26volume%3D7%26spage%3D183%26epage%3D195%26doi%3D10.1007%2Fs40121-018-0201-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Monit, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R. K.</span></span> <span> </span><span class="NLM_article-title">The impact of HIV-1 drug escape on the global treatment landscape</span>. <i>Cell Host Microbe</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">48</span>– <span class="NLM_lpage">60</span>, <span class="refDoi"> DOI: 10.1016/j.chom.2019.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.chom.2019.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=31295424" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2019&pages=48-60&author=D.+A.+Collierauthor=C.+Monitauthor=R.+K.+Gupta&title=The+impact+of+HIV-1+drug+escape+on+the+global+treatment+landscape&doi=10.1016%2Fj.chom.2019.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">The Impact of HIV-1 Drug Escape on the Global Treatment Landscape</span></div><div class="casAuthors">Collier, D. A.; Monit, C.; Gupta, R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Host & Microbe</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">48-60</span>CODEN:
                <span class="NLM_cas:coden">CHMECB</span>;
        ISSN:<span class="NLM_cas:issn">1931-3128</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">The rising prevalence of HIV drug resistance (HIVDR) could threaten gains made in combating the HIV epidemic and compromise the 90-90-90 target proposed by United Nations Program on HIV/AIDS (UNAIDS) to have achieved virol. suppression in 90% of all persons receiving antiretroviral therapy (ART) by the year 2020.  HIVDR has implications for the persistence of HIV, the selection of current and future ART drug regimens, and strategies of vaccine and cure development.  Focusing on drug classes that are in clin. use, this Review critically summarizes what is known about the mechanisms the virus utilizes to escape drug control.  Armed with this knowledge, strategies to limit the expansion of HIVDR are proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_HuvocDGDR7Vg90H21EOLACvtfcHk0lgADNBAZg0tDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKjsr%252FN&md5=cf776f99e1f4f748c66862d0da15db7e</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1016%2Fj.chom.2019.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chom.2019.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DCollier%26aufirst%3DD.%2BA.%26aulast%3DMonit%26aufirst%3DC.%26aulast%3DGupta%26aufirst%3DR.%2BK.%26atitle%3DThe%2520impact%2520of%2520HIV-1%2520drug%2520escape%2520on%2520the%2520global%2520treatment%2520landscape%26jtitle%3DCell%2520Host%2520Microbe%26date%3D2019%26volume%3D26%26spage%3D48%26epage%3D60%26doi%3D10.1016%2Fj.chom.2019.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ohrui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohgo, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kitano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">Syntheses of 4’-C-ethynyl-beta-D-arabino- and 4’-C-ethynyl-2′-deoxy-beta-D-ribo-pentofuranosylpyrimidines and -purines and evaluation of their anti-HIV activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">4516</span>– <span class="NLM_lpage">4525</span>, <span class="refDoi"> DOI: 10.1021/jm000209n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm000209n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnt1OisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4516-4525&author=H.+Ohruiauthor=S.+Kohgoauthor=K.+Kitanoauthor=S.+Sakataauthor=E.+Kodamaauthor=K.+Yoshimuraauthor=M.+Matsuokaauthor=S.+Shigetaauthor=H.+Mitsuya&title=Syntheses+of+4%E2%80%99-C-ethynyl-beta-D-arabino-+and+4%E2%80%99-C-ethynyl-2%E2%80%B2-deoxy-beta-D-ribo-pentofuranosylpyrimidines+and+-purines+and+evaluation+of+their+anti-HIV+activity&doi=10.1021%2Fjm000209n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of 4'-C-Ethynyl-β-D-arabino- and 4'-C-Ethynyl-2'-deoxy-β-D-ribo-pentofuranosylpyrimidines and -purines and Evaluation of Their Anti-HIV Activity</span></div><div class="casAuthors">Ohrui, Hiroshi; Kohgo, Satoru; Kitano, Kenji; Sakata, Shinji; Kodama, Eiichi; Yoshimura, Kazuhisa; Matsuoka, Masao; Shigeta, Shiro; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">4516-4525</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">4'-C-Ethynyl-β-D-arabino- and 4'-C-ethynyl-2'-deoxy-β-D-ribo-pentofuranosylpyrimidine and -purine nucleosides were synthesized and evaluated for their in vitro anti-HIV activity.  The key intermediate, 4-C-ethynyl- or 4-C-triethylsilylethynyl-D-ribo-pentofuranose, was prepd. from D-glucose and glycosidated with various pyrimidine or purine bases.  The arabino pyrimidine derivs. were prepd. from the corresponding ribo derivs. via O2,2'-anhydro nucleosides.  The 2'-deoxy-ribo derivs. were synthesized by radical redn. of 2'-bromo or 2'- phenoxythiocarbonyloxy nucleosides.  Among these 4'-C-ethynyl nucleosides, seven analogs proved to be potent against HIV-1 in vitro with EC50 values ranging from 0.0003 to 0.03 μM.  These compds. also exerted activity against clin. and multi-dideoxy-nucleoside-resistant HIV-1 strains with comparable EC50 values.  Three such 4'-C-ethynyl-2'-deoxypurine analogs including 4'-C-ethynyl-2'-deoxyadenosine and 4'-C-ethynyl-2,6-diamino-2'-deoxypurine were less cytotoxic [selectivity indexes (SIs): 975-2733] than three 4'-C-ethynyl-2'-deoxycytidine analogs (SIs: 63-363).  4'-C-Ethynyl-5-fluoro-2'-deoxycytidine was least toxic (SI: >3333) and potent against all HIV strains tested.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_ZOZ0AOXN8LVg90H21EOLACvtfcHk0lgADNBAZg0tDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnt1OisL4%253D&md5=b87278f85ea7d883cacdfadbfab3ff15</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1021%2Fjm000209n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000209n%26sid%3Dliteratum%253Aachs%26aulast%3DOhrui%26aufirst%3DH.%26aulast%3DKohgo%26aufirst%3DS.%26aulast%3DKitano%26aufirst%3DK.%26aulast%3DSakata%26aufirst%3DS.%26aulast%3DKodama%26aufirst%3DE.%26aulast%3DYoshimura%26aufirst%3DK.%26aulast%3DMatsuoka%26aufirst%3DM.%26aulast%3DShigeta%26aufirst%3DS.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3DSyntheses%2520of%25204%25E2%2580%2599-C-ethynyl-beta-D-arabino-%2520and%25204%25E2%2580%2599-C-ethynyl-2%25E2%2580%25B2-deoxy-beta-D-ribo-pentofuranosylpyrimidines%2520and%2520-purines%2520and%2520evaluation%2520of%2520their%2520anti-HIV%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D4516%26epage%3D4525%26doi%3D10.1021%2Fjm000209n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ohrui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span> <span> </span><span class="NLM_article-title">4 -C-Substituted-2 -Deoxynucleosides A Family of Antiretroviral Agents Which are Potent Against Drug-Resistant HIV Variants</span>. <i>Curr. Drug Targets Infect. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.2174/1568005013343218</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.2174%2F1568005013343218" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=12455229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjslCrsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=1-10&author=H.+Ohruiauthor=H.+Mitsuya&title=4+-C-Substituted-2+-Deoxynucleosides+A+Family+of+Antiretroviral+Agents+Which+are+Potent+Against+Drug-Resistant+HIV+Variants&doi=10.2174%2F1568005013343218"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">4'-C-substituted-2'-deoxynucleosides: a family of antiretroviral agents which are potent against drug-resistant HIV variants</span></div><div class="casAuthors">Ohrui, Hiroshi; Mitsuya, Hiroaki</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Infectious Disorders</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>CODEN:
                <span class="NLM_cas:coden">CDTIAS</span>;
        ISSN:<span class="NLM_cas:issn">1568-0053</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with 25 refs.  In the past years, a variety of 4'-C-substituted-2'-deoxynucleosides (4'SdNs) were designed, synthesized, and examd. as potential therapeutics against human immunodeficiency virus (HIV) infection and certain such analogs proved to exert potent activity against HIV-1 in vitro.  Unlike currently available nucleoside reverse transcriptase (RT) inhibitors such as 3'-azido-3'-deoxythymidine (AZT), which have the 2',3'-dideoxy configuration and thereby cause DNA chain termination in the elongating proviral DNA, 4'SdNs do retain the 3'-α-OH moiety but also appear to work against retrovirus as proviral DNA chain terminators.  Several 4'SdNs have been shown to be active against various lab. and clin. HIV-1 strains including known drug-resistant HIV-1 variants.  Among such 4'SdNs is 4'-azido-2'-deoxythymidine (4'-AZT) which exerts potent antiviral activity against wild type and AZT-resistant clin. HIV strains.  More anti-HIV 4'SdNs have recently been reported including 4'-ethynylthymidine, 4'-ethynyl-2'-deoxy-D-ribofuranosyl-2,6-diaminopurine (4'-E-dDAP), 4'-ethynyl-2'-deoxyguanosine (4'-E-dG) and 4'-ethynyl-2'-deoxyadenosine (4'-E-dA).  The latter three analogs are highly potent against HIV-1 and HIV-2 with EC50 values ranging from 0.0003 to 0.01 μM and have favorable cytotoxicity profiles with selective index (SI) values ranging from 975 to 2600.  These 4'-ethynyl-2'-deoxynucleosides also exert potent activity against all known drug-resistant HIV-1 variants including the multi-dideoxynucleoside-resistant HIV and the variants with the 6-base pair inserts.  Some of these compds. have favorable pharmacol. properties and further development as potential therapeutics against HIV-1 infection is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM1mEtWgugVrVg90H21EOLACvtfcHk0lgADNBAZg0tDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjslCrsbw%253D&md5=fa439842fb091d8632edaafab8d5537f</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.2174%2F1568005013343218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568005013343218%26sid%3Dliteratum%253Aachs%26aulast%3DOhrui%26aufirst%3DH.%26aulast%3DMitsuya%26aufirst%3DH.%26atitle%3D4%2520-C-Substituted-2%2520-Deoxynucleosides%2520A%2520Family%2520of%2520Antiretroviral%2520Agents%2520Which%2520are%2520Potent%2520Against%2520Drug-Resistant%2520HIV%2520Variants%26jtitle%3DCurr.%2520Drug%2520Targets%2520Infect.%2520Disord.%26date%3D2001%26volume%3D1%26spage%3D1%26epage%3D10%26doi%3D10.2174%2F1568005013343218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis of new 2′-deoxy-2′-fluoro-4′-azido nucleoside analogues as potent anti-HIV agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4178</span>– <span class="NLM_lpage">4183</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2011.06.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.ejmech.2011.06.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=21745701" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2rtL%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=4178-4183&author=Q.+Wangauthor=W.+Huauthor=S.+Wangauthor=Z.+Panauthor=L.+Taoauthor=X.+Guoauthor=K.+Qianauthor=C.-H.+Chenauthor=K.-H.+Leeauthor=J.+Chang&title=Synthesis+of+new+2%E2%80%B2-deoxy-2%E2%80%B2-fluoro-4%E2%80%B2-azido+nucleoside+analogues+as+potent+anti-HIV+agents&doi=10.1016%2Fj.ejmech.2011.06.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of new 2'-deoxy-2'-fluoro-4'-azido nucleoside analogs as potent anti-HIV agents</span></div><div class="casAuthors">Wang, Qiang; Hu, Weidong; Wang, Shuyang; Pan, Zhenliang; Tao, Le; Guo, Xiaohe; Qian, Keduo; Chen, Chin-Ho; Lee, Kuo-Hsiung; Chang, Junbiao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4178-4183</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We prepd. 1-(4'-azido-2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)cytosine (I) and its hydrochloride salt (II) as potential antiviral agents based on the favorable antiviral profiles of 4'-substituted nucleosides.  Compds. I and II were synthesized from 1,3,5-O-tribenzoyl-2-deoxy-2-fluoro-D-arabinofuranoside in multiple steps, and their structures were unequivocally established by IR, 1H NMR, 13C NMR, and 19F NMR spectroscopy, HRMS, and X-ray crystallog.  Compds. I and II exhibited potent anti-HIV-1 activity (EC50: 0.3 and 0.13 nM, resp.) without significant cytotoxicity in concns. up to 100 μM.  Compd. II exhibited extremely potent anti-HIV activity against NL4-3 (wild-type), NL4-3 (K101E), and RTMDR viral strains, with EC50 values of 0.086, 0.15, and 0.11 nM, resp.  Due to the high potency of II, it was also screened against an NIH Reagent Program NRTI-resistant virus panel contg. eleven mutated viral strains and for cytotoxicity against six different human cell lines.  The results of this screening indicated that II is a novel NRTI that could be developed as an anti-AIDS clin. trial candidate to overcome drug-resistance issues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-NQktrJjnQLVg90H21EOLACvtfcHk0ljyc4GxsCyEtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2rtL%252FO&md5=72f2a93a502eb99225c843c88ede16db</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2011.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2011.06.020%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHu%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DPan%26aufirst%3DZ.%26aulast%3DTao%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DQian%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DC.-H.%26aulast%3DLee%26aufirst%3DK.-H.%26aulast%3DChang%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520new%25202%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluoro-4%25E2%2580%25B2-azido%2520nucleoside%2520analogues%2520as%2520potent%2520anti-HIV%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D4178%26epage%3D4183%26doi%3D10.1016%2Fj.ejmech.2011.06.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span> <span> </span><span class="NLM_article-title">Quantification of 2′-deoxy-2′-β-fluoro-4′-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">379</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2014.06.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.jpba.2014.06.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=24999865" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1OjtrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2014&pages=379-386&author=Y.+Pengauthor=T.+Chengauthor=L.+Dongauthor=Y.+Zhangauthor=X.+Chenauthor=J.+Jiangauthor=J.+Zhangauthor=X.+Guoauthor=M.+Guoauthor=J.+Changauthor=Q.+Wang&title=Quantification+of+2%E2%80%B2-deoxy-2%E2%80%B2-%CE%B2-fluoro-4%E2%80%B2-azidocytidine+in+rat+and+dog+plasma+using+liquid+chromatography-quadrupole+time-of-flight+and+liquid+chromatography-triple+quadrupole+mass+spectrometry%3A+Application+to+bioavailability+and+pharmacokinetic+studies&doi=10.1016%2Fj.jpba.2014.06.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4aR"><div class="casContent"><span class="casTitleNuber">4a</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of 2'-deoxy-2'-β-fluoro-4'-azidocytidine in rat and dog plasma using liquid chromatography-quadrupole time-of-flight and liquid chromatography-triple quadrupole mass spectrometry: Application to bioavailability and pharmacokinetic studies</span></div><div class="casAuthors">Peng, Youmei; Cheng, Tiefeng; Dong, Lihong; Zhang, Yuhai; Chen, Xiaojing; Jiang, Jinhua; Zhang, Jingmin; Guo, Xiaohe; Guo, Mintong; Chang, Junbiao; Wang, Qingduan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">379-386</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2'-Deoxy-2'-β-fluoro-4'-azidocytidine (FNC) is a novel pyrimidine analog that inhibits not only the replication of the hepatitis B virus (HBV), hepatitis C virus (HCV) and HIV but also the replication of lamivudine-resistant HBV, 4'-azidocytidine or 2'-β-methylcytidine-resistant HCV, and nucleoside reverse-transcriptase inhibitor-resistant HIV variants.  The present study was undertaken to evaluate the abs. oral bioavailability of FNC in rats and the pharmacokinetic properties of FNC after intragastric administration of single and multiple doses in rats and dogs.  A sensitive high-performance liq. chromatog. tandem quadrupole time-of-flight mass spectrometry (HPLC/Q-TOF MS) method and a reliable high-performance liq. chromatog. tandem triple quadrupole mass spectrometry (HPLC/QqQ MS/MS) method were established for the detn. of FNC in the rat and dog plasmas, resp.  The sample prepn. involved a protein-pptn. method with methanol after the addn. of lamivudine as an internal std.  FNC was analyzed by LC using a YMC-Pack Pro C18 column (150 mm × 4.6 mm, 3 μm) with methanol (contg. 0.3% formic acid): 10 mM ammonium acetate (contg. 0.3% formic acid, pH 2.8) (35:65, vol./vol.) as the mobile phase.  Both mass spectrometers were equipped with an electrospray ionization interface in the pos.-ion mode.  The linear range was from 2.00 to 2000.00 ng mL-1 in rat plasma and 0.50 to 400.00 ng mL-1 in dog plasma.  The intraday and interday precision were less than 10.55%, and the accuracy was in the range of -5.86 to 5.13%.  The mean recoveries were greater than 82.70% and 82.97% for FNC and IS, resp.  The HPLC/Q-TOF MS and HPLC/QqQ MS/MS methods were both successfully applied in the pharmacokinetic studies of FNC in rats and dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4LIrQ22KTXLVg90H21EOLACvtfcHk0ljyc4GxsCyEtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1OjtrbM&md5=0aa39c2b9dbf9610eadf5b067152596c</span></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2014.06.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2014.06.019%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DT.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DJiang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26atitle%3DQuantification%2520of%25202%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-%25CE%25B2-fluoro-4%25E2%2580%25B2-azidocytidine%2520in%2520rat%2520and%2520dog%2520plasma%2520using%2520liquid%2520chromatography-quadrupole%2520time-of-flight%2520and%2520liquid%2520chromatography-triple%2520quadrupole%2520mass%2520spectrometry%253A%2520Application%2520to%2520bioavailability%2520and%2520pharmacokinetic%2520studies%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2014%26volume%3D98%26spage%3D379%26epage%3D386%26doi%3D10.1016%2Fj.jpba.2014.06.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, S. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span> <span> </span><span class="NLM_article-title">Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e105617</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0105617</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1371%2Fjournal.pone.0105617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=25144636" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CisLzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e105617&author=R.+R.+Wangauthor=Q.+H.+Yangauthor=R.+H.+Luoauthor=Y.+M.+Pengauthor=S.+X.+Daiauthor=X.+J.+Zhangauthor=H.+Chenauthor=X.+Q.+Cuiauthor=Y.+J.+Liuauthor=J.+F.+Huangauthor=J.+B.+Changauthor=Y.+T.+Zheng&title=Azvudine%2C+a+novel+nucleoside+reverse+transcriptase+inhibitor+showed+good+drug+combination+features+and+better+inhibition+on+drug-resistant+strains+than+lamivudine+in+vitro&doi=10.1371%2Fjournal.pone.0105617"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4bR"><div class="casContent"><span class="casTitleNuber">4b</span><div class="casTitle"><span class="NLM_cas:atitle">Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro</span></div><div class="casAuthors">Wang, Rui-Rui; Yang, Qing-Hua; Luo, Rong-Hua; Peng, You-Mei; Dai, Shao-Xing; Zhang, Xing-Jie; Chen, Huan; Cui, Xue-Qing; Liu, Ya-Juan; Huang, Jing-Fei; Chang, Jun-Biao; Zheng, Yong-Tang</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">e105617/1-e105617/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus.  Here we reported the in vitro activity of azvudine against HIV-1 and HIV-2 when used alone or in combination with other antiretroviral drugs and its drug resistance features.  Azvudine exerted highly potent inhibition on HIV-1 (EC50s ranging from 0.03 to 6.92 nM) and HIV-2 (EC50s ranging from 0.018 to 0.025 nM).  It also showed synergism in combination with six approved anti-HIV drugs on both C8166 and PBMC.  In combination assay, the concns. of azvudine used were 1000 or 500 fold lower than other drugs.  Azvudine also showed potent inhibition on NRTI-resistant strains (L74V and T69N).  Although M184V caused 250 fold redn. in susceptibility, azvudine remained active at nanomolar range.  In in vitro induced resistant assay, the frequency of M184I mutation increased with induction time which suggests M184I as the key mutation in azvudine treatment.  As control, lamivudine treatment resulted in a higher frequency of M184I/V given the same induction time and higher occurrence of M184V was found.  Mol. modeling anal. suggests that steric hindrance is more pronounced in mutant M184I than M184V due to the azido group of azvudine.  The present data demonstrates the potential of azvudine as a complementary drug to current anti-HIV drugs.  M184I should be the key mutation, however, azvudine still remains active on HIV-1LAI-M184V at nanomolar range.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohMi_dHAZKtLVg90H21EOLACvtfcHk0ljyc4GxsCyEtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CisLzJ&md5=50ebf3198554ff4a35814f18d892cceb</span></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0105617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0105617%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DR.%2BR.%26aulast%3DYang%26aufirst%3DQ.%2BH.%26aulast%3DLuo%26aufirst%3DR.%2BH.%26aulast%3DPeng%26aufirst%3DY.%2BM.%26aulast%3DDai%26aufirst%3DS.%2BX.%26aulast%3DZhang%26aufirst%3DX.%2BJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DCui%26aufirst%3DX.%2BQ.%26aulast%3DLiu%26aufirst%3DY.%2BJ.%26aulast%3DHuang%26aufirst%3DJ.%2BF.%26aulast%3DChang%26aufirst%3DJ.%2BB.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26atitle%3DAzvudine%252C%2520a%2520novel%2520nucleoside%2520reverse%2520transcriptase%2520inhibitor%2520showed%2520good%2520drug%2520combination%2520features%2520and%2520better%2520inhibition%2520on%2520drug-resistant%2520strains%2520than%2520lamivudine%2520in%2520vitro%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De105617%26doi%3D10.1371%2Fjournal.pone.0105617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Wójtowicz-Rajchel, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and applications of fluorinated nucleoside analogues</span>. <i>J. Fluorine Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>143</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.jfluchem.2012.06.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.jfluchem.2012.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVyktrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=143&publication_year=2012&pages=11-48&author=H.+W%C3%B3jtowicz-Rajchel&title=Synthesis+and+applications+of+fluorinated+nucleoside+analogues&doi=10.1016%2Fj.jfluchem.2012.06.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and applications of fluorinated nucleoside analogues</span></div><div class="casAuthors">Wojtowicz-Rajchel, Hanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Fluorine Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">143</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-48</span>CODEN:
                <span class="NLM_cas:coden">JFLCAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-1139</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The review presents the synthesis of fluorinated highly modified nucleoside analogs-carbanucleosides, arom. nucleosides, acyclic nucleosides and related derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoszEDibYWln7Vg90H21EOLACvtfcHk0ljyY45JYcL1JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVyktrjE&md5=df4a032247b009439fcc6b2cab92116b</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1016%2Fj.jfluchem.2012.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jfluchem.2012.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DW%25C3%25B3jtowicz-Rajchel%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520applications%2520of%2520fluorinated%2520nucleoside%2520analogues%26jtitle%3DJ.%2520Fluorine%2520Chem.%26date%3D2012%26volume%3D143%26spage%3D11%26epage%3D48%26doi%3D10.1016%2Fj.jfluchem.2012.06.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 4-substituted fluoronucleoside analogs for the treatment of hepatitis B virus infection</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">3693</span>– <span class="NLM_lpage">3703</span>, <span class="refDoi"> DOI: 10.1021/jm5012963</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm5012963" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXntVWns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=3693-3703&author=Q.+Yangauthor=J.+Kangauthor=L.+Zhengauthor=X.+J.+Wangauthor=N.+Wanauthor=J.+Wuauthor=Y.+Qiaoauthor=P.+Niuauthor=S.+Q.+Wangauthor=Y.+Pengauthor=Q.+Wangauthor=W.+Yuauthor=J.+Chang&title=Synthesis+and+biological+evaluation+of+4-substituted+fluoronucleoside+analogs+for+the+treatment+of+hepatitis+B+virus+infection&doi=10.1021%2Fjm5012963"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of 4-Substituted Fluoronucleoside Analogs for the Treatment of Hepatitis B Virus Infection</span></div><div class="casAuthors">Yang, Qinghua; Kang, Jinfeng; Zheng, Liyun; Wang, Xue-Jun; Wan, Na; Wu, Jie; Qiao, Yan; Niu, Pengfei; Wang, Sheng-Qi; Peng, Youmei; Wang, Qingduan; Yu, Wenquan; Chang, Junbiao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3693-3703</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of 4-substituted fluoronucleosides have been synthesized in order to address the toxicity issue of the parent nucleoside I (R = H), and after in vitro evaluation, the cyclopropylamino analog 1f was selected for in vivo study.  In mice, this compd. exhibited a significantly improved toxicity profile.  Administered orally, nucleoside I (R = cyclopropyl) was well-tolerated at a dose up to 3 g/kg and showed insignificant toxicity on white blood cells and a low mutagenic effect at dosages up to 80 mg/kg (single) or 20 mg/kg/day (5 days).  In duck HBV (DHBV)-infected duck models, both the serum and liver DHBV DNA levels (74.2 and 82.1%, resp.) were markedly reduced by the treatment of I (R = cyclopropyl) at a dose of 1 mg/kg/day for 10 days.  In addn., both the viral DNA levels had a lower degree of recovery after withdrawal of the test compd. for 3 days.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpLHHBv3qosbVg90H21EOLACvtfcHk0ljyY45JYcL1JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXntVWns7k%253D&md5=af8c2d92f70e50105518ce2b88c05ceb</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1021%2Fjm5012963&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm5012963%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DWan%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DQiao%26aufirst%3DY.%26aulast%3DNiu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DS.%2BQ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25204-substituted%2520fluoronucleoside%2520analogs%2520for%2520the%2520treatment%2520of%2520hepatitis%2520B%2520virus%2520infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D3693%26epage%3D3703%26doi%3D10.1021%2Fjm5012963" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehy, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaddis, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malim, M. H.</span></span> <span> </span><span class="NLM_article-title">Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>418</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">650</span>, <span class="refDoi"> DOI: 10.1038/nature00939</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnature00939" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=12167863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD38XlvVyltLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=418&publication_year=2002&pages=646-650&author=A.+M.+Sheehyauthor=N.+C.+Gaddisauthor=J.+D.+Choiauthor=M.+H.+Malim&title=Isolation+of+a+human+gene+that+inhibits+HIV-1+infection+and+is+suppressed+by+the+viral+Vif+protein&doi=10.1038%2Fnature00939"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein</span></div><div class="casAuthors">Sheehy, Ann M.; Gaddis, Nathan C.; Choi, Jonathan D.; Malim, Michael H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">418</span>
        (<span class="NLM_cas:issue">6898</span>),
    <span class="NLM_cas:pages">646-650</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Viruses have developed diverse non-immune strategies to counteract host-mediated mechanisms that confer resistance to infection.  The Vif (virion infectivity factor) proteins are encoded by primate immunodeficiency viruses, most notably human immunodeficiency virus-1 (HIV-1).  These proteins are potent regulators of virus infection and replication and are consequently essential for pathogenic infections in vivo.  HIV-1 Vif seems to be required during the late stages of virus prodn. for the suppression of an innate antiviral phenotype that resides in human T lymphocytes.  Thus, in the absence of Vif, expression of this phenotype renders progeny virions non-infectious.  Here, the authors describe a unique cellular gene, CEM15, whose transient or stable expression in cells that do not normally express CEM15 recreates this phenotype, but whose antiviral action is overcome by the presence of Vif.  Because the Vif:CEM15 regulatory circuit is crit. for HIV-1 replication, perturbing the circuit may be a promising target for future HIV/AIDS therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXIBE3wFqXQLVg90H21EOLACvtfcHk0ljyY45JYcL1JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlvVyltLs%253D&md5=a4793b246832bce94dbf88f2604cc6b5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1038%2Fnature00939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature00939%26sid%3Dliteratum%253Aachs%26aulast%3DSheehy%26aufirst%3DA.%2BM.%26aulast%3DGaddis%26aufirst%3DN.%2BC.%26aulast%3DChoi%26aufirst%3DJ.%2BD.%26aulast%3DMalim%26aufirst%3DM.%2BH.%26atitle%3DIsolation%2520of%2520a%2520human%2520gene%2520that%2520inhibits%2520HIV-1%2520infection%2520and%2520is%2520suppressed%2520by%2520the%2520viral%2520Vif%2520protein%26jtitle%3DNature%26date%3D2002%26volume%3D418%26spage%3D646%26epage%3D650%26doi%3D10.1038%2Fnature00939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lippa, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belashov, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wedekind, J. E.</span></span> <span> </span><span class="NLM_article-title">Core-binding factor β increases the affinity between human Cullin 5 and HIV-1 Vif within an E3 ligase complex</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">8702</span>– <span class="NLM_lpage">8704</span>, <span class="refDoi"> DOI: 10.1021/bi301244z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi301244z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFKmtb3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8702-8704&author=J.+D.+Salterauthor=G.+M.+Lippaauthor=I.+A.+Belashovauthor=J.+E.+Wedekind&title=Core-binding+factor+%CE%B2+increases+the+affinity+between+human+Cullin+5+and+HIV-1+Vif+within+an+E3+ligase+complex&doi=10.1021%2Fbi301244z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Core-Binding Factor β Increases the Affinity between Human Cullin 5 and HIV-1 Vif within an E3 Ligase Complex</span></div><div class="casAuthors">Salter, Jason D.; Lippa, Geoffrey M.; Belashov, Ivan A.; Wedekind, Joseph E.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">8702-8704</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">HIV-1 Vif masquerades as a receptor for a cellular E3 ligase harboring Elongin B, Elongin C, and Cullin 5 (EloB/C/Cul5) proteins that facilitate degrdn. of the antiretroviral factor APOBEC3G (A3G).  This Vif-mediated activity requires human core-binding factor β (CBFβ) in contrast to cellular substrate receptors.  We obsd. calorimetrically that Cul5 binds tighter to full-length Vif(1-192)/EloB/C/CBFβ (Kd = 5±2 nM) than to Vif(95-192)/EloB/C (Kd = 327±40 nM), which cannot bind CBFβ.  A comparison of heat capacity changes supports a model in which CBFβ prestabilizes Vif(1-192) relative to Vif(95-192), consistent with a stronger interaction of Cul5 with Vif's C-terminal Zn2+-binding motif.  An addnl. interface between Cul5 and an N-terminal region of Vif appears to be plausible, which has therapeutic design implications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokY2KFD9TX6bVg90H21EOLACvtfcHk0ljIKDO5mEZIBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFKmtb3P&md5=c2f5a3ef5472271f24b3c84390954735</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fbi301244z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi301244z%26sid%3Dliteratum%253Aachs%26aulast%3DSalter%26aufirst%3DJ.%2BD.%26aulast%3DLippa%26aufirst%3DG.%2BM.%26aulast%3DBelashov%26aufirst%3DI.%2BA.%26aulast%3DWedekind%26aufirst%3DJ.%2BE.%26atitle%3DCore-binding%2520factor%2520%25CE%25B2%2520increases%2520the%2520affinity%2520between%2520human%2520Cullin%25205%2520and%2520HIV-1%2520Vif%2520within%2520an%2520E3%2520ligase%2520complex%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D8702%26epage%3D8704%26doi%3D10.1021%2Fbi301244z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span> <span> </span><span class="NLM_article-title">Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>505</i></span>,  <span class="NLM_fpage">229</span>– <span class="NLM_lpage">233</span>, <span class="refDoi"> DOI: 10.1038/nature12884</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnature12884" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=24402281" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltVOjuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=505&publication_year=2014&pages=229-233&author=Y.+Guoauthor=L.+Dongauthor=X.+Qiuauthor=Y.+Wangauthor=B.+Zhangauthor=H.+Liuauthor=Y.+Yuauthor=Y.+Zangauthor=M.+Yangauthor=Z.+Huang&title=Structural+basis+for+hijacking+CBF-%CE%B2+and+CUL5+E3+ligase+complex+by+HIV-1+Vif&doi=10.1038%2Fnature12884"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6cR"><div class="casContent"><span class="casTitleNuber">6c</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for hijacking CBF-β and CUL5 E3 ligase complex by HIV-1 Vif</span></div><div class="casAuthors">Guo, Yingying; Dong, Liyong; Qiu, Xiaolin; Wang, Yishu; Zhang, Bailing; Liu, Hongnan; Yu, You; Zang, Yi; Yang, Maojun; Huang, Zhiwei</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">505</span>
        (<span class="NLM_cas:issue">7482</span>),
    <span class="NLM_cas:pages">229-233</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The human immunodeficiency virus (HIV)-1 protein Vif has a central role in the neutralization of host innate defences by hijacking cellular proteasomal degrdn. pathways to subvert the antiviral activity of host restriction factors; however, the underlying mechanism by which Vif achieves this remains unclear.  Here we report a crystal structure of the Vif-CBF-β-CUL5-ELOB-ELOC complex.  The structure reveals that Vif, by means of two domains, organizes formation of the pentameric complex by interacting with CBF-β, CUL5 and ELOC.  The larger domain (α/β domain) of Vif binds to the same side of CBF-β as RUNX1, indicating that Vif and RUNX1 are exclusive for CBF-β binding.  Interactions of the smaller domain (α-domain) of Vif with ELOC and CUL5 are cooperative and mimic those of SOCS2 with the latter two proteins.  A unique zinc-finger motif of Vif, which is located between the two Vif domains, makes no contacts with the other proteins but stabilizes the conformation of the α-domain, which may be important for Vif-CUL5 interaction.  Together, our data reveal the structural basis for Vif hijacking of the CBF-β and CUL5 E3 ligase complex, laying a foundation for rational design of novel anti-HIV drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE0_bPXlE0z7Vg90H21EOLACvtfcHk0ljIKDO5mEZIBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltVOjuw%253D%253D&md5=2022c24fcc896db3e4bd280688af10a5</span></div><a href="/servlet/linkout?suffix=cit6c&amp;dbid=16384&amp;doi=10.1038%2Fnature12884&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature12884%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DY.%26aulast%3DDong%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DZang%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DZ.%26atitle%3DStructural%2520basis%2520for%2520hijacking%2520CBF-%25CE%25B2%2520and%2520CUL5%2520E3%2520ligase%2520complex%2520by%2520HIV-1%2520Vif%26jtitle%3DNature%26date%3D2014%26volume%3D505%26spage%3D229%26epage%3D233%26doi%3D10.1038%2Fnature12884" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pomerantz, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arunachalam, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, L.</span></span> <span> </span><span class="NLM_article-title">The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">94</span>– <span class="NLM_lpage">98</span>, <span class="refDoi"> DOI: 10.1038/nature01707</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnature01707" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=12808465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVelsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2003&pages=94-98&author=H.+Zhangauthor=B.+Yangauthor=R.+J.+Pomerantzauthor=C.+Zhangauthor=S.+C.+Arunachalamauthor=L.+Gao&title=The+cytidine+deaminase+CEM15+induces+hypermutation+in+newly+synthesized+HIV-1+DNA&doi=10.1038%2Fnature01707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6dR"><div class="casContent"><span class="casTitleNuber">6d</span><div class="casTitle"><span class="NLM_cas:atitle">The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA</span></div><div class="casAuthors">Zhang, Hui; Yang, Bin; Pomerantz, Roger J.; Zhang, Chune; Arunachalam, Shyamala C.; Gao, Ling</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">424</span>
        (<span class="NLM_cas:issue">6944</span>),
    <span class="NLM_cas:pages">94-98</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">High mutation frequency during reverse transcription has a principal role in the genetic variation of primate lentiviral populations.  It is the main driving force for the generation of drug resistance and the escape from immune surveillance.  G to A hypermutation is one of the characteristics of primate lentiviruses, as well as other retroviruses, during replication in vivo and in cell culture.  The mol. mechanisms of this process, however, remain to be clarified.  Here, we demonstrate that CEM15 (also known as apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G; APOBEC3G), an endogenous inhibitor of human immunodeficiency virus type 1 (HIV-1) replication, is a cytidine deaminase and is able to induce G to A hypermutation in newly synthesized viral DNA.  This effect can be counteracted by the HIV-1 virion infectivity factor (Vif).  It seems that this viral DNA mutator is a viral defense mechanism in host cells that may induce either lethal hypermutation or instability of the incoming nascent viral reverse transcripts, which could account for the Vif-defective phenotype.  Importantly, the accumulation of CEM15-mediated non-lethal hypermutation in the replicating viral genome could potently contribute to the genetic variation of primate lentiviral populations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG9B1FKCT5prVg90H21EOLACvtfcHk0ljIKDO5mEZIBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVelsL4%253D&md5=0e21f73e84dcf215f0a4efc2e7292a63</span></div><a href="/servlet/linkout?suffix=cit6d&amp;dbid=16384&amp;doi=10.1038%2Fnature01707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01707%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DPomerantz%26aufirst%3DR.%2BJ.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DArunachalam%26aufirst%3DS.%2BC.%26aulast%3DGao%26aufirst%3DL.%26atitle%3DThe%2520cytidine%2520deaminase%2520CEM15%2520induces%2520hypermutation%2520in%2520newly%2520synthesized%2520HIV-1%2520DNA%26jtitle%3DNature%26date%3D2003%26volume%3D424%26spage%3D94%26epage%3D98%26doi%3D10.1038%2Fnature01707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrlich, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.-F.</span></span> <span> </span><span class="NLM_article-title">Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2867</span>– <span class="NLM_lpage">2872</span>, <span class="refDoi"> DOI: 10.1101/gad.1250204</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1101%2Fgad.1250204" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=15574593" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFShu7nM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2004&pages=2867-2872&author=Y.+Yuauthor=Z.+Xiaoauthor=E.+S.+Ehrlichauthor=X.+Yuauthor=X.-F.+Yu&title=Selective+assembly+of+HIV-1+Vif-Cul5-ElonginB-ElonginC+E3+ubiquitin+ligase+complex+through+a+novel+SOCS+box+and+upstream+cysteines&doi=10.1101%2Fgad.1250204"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6eR"><div class="casContent"><span class="casTitleNuber">6e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective assembly of HIV-1 Vif-Cul5-elonginB-elonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines</span></div><div class="casAuthors">Yu, Yunkai; Xiao, Zuoxiang; Ehrlich, Elana S.; Yu, Xianghui; Yu, Xiao-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">2867-2872</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">APOBEC3G, which induces hypermutations in newly synthesized viral DNA, is suppressed by HIV-1 Vif, acting through Cul5-ElonginB-ElonginC E3 ubiquitin ligase.  We have now characterized a novel SOCS box in HIV-1 Vif that mediates its interaction with ElonginC.  In this SOCS box, alanine replaces the consensus cysteine in the previously identified SOCS box.  This new motif was necessary but insufficient for interaction with Cul5-ElonginB-ElonginC, as two highly conserved Cys residues outside the SOCS box were required to interact with Cul5 but not ElonginC.  Therefore, selective assembly with Cul5 vs. Cul2 E3 may require protein interfaces besides the SOCS-box-ElonginC interaction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4Mszl5z9PqLVg90H21EOLACvtfcHk0lh-LlSY2oA0BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFShu7nM&md5=a87ebea2600296a10eca42bcd0940e19</span></div><a href="/servlet/linkout?suffix=cit6e&amp;dbid=16384&amp;doi=10.1101%2Fgad.1250204&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1250204%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DY.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DEhrlich%26aufirst%3DE.%2BS.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DX.-F.%26atitle%3DSelective%2520assembly%2520of%2520HIV-1%2520Vif-Cul5-ElonginB-ElonginC%2520E3%2520ubiquitin%2520ligase%2520complex%2520through%2520a%2520novel%2520SOCS%2520box%2520and%2520upstream%2520cysteines%26jtitle%3DGenes%2520Dev.%26date%3D2004%26volume%3D18%26spage%3D2867%26epage%3D2872%26doi%3D10.1101%2Fgad.1250204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.-F.</span></span> <span> </span><span class="NLM_article-title">Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>302</i></span>,  <span class="NLM_fpage">1056</span>– <span class="NLM_lpage">1060</span>, <span class="refDoi"> DOI: 10.1126/science.1089591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1126%2Fscience.1089591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=14564014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXos1Cmsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=302&publication_year=2003&pages=1056-1060&author=X.+Yuauthor=Y.+Yuauthor=B.+Liuauthor=K.+Luoauthor=W.+Kongauthor=P.+Maoauthor=X.-F.+Yu&title=Induction+of+APOBEC3G+ubiquitination+and+degradation+by+an+HIV-1+Vif-Cul5-SCF+complex&doi=10.1126%2Fscience.1089591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6fR"><div class="casContent"><span class="casTitleNuber">6f</span><div class="casTitle"><span class="NLM_cas:atitle">Induction of APOBEC3G Ubiquitination and Degradation by an HIV-1 Vif-Cul5-SCF Complex</span></div><div class="casAuthors">Yu, Xianghui; Yu, Yunkai; Liu, Bindong; Luo, Kun; Kong, Wei; Mao, Panyong; Yu, Xiao-Fang</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">302</span>
        (<span class="NLM_cas:issue">5647</span>),
    <span class="NLM_cas:pages">1056-1060</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Human immunodeficiency virus-1 (HIV-1) Vif is essential for viral evasion of host antiviral factor CEM15/APOBEC3G.  We report that Vif interacts with cellular proteins Cul5, elongins B and C, and Rbx1 to form an Skp1-cullin-F-box (SCF)-like complex.  The ability of Vif to suppress antiviral activity of APOBEC3G was specifically dependent on Cul5-SCF function, allowing Vif to interact with APOBEC3G and induce its ubiquitination and degrdn.  A Vif mutant that interacted with APOBEC3G but not with Cul5-SCF was functionally inactive.  The Cul5-SCF was also required for Vif function in distantly related simian immunodeficiency virus mac.  These results indicate that the conserved Cul5-SCF pathway used by Vif is a potential target for antiviral development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGf6QtjED_krVg90H21EOLACvtfcHk0lh-LlSY2oA0BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXos1Cmsbo%253D&md5=0cb1c6691663653b228151fa32006ffa</span></div><a href="/servlet/linkout?suffix=cit6f&amp;dbid=16384&amp;doi=10.1126%2Fscience.1089591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1089591%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DLuo%26aufirst%3DK.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DMao%26aufirst%3DP.%26aulast%3DYu%26aufirst%3DX.-F.%26atitle%3DInduction%2520of%2520APOBEC3G%2520ubiquitination%2520and%2520degradation%2520by%2520an%2520HIV-1%2520Vif-Cul5-SCF%2520complex%26jtitle%3DScience%26date%3D2003%26volume%3D302%26spage%3D1056%26epage%3D1060%26doi%3D10.1126%2Fscience.1089591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mangeat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caron, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trono, D.</span></span> <span> </span><span class="NLM_article-title">Broad antiretroviral defence by human apobec3g through lethal editing of nascent reverse transcripts</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>424</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">103</span>, <span class="refDoi"> DOI: 10.1038/nature01709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnature01709" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=12808466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD3sXltVelsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=424&publication_year=2003&pages=99-103&author=B.+Mangeatauthor=P.+Turelliauthor=G.+Caronauthor=M.+Friedliauthor=L.+Perrinauthor=D.+Trono&title=Broad+antiretroviral+defence+by+human+apobec3g+through+lethal+editing+of+nascent+reverse+transcripts&doi=10.1038%2Fnature01709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6gR"><div class="casContent"><span class="casTitleNuber">6g</span><div class="casTitle"><span class="NLM_cas:atitle">Broad antiretroviral defense by human APOBEC3G through lethal editing of nascent reverse transcripts</span></div><div class="casAuthors">Mangeat, Bastien; Turelli, Priscilla; Caron, Gersende; Friedli, Marc; Perrin, Luc; Trono, Didier</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">424</span>
        (<span class="NLM_cas:issue">6944</span>),
    <span class="NLM_cas:pages">99-103</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Viral replication usually requires that innate intracellular lines of defense be overcome, a task usually accomplished by specialized viral gene products.  The virion infectivity factor (Vif) protein of human immunodeficiency virus (HIV) is required during the late stages of viral prodn. to counter the antiviral activity of APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G; also known as CEM15), a protein expressed notably in human T lymphocytes.  When produced in the presence of APOBEC3G, vif-defective virus is non-infectious.  APOBEC3G is closely related to APOBEC1, the central component of an RNA-editing complex that deaminates a cytosine residue in apoB mRNA.  APOBEC family members also have potent DNA mutator activity through dC deamination; however, whether the editing potential of APOBEC3G has any relevance to HIV inhibition is unknown.  Here, we demonstrate that it does, as APOBEC3G exerts its antiviral effect during reverse transcription to trigger G-to-A hypermutation in the nascent retroviral DNA.  We also find that APOBEC3G can act on a broad range of retroviruses in addn. to HIV, suggesting that hypermutation by editing is a general innate defense mechanism against this important group of pathogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvBB6bv6N02rVg90H21EOLACvtfcHk0lh-LlSY2oA0BA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXltVelsL8%253D&md5=357bb5bf3bf2b94d9054323e91a9856e</span></div><a href="/servlet/linkout?suffix=cit6g&amp;dbid=16384&amp;doi=10.1038%2Fnature01709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01709%26sid%3Dliteratum%253Aachs%26aulast%3DMangeat%26aufirst%3DB.%26aulast%3DTurelli%26aufirst%3DP.%26aulast%3DCaron%26aufirst%3DG.%26aulast%3DFriedli%26aufirst%3DM.%26aulast%3DPerrin%26aufirst%3DL.%26aulast%3DTrono%26aufirst%3DD.%26atitle%3DBroad%2520antiretroviral%2520defence%2520by%2520human%2520apobec3g%2520through%2520lethal%2520editing%2520of%2520nascent%2520reverse%2520transcripts%26jtitle%3DNature%26date%3D2003%26volume%3D424%26spage%3D99%26epage%3D103%26doi%3D10.1038%2Fnature01709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelico, L.</span></span> <span> </span><span class="NLM_article-title">Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e1004024</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1004024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1371%2Fjournal.ppat.1004024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=24651717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVWmsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&author=A.+Araauthor=R.+P.+Loveauthor=L.+Chelico&title=Different+mutagenic+potential+of+HIV-1+restriction+factors+APOBEC3G+and+APOBEC3F+is+determined+by+distinct+single-stranded+DNA+scanning+mechanisms&doi=10.1371%2Fjournal.ppat.1004024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7aR"><div class="casContent"><span class="casTitleNuber">7a</span><div class="casTitle"><span class="NLM_cas:atitle">Different mutagenic potential of HIV-1 restriction factors APOBEC3G and APOBEC3F is determined by distinct single-stranded DNA scanning mechanisms</span></div><div class="casAuthors">Ara, Anjuman; Love, Robin P.; Chelico, Linda</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1004024/1-e1004024/21, 21 pp.</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The APOBEC3 deoxycytidine deaminase family functions as host restriction factors that can block replication of Vif (virus infectivity factor) deficient HIV-1 virions to differing degrees by deaminating cytosines to uracils in single-stranded (-)HIV-1 DNA.  Upon replication of the (-)DNA to (+)DNA, the HIV-1 reverse transcriptase incorporates adenines opposite the uracils, thereby inducing C/G→T/A mutations that can functionally inactivate HIV-1.  Although both APOBEC3F and APOBEC3G are expressed in cell types HIV-1 infects and are suppressed by Vif, there has been no prior biochem. anal. of APOBEC3F, in contrast to APOBEC3G.  Using synthetic DNA substrates, we characterized APOBEC3F and found that similar to APOBEC3G; it is a processive enzyme and can deaminate at least two cytosines in a single enzyme-substrate encounter.  However, APOBEC3F scanning movement is distinct from APOBEC3G, and relies on jumping rather than both jumping and sliding.  APOBEC3F jumping movements were also different from APOBEC3G.  The lack of sliding movement from APOBEC3F is due to an 190NPM192 motif, since insertion of this motif into APOBEC3G decreases its sliding movements.  The APOBEC3G NPM mutant induced significantly less mutations in comparison to wild-type APOBEC3G in an in vitro model HIV-1 replication assay and single-cycle infectivity assay, indicating that differences in DNA scanning were relevant to restriction of HIV-1.  Conversely, mutation of the APOBEC3F 191Pro to 191Gly enables APOBEC3F sliding movements to occur.  Although APOBEC3F 190NGM192 could slide, the enzyme did not induce more mutagenesis than wild-type APOBEC3F, demonstrating that the unique jumping mechanism of APOBEC3F abrogates the influence of sliding on mutagenesis.  Overall, we demonstrate key differences in the impact of APOBEC3F- and APOBEC3G-induced mutagenesis on HIV-1 that supports a model in which both the processive DNA scanning mechanism and preferred deamination motif (APOBEC3F, 5'TTC; APOBEC3G 5'CCC) influences the mutagenic and gene inactivation potential of an APOBEC3 enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGribF9Fh6pYjLVg90H21EOLACvtfcHk0lglYZQ_Gx46Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVWmsrrF&md5=80c1b9c2985417973a5d57de76501f48</span></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004024%26sid%3Dliteratum%253Aachs%26aulast%3DAra%26aufirst%3DA.%26aulast%3DLove%26aufirst%3DR.%2BP.%26aulast%3DChelico%26aufirst%3DL.%26atitle%3DDifferent%2520mutagenic%2520potential%2520of%2520HIV-1%2520restriction%2520factors%2520APOBEC3G%2520and%2520APOBEC3F%2520is%2520determined%2520by%2520distinct%2520single-stranded%2520DNA%2520scanning%2520mechanisms%26jtitle%3DPLoS%2520Pathog.%26date%3D2014%26volume%3D10%26doi%3D10.1371%2Fjournal.ppat.1004024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bélanger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, M. A.</span></span> <span> </span><span class="NLM_article-title">Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G</span>. <i>J. Gen. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">2878</span>– <span class="NLM_lpage">2887</span>, <span class="refDoi"> DOI: 10.1099/vir.0.000214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1099%2Fvir.0.000214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=26048885" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XislCkur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2015&pages=2878-2887&author=K.+B%C3%A9langerauthor=M.+A.+Langlois&title=Comparative+analysis+of+the+gene-inactivating+potential+of+retroviral+restriction+factors+APOBEC3F+and+APOBEC3G&doi=10.1099%2Fvir.0.000214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the gene-inactivating potential of retroviral restriction factors APOBEC3F and APOBEC3G</span></div><div class="casAuthors">Belanger, Kasandra; Langlois, Marc-Andre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of General Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2878-2887</span>CODEN:
                <span class="NLM_cas:coden">JGVIAY</span>;
        ISSN:<span class="NLM_cas:issn">0022-1317</span>.
    
            (<span class="NLM_cas:orgname">Society for General Microbiology</span>)
        </div><div class="casAbstract">APOBEC3 (A3) proteins are host-encoded restriction factors that inhibit retrovirus infection by mutagenic deamination of cytosines in minus-strand DNA replication intermediates.  APOBEC3F (A3F) and APOBEC3G (A3G) are two of the most potent A3 enzymes in humans with each having a different target DNA specificity.  A3G prefers to deaminate cytosines preceded by a cytosine (5'-CC), whereas A3F preferentially targets cytosines preceded by a thymine (5'-TC).  Here we performed a detailed comparative anal. of retrovirus-encoded gene sequences edited by A3F and A3G, with the aim of correlating the context and intensity of the mutations with their effects on gene function.  Our results revealed that, when there are few (TGG) tryptophan codons in the sequence, both enzymes alter gene function with a similar efficiency when given equal opportunities to deaminate in their preferred target DNA context.  In contrast, tryptophan-rich genes are efficiently inactivated in the presence of a low mutational burden, through termination codon generation by A3G but not A3F.  Overall, our results clearly demonstrated that the target DNA specificity of an A3 enzyme along with the intensity of the mutational burden and the tryptophan content of the gene being targeted are the factors that have the most forceful influence on whether A3-induced mutations will favor either terminal inactivation or genetic diversification of a retrovirus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobOrYNLw3KWLVg90H21EOLACvtfcHk0lglYZQ_Gx46Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XislCkur4%253D&md5=73821f92c456482e45b49f667dc3b63d</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1099%2Fvir.0.000214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1099%252Fvir.0.000214%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25A9langer%26aufirst%3DK.%26aulast%3DLanglois%26aufirst%3DM.%2BA.%26atitle%3DComparative%2520analysis%2520of%2520the%2520gene-inactivating%2520potential%2520of%2520retroviral%2520restriction%2520factors%2520APOBEC3F%2520and%2520APOBEC3G%26jtitle%3DJ.%2520Gen.%2520Virol.%26date%3D2015%26volume%3D96%26spage%3D2878%26epage%3D2887%26doi%3D10.1099%2Fvir.0.000214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ara, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Follack, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolph, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelico, L.</span></span> <span> </span><span class="NLM_article-title">Mechanism of enhanced HIV restriction by virion coencapsidated cytidine deaminases APOBEC3F and APOBEC3G</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">e02230</span>– <span class="NLM_lpage">e02216</span>, <span class="refDoi"> DOI: 10.1128/jvi.02230-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1128%2FJVI.02230-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=27881650" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXptFGqtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2017&pages=e02230-e02216&author=A.+Araauthor=R.+P.+Loveauthor=T.+B.+Follackauthor=K.+A.+Ahmedauthor=M.+B.+Adolphauthor=L.+Chelico&title=Mechanism+of+enhanced+HIV+restriction+by+virion+coencapsidated+cytidine+deaminases+APOBEC3F+and+APOBEC3G&doi=10.1128%2Fjvi.02230-16"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of enhanced HIV restriction by virion coencapsidated cytidine deaminases APOBEC3F and APOBEC3G</span></div><div class="casAuthors">Ara, Anjuman; Love, Robin P.; Follack, Tyson B.; Ahmed, Khawaja A.; Adolph, Madison B.; Chelico, Linda</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e02230-16/1-e02230-16/19</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">1098-5514</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The APOBEC3 (A3) enzymes, A3G and A3F, are coordinately expressed in CD4+ T cells and can become coencapsidated into HIV-1 virions, primarily in the absence of the viral infectivity factor (Vif).  A3F and A3G are deoxycytidine deaminases that inhibit HIV-1 replication by inducing guanine-to-adenine hypermutation through deamination of cytosine to form uracil in minus-strand DNA.  The effect of the simultaneous presence of both A3G and A3F on HIV-1 restriction ability is not clear.  Here, we used a single-cycle infectivity assay and biochem. analyses to det. if coencapsidated A3G and A3F differ in their restriction capacity from A3G or A3F alone.  Proviral DNA sequencing demonstrated that compared to each A3 enzyme alone, A3G and A3F, when combined, had a coordinate effect on hypermutation.  Using size exclusion chromatog., rotational anisotropy, and in vitro deamination assays, we demonstrate that A3F promotes A3G deamination activity by forming an A3F/G hetero-oligomer in the absence of RNA which is more efficient at deaminating cytosines.  Further, A3F caused the accumulation of shorter reverse transcripts due to decreasing reverse transcriptase efficiency, which would leave single-stranded minus-strand DNA exposed for longer periods of time, enabling more deamination events to occur.  Although A3G and A3F are known to function alongside each other, these data provide evidence for an A3F/G hetero-oligomeric A3 with unique properties compared to each individual counterpart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqm96mEFTqOwLVg90H21EOLACvtfcHk0lglYZQ_Gx46Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXptFGqtbY%253D&md5=af6a4f0108d6037c0597bcea9e397aee</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1128%2FJVI.02230-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.02230-16%26sid%3Dliteratum%253Aachs%26aulast%3DAra%26aufirst%3DA.%26aulast%3DLove%26aufirst%3DR.%2BP.%26aulast%3DFollack%26aufirst%3DT.%2BB.%26aulast%3DAhmed%26aufirst%3DK.%2BA.%26aulast%3DAdolph%26aufirst%3DM.%2BB.%26aulast%3DChelico%26aufirst%3DL.%26atitle%3DMechanism%2520of%2520enhanced%2520HIV%2520restriction%2520by%2520virion%2520coencapsidated%2520cytidine%2520deaminases%2520APOBEC3F%2520and%2520APOBEC3G%26jtitle%3DJ.%2520Virol.%26date%3D2017%26volume%3D91%26spage%3De02230%26epage%3De02216%26doi%3D10.1128%2Fjvi.02230-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zennou, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bieniasz, P. D.</span></span> <span> </span><span class="NLM_article-title">Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>349</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2005.12.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.virol.2005.12.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=16460778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD28Xks1Onu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=2006&pages=31-40&author=V.+Zennouauthor=P.+D.+Bieniasz&title=Comparative+analysis+of+the+antiretroviral+activity+of+APOBEC3G+and+APOBEC3F+from+primates&doi=10.1016%2Fj.virol.2005.12.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7dR"><div class="casContent"><span class="casTitleNuber">7d</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative analysis of the antiretroviral activity of APOBEC3G and APOBEC3F from primates</span></div><div class="casAuthors">Zennou, Veronique; Bieniasz, Paul D.</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">349</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">APOBEC3G and APOBEC3F exhibit antiretroviral activity primarily as a consequence of their ability to deaminate cytidines in retroviral DNA.  Here, the authors compare the properties of APOBEC3F and APOBEC3G from human, macaque, and African green monkey (AGM).  While all APOBEC proteins tested exhibited anti-HIV-1 activity, human APOBEC3F was, surprisingly, 10- to 50-fold less potent than human APOBEC3G.  However, similar discrepancies in antiviral potency were not found when pairs of proteins from macaque and AGM were compared.  Intrinsic differences in the ability of each APOBEC protein to induce hypermutation, rather than differences in packaging efficiency, partially accounted for variable antiretroviral activity.  Each of four primate lentivirus Vif proteins reduced human and AGM APOBEC3F expression and antiviral activity, but all were only partially effective and species-specific effects were relatively minor.  Overall, highly efficient and species-specific neutralization of APOBEC3G, and less efficient neutralization of APOBEC3F, appears to be a general property of Vif proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC7k4S0qIV9rVg90H21EOLACvtfcHk0lglYZQ_Gx46Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xks1Onu78%253D&md5=403096fd2264f644cac4f456513b577f</span></div><a href="/servlet/linkout?suffix=cit7d&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2005.12.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2005.12.035%26sid%3Dliteratum%253Aachs%26aulast%3DZennou%26aufirst%3DV.%26aulast%3DBieniasz%26aufirst%3DP.%2BD.%26atitle%3DComparative%2520analysis%2520of%2520the%2520antiretroviral%2520activity%2520of%2520APOBEC3G%2520and%2520APOBEC3F%2520from%2520primates%26jtitle%3DVirology%26date%3D2006%26volume%3D349%26spage%3D31%26epage%3D40%26doi%3D10.1016%2Fj.virol.2005.12.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chaipan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, V. K.</span></span> <span> </span><span class="NLM_article-title">APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">444</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1128/JVI.00676-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1128%2FJVI.00676-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=23097438" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltV2jsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2013&pages=444-453&author=C.+Chaipanauthor=J.+L.+Smithauthor=W.+S.+Huauthor=V.+K.+Pathak&title=APOBEC3G+restricts+HIV-1+to+a+greater+extent+than+APOBEC3F+and+APOBEC3DE+in+human+primary+CD4%2B+T+cells+and+macrophages&doi=10.1128%2FJVI.00676-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7eR"><div class="casContent"><span class="casTitleNuber">7e</span><div class="casTitle"><span class="NLM_cas:atitle">APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages</span></div><div class="casAuthors">Chaipan, Chawaree; Smith, Jessica L.; Hu, Wei-Shau; Pathak, Vinay K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">444-453</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">APOBEC3 proteins inhibit HIV-1 replication in exptl. systems and induce hypermutation in infected patients; however, the relative contributions of several APOBEC3 proteins to restriction of HIV-1 replication in the absence of the viral Vif protein in human primary CD4+ T cells and macrophages are unknown.  We obsd. significant inhibition of HIV-1Δvif produced in 293T cells in the presence of APOBEC3DE (A3DE), APOBEC3F (A3F), APOBEC3G (A3G), and APOBEC3H haplotype II (A3H HapII) but not APOBEC3B (A3B), APOBEC3C (A3C), or APOBEC3H haplotype I (A3H HapI).  Our previous studies showed that Vif amino acids Y40RHHY44 are important for inducing proteasomal degrdn. of A3G, whereas amino acids 14DRMR17 are important for degrdn. of A3F and A3DE.  Here, we introduced substitution mutations of 40YRHHY44 and 14DRMR17 in replication-competent HIV-1 to generate vif mutants NL4-3 YRHHY>A5 and NL4-3 DRMR>A4 to compare the antiviral activity of A3G to the combined antiviral activity of A3F and A3DE in activated CD4+ T cells and macrophages.  During the first 15 days (round 1), in which multiple cycles of viral replication occurred, both the NL4-3 YRHHY>A5 and NL4-3 DRMR>A4 mutants replicated in activated CD4+ T cells and macrophages, and only the NL4-3 YRHHY>A5 mutant showed a 2- to 4-day delay in replication compared to the wild type.  During the subsequent 27 days (round 2) of cultures initiated with peak virus obtained from round 1, the NL4-3 YRHHY>A5 mutant exhibited a longer, 8- to 10-day delay and the NL4-3 DRMR>A4 mutant exhibited a 2- to 6-day delay in replication compared to the wild type.  The NL4-3 YRHHY>A5 and NL4-3 DRMR>A4 mutant proviruses displayed G-to-A hypermutations primarily in GG and GA dinucleotides as expected of A3G- and A3F- or A3DE-mediated deamination, resp.  We conclude that A3G exerts a greater restriction effect on HIV-1 than A3F and A3DE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOpC2WNMKisLVg90H21EOLACvtfcHk0lhdoakCTmfrdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltV2jsb4%253D&md5=f08c6c8fd28710b680985881f9951565</span></div><a href="/servlet/linkout?suffix=cit7e&amp;dbid=16384&amp;doi=10.1128%2FJVI.00676-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.00676-12%26sid%3Dliteratum%253Aachs%26aulast%3DChaipan%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DHu%26aufirst%3DW.%2BS.%26aulast%3DPathak%26aufirst%3DV.%2BK.%26atitle%3DAPOBEC3G%2520restricts%2520HIV-1%2520to%2520a%2520greater%2520extent%2520than%2520APOBEC3F%2520and%2520APOBEC3DE%2520in%2520human%2520primary%2520CD4%252B%2520T%2520cells%2520and%2520macrophages%26jtitle%3DJ.%2520Virol.%26date%3D2013%26volume%3D87%26spage%3D444%26epage%3D453%26doi%3D10.1128%2FJVI.00676-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeuchi, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Izumi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaori-Kondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aihara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koyanagi, Y.</span></span> <span> </span><span class="NLM_article-title">APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e1004453</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1004453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1371%2Fjournal.ppat.1004453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=25330146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyisbjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2014&author=K.+Satoauthor=J.+S.+Takeuchiauthor=N.+Misawaauthor=T.+Izumiauthor=T.+Kobayashiauthor=Y.+Kimuraauthor=S.+Iwamiauthor=A.+Takaori-Kondoauthor=W.+S.+Huauthor=K.+Aiharaauthor=M.+Itoauthor=D.+S.+Anauthor=V.+K.+Pathakauthor=Y.+Koyanagi&title=APOBEC3D+and+APOBEC3F+potently+promote+HIV-1+diversification+and+evolution+in+humanized+mouse+model&doi=10.1371%2Fjournal.ppat.1004453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7fR"><div class="casContent"><span class="casTitleNuber">7f</span><div class="casTitle"><span class="NLM_cas:atitle">APOBEC3D and APOBEC3F potently promote HIV-1 diversification and evolution in humanized mouse model</span></div><div class="casAuthors">Sato, Kei; Takeuchi, Junko S.; Misawa, Naoko; Izumi, Taisuke; Kobayashi, Tomoko; Kimura, Yuichi; Iwami, Shingo; Takaori-Kondo, Akifumi; Hu, Wei-shau; Aihara, Kazuyuki; Ito, Mamoru; An, Dong Sung; Pathak, Vinay K.; Koyanagi, Yoshio</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e1004453/1-e1004453/15, 15 pp.</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Several APOBEC3 proteins, particularly APOBEC3D, APOBEC3F and APOBEC3G, induce G-to-A hypermutations in HIV-1 genome and abrogate viral replication in exptl. systems, but their relative contributions to controlling viral replication and viral genetic variation in vivo have not been elucidated.  On the other hand, an HIV-1-encoded protein, Vif, can degrade these APOBEC3 proteins via a ubiquitin/proteasome pathway.  Although APOBEC3 proteins have been widely considered as potent restriction factors against HIV-1, it remains unclear which endogenous APOBEC3 protein(s) affect HIV-1 propagation in vivo.  Here we use a humanized mouse model and HIV-1 with mutations in Vif motifs that are responsible for specific APOBEC3 interactions, DRMR/AAAA (4A) or YRHHY/AAAAA (5A) and demonstrate that endogenous APOBEC3D/F and APOBEC3G exert strong anti-HIV-1 activity in vivo.  We also show that the growth kinetics of 4A HIV-1 neg. correlated with the expression level of APOBEC3F.  Moreover, single genome sequencing analyses of viral RNA in plasma of infected mice reveal that 4A HIV-1 is specifically and significantly diversified.  Furthermore, a mutated virus that is capable of using both CCR5 and CXCR4 as entry coreceptor is specifically detected in 4A HIV-1-infected mice.  Taken together, our results demonstrate that APOBEC3D/F and APOBEC3G fundamentally work as restriction factors against HIV-1 in vivo, but at the same time, that APOBEC3D and APOBEC3F are capable of promoting viral diversification and evolution in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq1aUjxdqezorVg90H21EOLACvtfcHk0lhdoakCTmfrdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyisbjF&md5=715df81dcd53223dcd95325063630324</span></div><a href="/servlet/linkout?suffix=cit7f&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1004453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1004453%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DK.%26aulast%3DTakeuchi%26aufirst%3DJ.%2BS.%26aulast%3DMisawa%26aufirst%3DN.%26aulast%3DIzumi%26aufirst%3DT.%26aulast%3DKobayashi%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DIwami%26aufirst%3DS.%26aulast%3DTakaori-Kondo%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DW.%2BS.%26aulast%3DAihara%26aufirst%3DK.%26aulast%3DIto%26aufirst%3DM.%26aulast%3DAn%26aufirst%3DD.%2BS.%26aulast%3DPathak%26aufirst%3DV.%2BK.%26aulast%3DKoyanagi%26aufirst%3DY.%26atitle%3DAPOBEC3D%2520and%2520APOBEC3F%2520potently%2520promote%2520HIV-1%2520diversification%2520and%2520evolution%2520in%2520humanized%2520mouse%2520model%26jtitle%3DPLoS%2520Pathog.%26date%3D2014%26volume%3D10%26doi%3D10.1371%2Fjournal.ppat.1004453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit7g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammadzadeh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Love, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arts, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poon, A. F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chelico, L.</span></span> <span> </span><span class="NLM_article-title">Role of co-expressed APOBEC3F and APOBEC3G in inducing HIV-1 drug resistance</span>. <i>Heliyon</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>5</i></span>, <span class="NLM_elocation-id">e01498</span> <span class="refDoi"> DOI: 10.1016/j.heliyon.2019.e01498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.heliyon.2019.e01498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=31025011" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2019&author=N.+Mohammadzadehauthor=R.+P.+Loveauthor=R.+Gibsonauthor=E.+J.+Artsauthor=A.+F.+Y.+Poonauthor=L.+Chelico&title=Role+of+co-expressed+APOBEC3F+and+APOBEC3G+in+inducing+HIV-1+drug+resistance&doi=10.1016%2Fj.heliyon.2019.e01498"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7g&amp;dbid=16384&amp;doi=10.1016%2Fj.heliyon.2019.e01498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.heliyon.2019.e01498%26sid%3Dliteratum%253Aachs%26aulast%3DMohammadzadeh%26aufirst%3DN.%26aulast%3DLove%26aufirst%3DR.%2BP.%26aulast%3DGibson%26aufirst%3DR.%26aulast%3DArts%26aufirst%3DE.%2BJ.%26aulast%3DPoon%26aufirst%3DA.%2BF.%2BY.%26aulast%3DChelico%26aufirst%3DL.%26atitle%3DRole%2520of%2520co-expressed%2520APOBEC3F%2520and%2520APOBEC3G%2520in%2520inducing%2520HIV-1%2520drug%2520resistance%26jtitle%3DHeliyon%26date%3D2019%26volume%3D5%26doi%3D10.1016%2Fj.heliyon.2019.e01498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. C.</span></span> <span> </span><span class="NLM_article-title">A new class of antiretroviral enabling innate immunity by protecting APOBEC3 from HIV Vif-dependent degradation</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">507</span>– <span class="NLM_lpage">520</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2018.03.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.molmed.2018.03.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=29609878" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlslKntbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2018&pages=507-520&author=R.+P.+Bennettauthor=J.+D.+Salterauthor=H.+C.+Smith&title=A+new+class+of+antiretroviral+enabling+innate+immunity+by+protecting+APOBEC3+from+HIV+Vif-dependent+degradation&doi=10.1016%2Fj.molmed.2018.03.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">A New Class of Antiretroviral Enabling Innate Immunity by Protecting APOBEC3 from HIV Vif-Dependent Degradation</span></div><div class="casAuthors">Bennett, Ryan P.; Salter, Jason D.; Smith, Harold C.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">507-520</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The infectivity of HIV depends on overcoming APOBEC3 (A3) innate immunity, predominantly through the expression of the viral protein Vif, which induces A3 degrdn. in the proteasome.  Disruption of the functional interactions of Vif enables A3 mutagenesis of the HIV genome during viral replication, which can result in a broadly neutralizing antiviral effect.  Vif function requires self-assocn. along with interactions with A3 proteins, protein chaperones, and factors of the ubiquitination machinery and these are described here as a potential platform for novel antiviral drug discovery.  This Review will examine the current state of development of Vif inhibitors that we believe to have therapeutic and functional cure potential.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYFlHx5NZHQbVg90H21EOLACvtfcHk0lhgS3FjhEBmDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlslKntbs%253D&md5=926251d193e3fa81d373248c00103b91</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2018.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2018.03.004%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DR.%2BP.%26aulast%3DSalter%26aufirst%3DJ.%2BD.%26aulast%3DSmith%26aufirst%3DH.%2BC.%26atitle%3DA%2520new%2520class%2520of%2520antiretroviral%2520enabling%2520innate%2520immunity%2520by%2520protecting%2520APOBEC3%2520from%2520HIV%2520Vif-dependent%2520degradation%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2018%26volume%3D24%26spage%3D507%26epage%3D520%26doi%3D10.1016%2Fj.molmed.2018.03.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Reingewertz, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Britan-Rosich, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rotem-Bamberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Viard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blumenthal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedler, A.</span></span> <span> </span><span class="NLM_article-title">Mapping the Vif-A3G interaction using peptide arrays: a basis for anti-HIV lead peptides</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3523</span>– <span class="NLM_lpage">3532</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2013.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.bmc.2013.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=23545135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC3sXltVGis74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=3523-3532&author=T.+H.+Reingewertzauthor=E.+Britan-Rosichauthor=S.+Rotem-Bambergerauthor=M.+Viardauthor=A.+Jacobsauthor=A.+Millerauthor=J.+Y.+Leeauthor=J.+Hwangauthor=R.+Blumenthalauthor=M.+Kotlerauthor=A.+Friedler&title=Mapping+the+Vif-A3G+interaction+using+peptide+arrays%3A+a+basis+for+anti-HIV+lead+peptides&doi=10.1016%2Fj.bmc.2013.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Mapping the Vif-A3G interaction using peptide arrays: A basis for anti-HIV lead peptides</span></div><div class="casAuthors">Reingewertz, Tali H.; Britan-Rosich, Elena; Rotem-Bamberger, Shahar; Viard, Mathias; Jacobs, Amy; Miller, Abigail; Lee, Ji Youn; Hwang, Jeeseong; Blumenthal, Robert; Kotler, Moshe; Friedler, Assaf</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3523-3532</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Human apolipoprotein-B mRNA-editing catalytic polypeptide-like 3G (A3G) is a cytidine deaminase that restricts retroviruses, endogenous retro-elements and DNA viruses.  A3G plays a key role in the anti-HIV-1 innate cellular immunity.  The HIV-1 Vif protein counteracts A3G mainly by leading A3G towards the proteosomal machinery and by direct inhibition of its enzymic activity.  Both activities involve direct interaction between Vif and A3G.  Disrupting the interaction between A3G and Vif may rescue A3G antiviral activity and inhibit HIV-1 propagation.  Here, mapping the interaction sites between A3G and Vif by peptide array screening revealed distinct regions in Vif important for A3G binding, including the N-terminal domain (NTD), C-terminal domain (CTD) and residues 83-99.  The Vif-binding sites in A3G included 12 different peptides that showed strong binding to either full-length Vif, Vif CTD or both.  Sequence similarity was found between Vif-binding peptides from the A3G CTD and NTD.  A3G peptides were synthesized and tested for their ability to counteract Vif action.  A3G 211-225 inhibited HIV-1 replication in cell culture and impaired Vif dependent A3G degrdn.  In vivo co-localization of full-length Vif with A3G 211-225 was demonstrated by use of FRET.  This peptide has the potential to serve as an anti-HIV-1 lead compd.  Our results suggest a complex interaction between Vif and A3G that is mediated by discontinuous binding regions with different affinities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8G3Ff-movXrVg90H21EOLACvtfcHk0lhgS3FjhEBmDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXltVGis74%253D&md5=7eb43d623b55b2d0cbbae7758afd3b28</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2013.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2013.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DReingewertz%26aufirst%3DT.%2BH.%26aulast%3DBritan-Rosich%26aufirst%3DE.%26aulast%3DRotem-Bamberger%26aufirst%3DS.%26aulast%3DViard%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DA.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26aulast%3DHwang%26aufirst%3DJ.%26aulast%3DBlumenthal%26aufirst%3DR.%26aulast%3DKotler%26aufirst%3DM.%26aulast%3DFriedler%26aufirst%3DA.%26atitle%3DMapping%2520the%2520Vif-A3G%2520interaction%2520using%2520peptide%2520arrays%253A%2520a%2520basis%2520for%2520anti-HIV%2520lead%2520peptides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D3523%26epage%3D3532%26doi%3D10.1016%2Fj.bmc.2013.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pery, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nebane, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brazier, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rajendran, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buhrlage, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabuzda, D.</span></span> <span> </span><span class="NLM_article-title">Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>290</i></span>,  <span class="NLM_fpage">10504</span>– <span class="NLM_lpage">10517</span>, <span class="refDoi"> DOI: 10.1074/jbc.M114.626903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1074%2Fjbc.M114.626903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=25724652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsF2lu7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=290&publication_year=2015&pages=10504-10517&author=E.+Peryauthor=A.+Sheehyauthor=N.+M.+Nebaneauthor=A.+J.+Brazierauthor=V.+Misraauthor=K.+S.+Rajendranauthor=S.+J.+Buhrlageauthor=M.+K.+Mankowskiauthor=L.+Rasmussenauthor=E.+L.+Whiteauthor=R.+G.+Ptakauthor=D.+Gabuzda&title=Identification+of+a+novel+HIV-1+inhibitor+targeting+Vif-dependent+degradation+of+human+APOBEC3G+protein&doi=10.1074%2Fjbc.M114.626903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8cR"><div class="casContent"><span class="casTitleNuber">8c</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Novel HIV-1 Inhibitor Targeting Vif-dependent Degradation of Human APOBEC3G Protein</span></div><div class="casAuthors">Pery, Erez; Sheehy, Ann; Nebane, N. Miranda; Brazier, Andrew Jay; Misra, Vikas; Rajendran, Kottampatty S.; Buhrlage, Sara J.; Mankowski, Marie K.; Rasmussen, Lynn; White, E. Lucile; Ptak, Roger G.; Gabuzda, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">290</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10504-10517</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">APOBEC3G (A3G) is a cellular cytidine deaminase that restricts HIV-1 replication by inducing G-to-A hypermutation in viral DNA and by deamination-independent mechanisms.  HIV-1 Vif binds to A3G, resulting in its degrdn. via the 26 S proteasome.  Therefore, this interaction represents a potential therapeutic target.  To identify compds. that inhibit interaction between A3G and HIV-1 Vif in a high throughput format, the authors developed a homogeneous time-resolved fluorescence resonance energy transfer assay.  A 307,520 compd. library from the NIH Mol. Libraries Small Mol. Repository was screened.  Secondary screens to evaluate dose-response performance and off-target effects, cell-based assays to identify compds. that attenuate Vif-dependent degrdn. of A3G, and assays testing antiviral activity in peripheral blood mononuclear cells and T cells were employed.  One compd., N.41, showed potent antiviral activity in A3G(+) but not in A3G(-) T cells and had an IC50 as low as 8.4 μm and a TC50 of >100 μm when tested against HIV-1Ba-L replication in peripheral blood mononuclear cells.  N.41 inhibited the Vif-A3G interaction and increased cellular A3G levels and incorporation of A3G into virions, thereby attenuating virus infectivity in a Vif-dependent manner.  N.41 activity was also species- and Vif-dependent.  Preliminary structure-activity relation studies suggest that a hydroxyl moiety located at a phenylamino group is crit. for N.41 anti-HIV activity and identified N.41 analogs with better potency (IC50 as low as 4.2 μm).  These findings identify a new lead compd. that attenuates HIV replication by liberating A3G from Vif regulation and increasing its innate antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDZALKQSjuVrVg90H21EOLACvtfcHk0lhgS3FjhEBmDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsF2lu7c%253D&md5=f14381987a1d698f975ba516b001a652</span></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M114.626903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M114.626903%26sid%3Dliteratum%253Aachs%26aulast%3DPery%26aufirst%3DE.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DNebane%26aufirst%3DN.%2BM.%26aulast%3DBrazier%26aufirst%3DA.%2BJ.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DRajendran%26aufirst%3DK.%2BS.%26aulast%3DBuhrlage%26aufirst%3DS.%2BJ.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DRasmussen%26aufirst%3DL.%26aulast%3DWhite%26aufirst%3DE.%2BL.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DGabuzda%26aufirst%3DD.%26atitle%3DIdentification%2520of%2520a%2520novel%2520HIV-1%2520inhibitor%2520targeting%2520Vif-dependent%2520degradation%2520of%2520human%2520APOBEC3G%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2015%26volume%3D290%26spage%3D10504%26epage%3D10517%26doi%3D10.1074%2Fjbc.M114.626903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Z. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, J. D.</span></span> <span> </span><span class="NLM_article-title">Small molecular compounds inhibit HIV-1 replication through specifically stabilizing APOBEC3G</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>285</i></span>,  <span class="NLM_fpage">16546</span>– <span class="NLM_lpage">16552</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.085308</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1074%2Fjbc.M109.085308" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=20363737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtlygs7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2010&pages=16546-16552&author=S.+Cenauthor=Z.+G.+Pengauthor=X.+Y.+Liauthor=Z.+R.+Liauthor=J.+Maauthor=Y.+M.+Wangauthor=B.+Fanauthor=X.+F.+Youauthor=Y.+P.+Wangauthor=F.+Liuauthor=R.+G.+Shaoauthor=L.+X.+Zhaoauthor=L.+Yuauthor=J.+D.+Jiang&title=Small+molecular+compounds+inhibit+HIV-1+replication+through+specifically+stabilizing+APOBEC3G&doi=10.1074%2Fjbc.M109.085308"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecular Compounds Inhibit HIV-1 Replication through Specifically Stabilizing APOBEC3G</span></div><div class="casAuthors">Cen, Shan; Peng, Zong-Gen; Li, Xiao-Yu; Li, Zhuo-Rong; Ma, Jing; Wang, Yue-Ming; Fan, Bo; You, Xue-Fu; Wang, Yu-Ping; Liu, Fei; Shao, Rong-Guang; Zhao, Li-Xun; Yu, Liyan; Jiang, Jian-Dong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">16546-16552</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">APOBEC3G (hA3G) is a host inhibitor for human immunodeficiency virus, type 1 (HIV-1).  However, HIV-1 Vif binds hA3G and induces its degrdn.  We have established a screening system to discover inhibitors that protect hA3G from Vif-mediated degrdn.  Through screening, compds. IMB-26 and IMB-35 were identified to be specific inhibitors for the degrdn. of hA3G by Vif.  The inhibitors suppressed HIV-1 replication in hA3G-contg. cells but not in those without hA3G.  The anti-HIV effect correlated with the endogenous hA3G level.  HIV-1 particles from hA3G(+) cells treated with IMB-26/35 contained a hA3G level higher than that from those without IMB-26/35 treatment and showed decreased infectivity.  IMB-26/35 bound directly to the hA3G protein, suppressed Vif/hA3G interaction, and therefore protected hA3G from Vif-mediated degrdn.  The compds. were safe with an anti-HIV therapeutic index >200 in vitro.  LD50 of IMB-26 in mice was >1000 mg/kg (i.p.).  Therefore, IMB-26 and IMB-35 are novel anti-HIV leads working through specific stabilization of hA3G.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6S5ic-i8s_bVg90H21EOLACvtfcHk0ljG5S9xDwUt8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtlygs7k%253D&md5=dc861b059d80cd5da86af1dd4e3874d3</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.085308&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.085308%26sid%3Dliteratum%253Aachs%26aulast%3DCen%26aufirst%3DS.%26aulast%3DPeng%26aufirst%3DZ.%2BG.%26aulast%3DLi%26aufirst%3DX.%2BY.%26aulast%3DLi%26aufirst%3DZ.%2BR.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%2BM.%26aulast%3DFan%26aufirst%3DB.%26aulast%3DYou%26aufirst%3DX.%2BF.%26aulast%3DWang%26aufirst%3DY.%2BP.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DShao%26aufirst%3DR.%2BG.%26aulast%3DZhao%26aufirst%3DL.%2BX.%26aulast%3DYu%26aufirst%3DL.%26aulast%3DJiang%26aufirst%3DJ.%2BD.%26atitle%3DSmall%2520molecular%2520compounds%2520inhibit%2520HIV-1%2520replication%2520through%2520specifically%2520stabilizing%2520APOBEC3G%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2010%26volume%3D285%26spage%3D16546%26epage%3D16552%26doi%3D10.1074%2Fjbc.M109.085308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Miyakawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanou, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morishita, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudoh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shindo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokoyama, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takaori-Kondo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryo, A.</span></span> <span> </span><span class="NLM_article-title">ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">6945</span>, <span class="refDoi"> DOI: 10.1038/ncomms7945</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fncomms7945" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=25901786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtF2it7nF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=6945&author=K.+Miyakawaauthor=S.+Matsunagaauthor=K.+Kanouauthor=A.+Matsuzawaauthor=R.+Morishitaauthor=A.+Kudohauthor=K.+Shindoauthor=M.+Yokoyamaauthor=H.+Satoauthor=H.+Kimuraauthor=T.+Tamuraauthor=N.+Yamamotoauthor=H.+Ichijoauthor=A.+Takaori-Kondoauthor=A.+Ryo&title=ASK1+restores+the+antiviral+activity+of+APOBEC3G+by+disrupting+HIV-1+Vif-mediated+counteraction&doi=10.1038%2Fncomms7945"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">ASK1 restores the antiviral activity of APOBEC3G by disrupting HIV-1 Vif-mediated counteraction</span></div><div class="casAuthors">Miyakawa, Kei; Matsunaga, Satoko; Kanou, Kazuhiko; Matsuzawa, Atsushi; Morishita, Ryo; Kudoh, Ayumi; Shindo, Keisuke; Yokoyama, Masaru; Sato, Hironori; Kimura, Hirokazu; Tamura, Tomohiko; Yamamoto, Naoki; Ichijo, Hidenori; Takaori-Kondo, Akifumi; Ryo, Akihide</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">6945</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">APOBEC3G (A3G) is an innate antiviral restriction factor that strongly inhibits the replication of human immunodeficiency virus type 1 (HIV-1).  An HIV-1 accessory protein, Vif, hijacks the host ubiquitin-proteasome system to execute A3G degrdn.  Identification of the host pathways that obstruct the action of Vif could provide a new strategy for blocking viral replication.  We demonstrate here that the host protein ASK1 (apoptosis signal-regulating kinase 1) interferes with the counteraction by Vif and revitalizes A3G-mediated viral restriction.  ASK1 binds the BC-box of Vif, thereby disrupting the assembly of the Vif-ubiquitin ligase complex.  Consequently, ASK1 stabilizes A3G and promotes its incorporation into viral particles, ultimately reducing viral infectivity.  Furthermore, treatment with the antiretroviral drug AZT (zidovudine) induces ASK1 expression and restores the antiviral activity of A3G in HIV-1-infected cells.  This study thus demonstrates a distinct function of ASK1 in restoring the host antiviral system that can be enhanced by AZT treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrTJnh6PZVvbVg90H21EOLACvtfcHk0ljG5S9xDwUt8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtF2it7nF&md5=9d90f44c773556be3478b80e1ab46eaf</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1038%2Fncomms7945&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms7945%26sid%3Dliteratum%253Aachs%26aulast%3DMiyakawa%26aufirst%3DK.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DKanou%26aufirst%3DK.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DMorishita%26aufirst%3DR.%26aulast%3DKudoh%26aufirst%3DA.%26aulast%3DShindo%26aufirst%3DK.%26aulast%3DYokoyama%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTamura%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DTakaori-Kondo%26aufirst%3DA.%26aulast%3DRyo%26aufirst%3DA.%26atitle%3DASK1%2520restores%2520the%2520antiviral%2520activity%2520of%2520APOBEC3G%2520by%2520disrupting%2520HIV-1%2520Vif-mediated%2520counteraction%26jtitle%3DNat.%2520Commun.%26date%3D2015%26volume%3D6%26spage%3D6945%26doi%3D10.1038%2Fncomms7945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, C.</span></span> <span> </span><span class="NLM_article-title">Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">20</span>– <span class="NLM_lpage">27</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2015.07.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.antiviral.2015.07.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=26241003" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1OqtLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2015&pages=20-27&author=S.+Zhangauthor=L.+Zhongauthor=B.+Chenauthor=T.+Panauthor=X.+Zhangauthor=L.+Liangauthor=Q.+Liauthor=Z.+Zhangauthor=H.+Chenauthor=J.+Zhouauthor=H.+Luoauthor=H.+Zhangauthor=C.+Bai&title=Identification+of+an+HIV-1+replication+inhibitor+which+rescues+host+restriction+factor+APOBEC3G+in+Vif-APOBEC3G+complex&doi=10.1016%2Fj.antiviral.2015.07.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of an HIV-1 replication inhibitor which rescues host restriction factor APOBEC3G in Vif-APOBEC3G complex</span></div><div class="casAuthors">Zhang, Shaoyang; Zhong, Limei; Chen, Bing; Pan, Ting; Zhang, Xue; Liang, Liting; Li, Qianwen; Zhang, Ziying; Chen, Hui; Zhou, Jie; Luo, Haihua; Zhang, Hui; Bai, Chuan</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">20-27</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">HIV-1 Vif protein is one of the most crucial accessory proteins for viral replication.  It efficiently counteracts the important host restriction factor APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G, A3G) which is lethal to HIV-1 by causing G to A mutation of viral genome.  Vif protein mediates degrdn. of APOBEC3G via the complicated protein-protein interactions of Vif, APOBEC3G, Elongin C/B and Cullin 5.  The importance of Vif-APOBEC3G complex makes it a good potential target to develop new therapeutics of HIV-1.  We identified a potent HIV-1 replication inhibitor (ZBMA-1, IC50 = 1.01 μM) that efficiently protected APOBEC3G protein by targeting Vif-APOBEC3G complex.  The co-immunopptn. and docking studies indicated that compd. ZBMA-1 affected the binding of Elongin C with Vif protein.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxlGmCtQl7WbVg90H21EOLACvtfcHk0lh7_nYBbvWn6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1OqtLvM&md5=9dfaaa95c21ce7ca270f2597bc94a082</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2015.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2015.07.009%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLiang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBai%26aufirst%3DC.%26atitle%3DIdentification%2520of%2520an%2520HIV-1%2520replication%2520inhibitor%2520which%2520rescues%2520host%2520restriction%2520factor%2520APOBEC3G%2520in%2520Vif-APOBEC3G%2520complex%26jtitle%3DAntiviral%2520Res.%26date%3D2015%26volume%3D122%26spage%3D20%26epage%3D27%26doi%3D10.1016%2Fj.antiviral.2015.07.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8g"><span><span class="NLM_label">(g) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC</span>. <i>J. Virol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">5497</span>– <span class="NLM_lpage">5507</span>, <span class="refDoi"> DOI: 10.1128/JVI.06957-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1128%2FJVI.06957-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=22379088" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC38XmslOisb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2012&pages=5497-5507&author=T.+Zuoauthor=D.+Liuauthor=W.+Lvauthor=X.+Wangauthor=J.+Wangauthor=M.+Lvauthor=W.+Huangauthor=J.+Wuauthor=H.+Zhangauthor=H.+Jinauthor=L.+Zhangauthor=W.+Kongauthor=X.+Yu&title=Small-molecule+inhibition+of+human+immunodeficiency+virus+type+1+replication+by+targeting+the+interaction+between+Vif+and+ElonginC&doi=10.1128%2FJVI.06957-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8gR"><div class="casContent"><span class="casTitleNuber">8g</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC</span></div><div class="casAuthors">Zuo, Tao; Liu, Donglai; Lv, Wei; Wang, Xiaodan; Wang, Jiawen; Lv, Mingyu; Huang, Wenlin; Wu, Jiaxin; Zhang, Haihong; Jin, Hongwei; Zhang, Liangren; Kong, Wei; Yu, Xianghui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">5497-5507</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The HIV-1 viral infectivity factor (Vif) protein is essential for viral replication.  Vif recruits cellular ElonginB/C-Cullin5 E3 ubiquitin ligase to target the host antiviral protein APOBEC3G (A3G) for proteasomal degrdn.  In the absence of Vif, A3G is packaged into budding HIV-1 virions and introduces multiple mutations in the newly synthesized minus-strand viral DNA to restrict virus replication.  Thus, the A3G-Vif-E3 complex represents an attractive target for development of novel anti-HIV drugs.  In this study, we identified a potent small mol. compd. (VEC-5) by virtual screening and validated its anti-Vif activity through biochem. anal.  We show that VEC-5 inhibits virus replication only in A3G-pos. cells.  Treatment with VEC-5 increased cellular A3G levels when Vif was coexpressed and enhanced A3G incorporation into HIV-1 virions to reduce viral infectivity.  Coimmunopptn. and computational anal. further attributed the anti-Vif activity of VEC-5 to the inhibition of Vif from direct binding to the ElonginC protein.  These findings support the notion that suppressing Vif function can liberate A3G to carry out its antiviral activity and demonstrate that regulation of the Vif-ElonginC interaction is a novel target for small-mol. inhibitors of HIV-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorkfZuyomFT7Vg90H21EOLACvtfcHk0lh7_nYBbvWn6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmslOisb8%253D&md5=f155f1f4dd5ea631d7baaba9c1c4b7ea</span></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=10.1128%2FJVI.06957-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.06957-11%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DLv%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLv%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DW.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DKong%26aufirst%3DW.%26aulast%3DYu%26aufirst%3DX.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520human%2520immunodeficiency%2520virus%2520type%25201%2520replication%2520by%2520targeting%2520the%2520interaction%2520between%2520Vif%2520and%2520ElonginC%26jtitle%3DJ.%2520Virol.%26date%3D2012%26volume%3D86%26spage%3D5497%26epage%3D5507%26doi%3D10.1128%2FJVI.06957-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8h"><span><span class="NLM_label">(h) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cen, S.</span></span> <span> </span><span class="NLM_article-title">Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">8067</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-26318-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fs41598-018-26318-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=29795228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A280%3ADC%252BC1Mfms1Wruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=8067&author=L.+Maauthor=Z.+Zhangauthor=Z.+Liuauthor=Q.+Panauthor=J.+Wangauthor=X.+Liauthor=F.+Guoauthor=C.+Liangauthor=L.+Huauthor=J.+Zhouauthor=S.+Cen&title=Identification+of+small+molecule+compounds+targeting+the+interaction+of+HIV-1+Vif+and+human+APOBEC3G+by+virtual+screening+and+biological+evaluation&doi=10.1038%2Fs41598-018-26318-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8hR"><div class="casContent"><span class="casTitleNuber">8h</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of small molecule compounds targeting the interaction of HIV-1 Vif and human APOBEC3G by virtual screening and biological evaluation</span></div><div class="casAuthors">Ma Ling; Zhang Zhixin; Wang Jing; Li Xiaoyu; Hu Laixing; Zhou Jinming; Cen Shan; Liu Zhenlong; Pan Qinghua; Liang Chen; Guo Fei</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8067</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Human APOBEC3G (hA3G) is a restriction factor that inhibits human immunodeficiency 1 virus (HIV-1) replication.  The virally encoded protein Vif binds to hA3G and induces its degradation, thereby counteracting the antiviral activity of hA3G.  Vif-mediated hA3G degradation clearly represents a potential target for anti-HIV drug development.  Herein, we have performed virtual screening to discover small molecule inhibitors that target the binding interface of the Vif/hA3G complex.  Subsequent biochemical studies have led to the identification of a small molecule inhibitor, IMB-301 that binds to hA3G, interrupts the hA3G-Vif interaction and inhibits Vif-mediated degradation of hA3G.  As a result, IMB-301 strongly inhibits HIV-1 replication in a hA3G-dependent manner.  Our study further demonstrates the feasibility of inhibiting HIV replication by abrogating the Vif-hA3G interaction with small molecules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQmhRizwKUbL91QT_1O5WBYfW6udTcc2eaXh2s4Vymf6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1Mfms1Wruw%253D%253D&md5=6abc264787e99c1a0cc46b8063f766ad</span></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-26318-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-26318-3%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DF.%26aulast%3DLiang%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DCen%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520small%2520molecule%2520compounds%2520targeting%2520the%2520interaction%2520of%2520HIV-1%2520Vif%2520and%2520human%2520APOBEC3G%2520by%2520virtual%2520screening%2520and%2520biological%2520evaluation%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D8067%26doi%3D10.1038%2Fs41598-018-26318-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8i"><span><span class="NLM_label">(i) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harki, D. A.</span></span> <span> </span><span class="NLM_article-title">APOBEC enzymes as targets for virus and cancer therapy</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2017.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.chembiol.2017.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=29153851" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVartb%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=36-49&author=M.+E.+Olsonauthor=R.+S.+Harrisauthor=D.+A.+Harki&title=APOBEC+enzymes+as+targets+for+virus+and+cancer+therapy&doi=10.1016%2Fj.chembiol.2017.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8iR"><div class="casContent"><span class="casTitleNuber">8i</span><div class="casTitle"><span class="NLM_cas:atitle">APOBEC Enzymes as Targets for Virus and Cancer Therapy</span></div><div class="casAuthors">Olson, Margaret E.; Harris, Reuben S.; Harki, Daniel A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-49</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Human DNA cytosine-to-uracil deaminases catalyze mutations in both pathogen and cellular genomes.  APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H restrict human immunodeficiency virus 1 (HIV-1) infection in cells deficient in the viral infectivity factor (Vif), and have the potential to catalyze sublethal levels of mutation in viral genomes in Vif-proficient cells.  At least two APOBEC3 enzymes, and in particular APOBEC3B, are sources of somatic mutagenesis in cancer cells that drive tumor evolution and may manifest clin. as recurrence, metastasis, and/or therapy resistance.  Consequently, APOBEC3 enzymes are tantalizing targets for developing chem. probes and therapeutic mols. to harness mutational processes in human disease.  This review highlights recent efforts to chem. manipulate APOBEC3 activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgDIHc8ehwMrVg90H21EOLACvtfcHk0lhc8zwzln12tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVartb%252FE&md5=b30784e7e7d5b22ce1cd2b19c08e927e</span></div><a href="/servlet/linkout?suffix=cit8i&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2017.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2017.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DOlson%26aufirst%3DM.%2BE.%26aulast%3DHarris%26aufirst%3DR.%2BS.%26aulast%3DHarki%26aufirst%3DD.%2BA.%26atitle%3DAPOBEC%2520enzymes%2520as%2520targets%2520for%2520virus%2520and%2520cancer%2520therapy%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D36%26epage%3D49%26doi%3D10.1016%2Fj.chembiol.2017.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8j"><span><span class="NLM_label">(j) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y. Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8j&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.ejmech.2017.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8j&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=28235704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjsVGgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=310-324&author=M.+Zhouauthor=R.+H.+Luoauthor=X.+Y.+Houauthor=R.+R.+Wangauthor=G.+Y.+Yanauthor=H.+Chenauthor=R.+H.+Zhangauthor=J.+Y.+Shiauthor=Y.+T.+Zhengauthor=R.+Liauthor=Y.+Q.+Wei&title=Synthesis%2C+biological+evaluation+and+molecular+docking+study+of+N-%282-methoxyphenyl%29-6-%28%284-nitrophenyl%29sulfonyl%29benzamide+derivatives+as+potent+HIV-1+Vif+antagonists&doi=10.1016%2Fj.ejmech.2017.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8jR"><div class="casContent"><span class="casTitleNuber">8j</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological evaluation and molecular docking study of N-(2-methoxyphenyl)-6-((4-nitrophenyl)sulfonyl)benzamide derivatives as potent HIV-1 Vif antagonists</span></div><div class="casAuthors">Zhou, Meng; Luo, Rong-Hua; Hou, Xue-Yan; Wang, Rui-Rui; Yan, Guo-Yi; Chen, Huan; Zhang, Rong-Hong; Shi, Jian-You; Zheng, Yong-Tang; Li, Rui; Wei, Yu-Quan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">310-324</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Design, synthesis, antiviral evaluation and mol. docking study of N-(methoxyphenyl)((nitrophenyl)sulfonyl)benzamide derivs. e.g., I [R = H (II), C(O)CH2NH2 (III)] as potent HIV-1 Vif antagonists was reported.  Among the synthesized compds., compd. II was found to be a potent with EC50 value of 1.54 μM, enhancing the antiviral activity more than 150-fold compared with N-(2-methoxyphenyl)-2-((4-nitrophenyl)thio)benzamide (Vif antagonists) in nonpermissive H9 cells.  Further, II protected A3G from degrdn. by inhibiting Vif function.  Besides, II suppressed different HIV-1 clin. strains (HIV-1KM018, HIV-1TC-1 and HIV-1WAN) and drug-resistant strains (NRTI, NNRTI, PI, and FI) with relatively high activities.  Amidation of II with glycine gave a prodrug III, improving the water soly. about 2600-fold compared with II.  Moreover, III inhibited the virus replication efficiently with an EC50 value of 0.228 μM.  These results suggested that the prodrug III was a promising candidate agent for the treatment of AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdAYSD5KNLYbVg90H21EOLACvtfcHk0lhc8zwzln12tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjsVGgs7s%253D&md5=298b94a5c4018b9622f14d558e278ddd</span></div><a href="/servlet/linkout?suffix=cit8j&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DR.%2BH.%26aulast%3DHou%26aufirst%3DX.%2BY.%26aulast%3DWang%26aufirst%3DR.%2BR.%26aulast%3DYan%26aufirst%3DG.%2BY.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%2BH.%26aulast%3DShi%26aufirst%3DJ.%2BY.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26aulast%3DLi%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DY.%2BQ.%26atitle%3DSynthesis%252C%2520biological%2520evaluation%2520and%2520molecular%2520docking%2520study%2520of%2520N-%25282-methoxyphenyl%2529-6-%2528%25284-nitrophenyl%2529sulfonyl%2529benzamide%2520derivatives%2520as%2520potent%2520HIV-1%2520Vif%2520antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D129%26spage%3D310%26epage%3D324%26doi%3D10.1016%2Fj.ejmech.2017.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8k"><span><span class="NLM_label">(k) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogan, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartman, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buckheit, R. W.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, H. C.</span></span> <span> </span><span class="NLM_article-title">An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2016.11.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.antiviral.2016.11.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=27825797" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVGqtLfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2016&pages=51-59&author=R.+P.+Bennettauthor=R.+A.+Stewartauthor=P.+A.+Hoganauthor=R.+G.+Ptakauthor=M.+K.+Mankowskiauthor=T.+L.+Hartmanauthor=R.+W.+Buckheitauthor=B.+A.+Snyderauthor=J.+D.+Salterauthor=G.+A.+Moralesauthor=H.+C.+Smith&title=An+analog+of+camptothecin+inactive+against+Topoisomerase+I+is+broadly+neutralizing+of+HIV-1+through+inhibition+of+Vif-dependent+APOBEC3G+degradation&doi=10.1016%2Fj.antiviral.2016.11.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8kR"><div class="casContent"><span class="casTitleNuber">8k</span><div class="casTitle"><span class="NLM_cas:atitle">An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation</span></div><div class="casAuthors">Bennett, Ryan P.; Stewart, Ryan A.; Hogan, Priscilla A.; Ptak, Roger G.; Mankowski, Marie K.; Hartman, Tracy L.; Buckheit, Robert W., Jr.; Snyder, Beth A.; Salter, Jason D.; Morales, Guillermo A.; Smith, Harold C.</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">51-59</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Camptothecin (CPT) is a natural product discovered to be active against various cancers through its ability to inhibit Topoisomerase I (TOP1).  CPT analogs also have anti-HIV-1 (HIV) activity that was previously shown to be independent of TOP1 inhibition.  We show that a cancer inactive CPT analog (O2-16) inhibits HIV infection by disrupting multimerization of the HIV protein Vif.  Antiviral activity depended on the expression of the cellular viral restriction factor APOBEC3G (A3G) that, in the absence of functional Vif, has the ability to hypermutate HIV proviral DNA during reverse transcription.  Our studies demonstrate that O2-16 has low cytotoxicity and inhibits Vif-dependent A3G degrdn., enabling A3G packaging into HIV viral particles that results in A3G signature hypermutations in viral genomes.  This antiviral activity was A3G-dependent and broadly neutralizing against sixteen HIV clin. isolates from groups M (subtypes A-G), N, and O as well as seven single and multi-drug resistant strains of HIV.  Mol. modeling predicted binding near the PPLP motif crucial for Vif multimerization and activity.  O2-16 also was active in blocking Vif degrdn. of APOBEC3F (A3F).  We propose that CPT analogs not active against TOP1 have novel therapeutic potential as Vif antagonists that enable A3G-dependent hypermutation of HIV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqATlWSwY5_5rVg90H21EOLACvtfcHk0lhc8zwzln12tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVGqtLfJ&md5=d894832d96cf6e3061405ddd83915fde</span></div><a href="/servlet/linkout?suffix=cit8k&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2016.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2016.11.001%26sid%3Dliteratum%253Aachs%26aulast%3DBennett%26aufirst%3DR.%2BP.%26aulast%3DStewart%26aufirst%3DR.%2BA.%26aulast%3DHogan%26aufirst%3DP.%2BA.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DHartman%26aufirst%3DT.%2BL.%26aulast%3DBuckheit%26aufirst%3DR.%2BW.%26aulast%3DSnyder%26aufirst%3DB.%2BA.%26aulast%3DSalter%26aufirst%3DJ.%2BD.%26aulast%3DMorales%26aufirst%3DG.%2BA.%26aulast%3DSmith%26aufirst%3DH.%2BC.%26atitle%3DAn%2520analog%2520of%2520camptothecin%2520inactive%2520against%2520Topoisomerase%2520I%2520is%2520broadly%2520neutralizing%2520of%2520HIV-1%2520through%2520inhibition%2520of%2520Vif-dependent%2520APOBEC3G%2520degradation%26jtitle%3DAntiviral%2520Res.%26date%3D2016%26volume%3D136%26spage%3D51%26epage%3D59%26doi%3D10.1016%2Fj.antiviral.2016.11.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit8l"><span><span class="NLM_label">(l) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammed, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huff, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kummetha, I. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, M.</span></span> <span> </span><span class="NLM_article-title">HIV-1 escape from small-molecule antagonism of Vif</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">e00144</span>– <span class="NLM_lpage">e00119</span>, <span class="refDoi"> DOI: 10.1128/mbio.00144-19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8l&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1128%2FmBio.00144-19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8l&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=30808702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8l&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlKgsbfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=e00144-e00119&author=M.+Sharkeyauthor=N.+Sharovaauthor=I.+Mohammedauthor=S.+E.+Huffauthor=I.+R.+Kummethaauthor=G.+Singhauthor=T.+M.+Ranaauthor=M.+Stevenson&title=HIV-1+escape+from+small-molecule+antagonism+of+Vif&doi=10.1128%2Fmbio.00144-19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8lR"><div class="casContent"><span class="casTitleNuber">8l</span><div class="casTitle"><span class="NLM_cas:atitle">HIV-1 escape from small-molecule antagonism of Vif</span></div><div class="casAuthors">Sharkey, Mark; Sharova, Natalia; Mohammed, Idrees; Huff, Sarah E.; Kummetha, Indrasena Reddy; Singh, Gatikrushna; Rana, Tariq M.; Stevenson, Mario</div><div class="citationInfo"><span class="NLM_cas:title">mBio</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e00144-19</span>CODEN:
                <span class="NLM_cas:coden">MBIOCL</span>;
        ISSN:<span class="NLM_cas:issn">2150-7511</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">The HIV-1 accessory protein Vif, which counteracts the antiviral action of the DNA-editing cytidine deaminase APOBEC3G (A3G), is an attractive and yet unexploited therapeutic target.  Vif reduces the virion incorporation of A3G by targeting the restriction factor for proteasomal degrdn. in the virus-producing cell.  Compds. that inhibit Vif-mediated degrdn. of A3G in cells targeted by HIV-1 would represent a novel antiviral therapeutic.  We previously described small mols. with activity consistent with Vif antagonism.  In this study, we derived inhibitor escape HIV-1 variants to characterize the mechanism by which these novel agents inhibit virus replication.  Here we show that resistance to these agents is dependent on an amino acid substitution in Vif (V142I) and on a point mutation that likely upregulates transcription by modifying the lymphocyte enhancing factor 1 (LEF-1) binding site.  Mol. modeling demonstrated a docking site in the Vif-Elongin C complex that is disrupted by these inhibitors.  This docking site is lost when Vif acquires the V142I mutation that leads to inhibitor resistance.  Competitive fitness expts. indicated that the V142I Vif and LEF-1 binding site mutations created a virus that is better adapted to growing in the presence of A3G than the wild-type virus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJd1Lul1f887Vg90H21EOLACvtfcHk0likZdaJGaMXxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlKgsbfI&md5=442b9c797eaf12015754323a0b6ec8c6</span></div><a href="/servlet/linkout?suffix=cit8l&amp;dbid=16384&amp;doi=10.1128%2FmBio.00144-19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00144-19%26sid%3Dliteratum%253Aachs%26aulast%3DSharkey%26aufirst%3DM.%26aulast%3DSharova%26aufirst%3DN.%26aulast%3DMohammed%26aufirst%3DI.%26aulast%3DHuff%26aufirst%3DS.%2BE.%26aulast%3DKummetha%26aufirst%3DI.%2BR.%26aulast%3DSingh%26aufirst%3DG.%26aulast%3DRana%26aufirst%3DT.%2BM.%26aulast%3DStevenson%26aufirst%3DM.%26atitle%3DHIV-1%2520escape%2520from%2520small-molecule%2520antagonism%2520of%2520Vif%26jtitle%3DmBio%26date%3D2019%26volume%3D10%26spage%3De00144%26epage%3De00119%26doi%3D10.1128%2Fmbio.00144-19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lv, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of new N(4)-Substituted 2′-deoxy-2′-fluoro-4′-azido cytidine derivatives as potent anti-HBV agents</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">103</span>– <span class="NLM_lpage">110</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.06.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.ejmech.2015.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=26119991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsbnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2015&pages=103-110&author=Z.+Lvauthor=W.+Heauthor=X.+Tianauthor=J.+Kangauthor=Y.+Liuauthor=Y.+Pengauthor=L.+Zhengauthor=Q.+Wangauthor=W.+Yuauthor=J.+Chang&title=Design%2C+synthesis%2C+and+biological+evaluation+of+new+N%284%29-Substituted+2%E2%80%B2-deoxy-2%E2%80%B2-fluoro-4%E2%80%B2-azido+cytidine+derivatives+as+potent+anti-HBV+agents&doi=10.1016%2Fj.ejmech.2015.06.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of new N4-Substituted 2'-deoxy-2'-fluoro-4'-azido cytidine derivatives as potent anti-HBV agents</span></div><div class="casAuthors">Lv, Zhigang; He, Wu; Tian, Xianhai; Kang, Jinfeng; Liu, Yangxue; Peng, Youmei; Zheng, Liyun; Wang, Qingduan; Yu, Wenquan; Chang, Junbiao</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103-110</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of new 2'-deoxy-2'-β-fluoro-4'-azido-β-D-arabinofuranosyl cytidine derivs. bearing heteroatom-contg. N4-substituents were designed and synthesized.  Antiviral screening in HepG2.2.15 cells identified three analogs (1a, 1d & 1g) with good anti-HBV activity and low cytotoxicty.  Of them, compd. 1g exhibited significant inhibitory activity on both HBV antigens secretion (EC50, HBsAg = 9 nM, EC50, HBeAg = 0.25 μM) and viral DNA replication (intracellular, EC50 = 0.099 μM; extracellular, EC50 < 0.01 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0gLpgiRfy_bVg90H21EOLACvtfcHk0likZdaJGaMXxw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlCqsbnP&md5=5c6d89c17897a2fe42a0c4604ec9ce23</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DLv%26aufirst%3DZ.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DKang%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DYu%26aufirst%3DW.%26aulast%3DChang%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520new%2520N%25284%2529-Substituted%25202%25E2%2580%25B2-deoxy-2%25E2%2580%25B2-fluoro-4%25E2%2580%25B2-azido%2520cytidine%2520derivatives%2520as%2520potent%2520anti-HBV%2520agents%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2015%26volume%3D101%26spage%3D103%26epage%3D110%26doi%3D10.1016%2Fj.ejmech.2015.06.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span>; <span class="NLM_string-name">Bao, X.</span>; <span class="NLM_string-name">Wang, Q.</span>; <span class="NLM_string-name">Guo, X.</span>; <span class="NLM_string-name">Wang, W.</span>; <span class="NLM_string-name">Qi, X.</span></span> <span> </span><span class="NLM_article-title">2’-Fluoro-4’-Substituted Nucleosides, the Preparation and Use</span>. CN Patent <span class="NLM_patent">ZL200710137548.0</span>, August 26, <span class="NLM_year">2009</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=J.+Chang&author=X.+Bao&author=Q.+Wang&author=X.+Guo&author=W.+Wang&author=X.+Qi&title=2%E2%80%99-Fluoro-4%E2%80%99-Substituted+Nucleosides%2C+the+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%26atitle%3D2%25E2%2580%2599-Fluoro-4%25E2%2580%2599-Substituted%2520Nucleosides%252C%2520the%2520Preparation%2520and%2520Use%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span> <span> </span><span class="NLM_article-title">2’-Fluoro-4’-Substituted Nucleosides, the Preparation and Use</span>. Eur. Patent <span class="NLM_patent">EP2177527B</span>, December 18, <span class="NLM_year">2013</span>;</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+Chang&title=2%E2%80%99-Fluoro-4%E2%80%99-Substituted+Nucleosides%2C+the+Preparation+and+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DJ.%26atitle%3D2%25E2%2580%2599-Fluoro-4%25E2%2580%2599-Substituted%2520Nucleosides%252C%2520the%2520Preparation%2520and%2520Use%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9d"><span>US Patent <span class="NLM_patent">US8835615B2</span>, September
16, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=US+Patent+US8835615B2%2C+September%0A16%2C+2014."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span> <span> </span><span class="NLM_article-title">Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections</span>. <i>Antiviral Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>169</i></span>,  <span class="NLM_fpage">104555</span>, <span class="refDoi"> DOI: 10.1016/j.antiviral.2019.104555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.antiviral.2019.104555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=31295520" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsValsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=2019&pages=104555&author=H.+Yangauthor=X.+Liauthor=X.+Yangauthor=P.+Luauthor=Y.+Wangauthor=Z.+Jiangauthor=H.+Panauthor=L.+Zhaoauthor=Y.+Zhuauthor=I.+U.+Khanauthor=Y.+Shenauthor=H.+Luauthor=T.+Zhangauthor=G.+Jiangauthor=Z.+Maauthor=H.+Wuauthor=H.+Zhu&title=Dual+effects+of+the+novel+ingenol+derivatives+on+the+acute+and+latent+HIV-1+infections&doi=10.1016%2Fj.antiviral.2019.104555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Dual effects of the novel ingenol derivatives on the acute and latent HIV-1 infections</span></div><div class="casAuthors">Yang, He; Li, Xian; Yang, Xinyi; Lu, Panpan; Wang, Yanan; Jiang, Zhengtao; Pan, Hanyu; Zhao, Lin; Zhu, Yuqi; Khan, InamUllah; Shen, Yinzhong; Lu, Hongzhou; Zhang, Tong; Jiang, Guochun; Ma, Zhongjun; Wu, Hao; Zhu, Huanzhang</div><div class="citationInfo"><span class="NLM_cas:title">Antiviral Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104555</span>CODEN:
                <span class="NLM_cas:coden">ARSRDR</span>;
        ISSN:<span class="NLM_cas:issn">0166-3542</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The latent reservoir of HIV-1 in resting memory CD4+ T cells serves as a major barrier to curing HIV-1 infection.  Reactivation of latent HIV-1 is proposed as a promising strategy for the clearance of the viral reservoirs.  Because of the limitations of current latency reversal agents (LRAs), identification of new LRAs is urgently required.  Here, we analyzed Euphorbia kansui exts. and obtained three ingenol deriv. compds. named EK-1A, EK-5A and EK-15A.  We found that ingenol derivs. can effectively reactivate latent HIV-1 at very low (nanomolar) concns. in HIV latency model in vitro.  Furthermore, ingenol derivs. exhibited synergy with other LRAs in reactivating latent HIV-1.  We verified that EK-15A can promote latent HIV-1 reactivation in the ex vivo resting CD4+ T cells isolated from the peripheral blood of HIV-infected individuals on suppressive antiretroviral therapy.  In addn., ingenol derivs. down-regulated the expression of cell surface HIV co-receptors CCR5 and CXCR4, therefore potentially preventing new infection of HIV-1.  Our results indicated that the ingenol derivs. extd. from Euphorbia kansui have dual functions: reactivation of latent HIV-1 and inhibition of HIV-1 infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLw_ixuFPywLVg90H21EOLACvtfcHk0lgvt0TVTXGNyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsValsLzM&md5=aa5f3c4ded7c0b19a1e650620d9ca76e</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.antiviral.2019.104555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.antiviral.2019.104555%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLu%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DZ.%26aulast%3DPan%26aufirst%3DH.%26aulast%3DZhao%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DKhan%26aufirst%3DI.%2BU.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DJiang%26aufirst%3DG.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DWu%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DH.%26atitle%3DDual%2520effects%2520of%2520the%2520novel%2520ingenol%2520derivatives%2520on%2520the%2520acute%2520and%2520latent%2520HIV-1%2520infections%26jtitle%3DAntiviral%2520Res.%26date%3D2019%26volume%3D169%26spage%3D104555%26doi%3D10.1016%2Fj.antiviral.2019.104555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pery, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheehy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miranda
Nebane, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankowski, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucile White, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ptak, R. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabuzda, D.</span></span> <span> </span><span class="NLM_article-title">Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1</span>. <i>Virology</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>484</i></span>,  <span class="NLM_fpage">276</span>– <span class="NLM_lpage">287</span>, <span class="refDoi"> DOI: 10.1016/j.virol.2015.06.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.virol.2015.06.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=26141568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVygtL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=484&publication_year=2015&pages=276-287&author=E.+Peryauthor=A.+Sheehyauthor=N.+Miranda%0ANebaneauthor=V.+Misraauthor=M.+K.+Mankowskiauthor=L.+Rasmussenauthor=E.+Lucile+Whiteauthor=R.+G.+Ptakauthor=D.+Gabuzda&title=Redoxal%2C+an+inhibitor+of+de+novo+pyrimidine+biosynthesis%2C+augments+APOBEC3G+antiviral+activity+against+human+immunodeficiency+virus+type+1&doi=10.1016%2Fj.virol.2015.06.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">Redoxal, an inhibitor of de novo pyrimidine biosynthesis, augments APOBEC3G antiviral activity against human immunodeficiency virus type 1</span></div><div class="casAuthors">Pery, Erez; Sheehy, Ann; Miranda Nebane, N.; Misra, Vikas; Mankowski, Marie K.; Rasmussen, Lynn; Lucile White, E.; Ptak, Roger G.; Gabuzda, Dana</div><div class="citationInfo"><span class="NLM_cas:title">Virology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">484</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">276-287</span>CODEN:
                <span class="NLM_cas:coden">VIRLAX</span>;
        ISSN:<span class="NLM_cas:issn">0042-6822</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">APOBEC3G (A3G) is a cytidine deaminase that restricts HIV-1 replication by inducing G-to-A hypermutation in viral DNA; deamination-independent mechanisms are also implicated.  HIV-1 Vif protein counteracts A3G by inducing its proteasomal degrdn.  Thus, the Vif-A3G axis is a potential therapeutic target.  To identify compds. that inhibit Vif:A3G interaction, a 307,520 compd. library was tested in a TR-FRET screen.  Two identified compds., redoxal and lomofungin, inhibited HIV-1 replication in peripheral blood mononuclear cells.  Lomofungin activity was linked to A3G, but not pursued further due to cytotoxicity.  Redoxal displayed A3G-dependent restriction, inhibiting viral replication by stabilizing A3G protein levels and increasing A3G in virions.  A3G-independent activity was also detected.  Treatment with uridine or orotate, intermediates of pyrimidine synthesis, diminished redoxal-induced stabilization of A3G and antiviral activity.  These results identify redoxal as an inhibitor of HIV-1 replication and suggest its ability to inhibit pyrimidine biosynthesis suppresses viral replication by augmenting A3G antiviral activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7PpA3KmqMxLVg90H21EOLACvtfcHk0lgvt0TVTXGNyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVygtL3P&md5=7a8e8f0cae803db53b0700d5e36057e3</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1016%2Fj.virol.2015.06.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.virol.2015.06.014%26sid%3Dliteratum%253Aachs%26aulast%3DPery%26aufirst%3DE.%26aulast%3DSheehy%26aufirst%3DA.%26aulast%3DMiranda%2BNebane%26aufirst%3DN.%26aulast%3DMisra%26aufirst%3DV.%26aulast%3DMankowski%26aufirst%3DM.%2BK.%26aulast%3DRasmussen%26aufirst%3DL.%26aulast%3DLucile%2BWhite%26aufirst%3DE.%26aulast%3DPtak%26aufirst%3DR.%2BG.%26aulast%3DGabuzda%26aufirst%3DD.%26atitle%3DRedoxal%252C%2520an%2520inhibitor%2520of%2520de%2520novo%2520pyrimidine%2520biosynthesis%252C%2520augments%2520APOBEC3G%2520antiviral%2520activity%2520against%2520human%2520immunodeficiency%2520virus%2520type%25201%26jtitle%3DVirology%26date%3D2015%26volume%3D484%26spage%3D276%26epage%3D287%26doi%3D10.1016%2Fj.virol.2015.06.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Nathans, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharova, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharkey, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stranska, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevenson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rana, T. M.</span></span> <span> </span><span class="NLM_article-title">Small-molecule inhibition of HIV-1 Vif</span>. <i>Nat. Biotechnol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">1187</span>– <span class="NLM_lpage">1192</span>, <span class="refDoi"> DOI: 10.1038/nbt.1496</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1038%2Fnbt.1496" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=18806783" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1aisr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=1187-1192&author=R.+Nathansauthor=H.+Caoauthor=N.+Sharovaauthor=A.+Aliauthor=M.+Sharkeyauthor=R.+Stranskaauthor=M.+Stevensonauthor=T.+M.+Rana&title=Small-molecule+inhibition+of+HIV-1+Vif&doi=10.1038%2Fnbt.1496"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of HIV-1 Vif</span></div><div class="casAuthors">Nathans, Robin; Cao, Hong; Sharova, Natalia; Ali, Akbar; Sharkey, Mark; Stranska, Ruzena; Stevenson, Mario; Rana, Tariq M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Biotechnology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1187-1192</span>CODEN:
                <span class="NLM_cas:coden">NABIF9</span>;
        ISSN:<span class="NLM_cas:issn">1087-0156</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The HIV-1 protein Vif, essential for in vivo viral replication, targets the human DNA-editing enzyme, APOBEC3G (A3G), which inhibits replication of retroviruses and hepatitis B virus.  As Vif has no known cellular homologs, it is an attractive, yet unrealized, target for antiviral intervention.  Although zinc chelation inhibits Vif and enhances viral sensitivity to A3G, this effect is unrelated to the interaction of Vif with A3G.  We identify a small mol., RN-18, that antagonizes Vif function and inhibits HIV-1 replication only in the presence of A3G.  RN-18 increases cellular A3G levels in a Vif-dependent manner and increases A3G incorporation into virions without inhibiting general proteasome-mediated protein degrdn.  RN-18 enhances Vif degrdn. only in the presence of A3G, reduces viral infectivity by increasing A3G incorporation into virions and enhances cytidine deamination of the viral genome.  These results demonstrate that the HIV-1 Vif-A3G axis is a valid target for developing small mol.-based new therapies for HIV infection or for enhancing innate immunity against viruses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWRpTfp6uVArVg90H21EOLACvtfcHk0lgvt0TVTXGNyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1aisr3K&md5=f80228275d0e19e40e049ea715c11895</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1038%2Fnbt.1496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnbt.1496%26sid%3Dliteratum%253Aachs%26aulast%3DNathans%26aufirst%3DR.%26aulast%3DCao%26aufirst%3DH.%26aulast%3DSharova%26aufirst%3DN.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DSharkey%26aufirst%3DM.%26aulast%3DStranska%26aufirst%3DR.%26aulast%3DStevenson%26aufirst%3DM.%26aulast%3DRana%26aufirst%3DT.%2BM.%26atitle%3DSmall-molecule%2520inhibition%2520of%2520HIV-1%2520Vif%26jtitle%3DNat.%2520Biotechnol.%26date%3D2008%26volume%3D26%26spage%3D1187%26epage%3D1192%26doi%3D10.1038%2Fnbt.1496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Pu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of indole derivatives as Vif inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">4150</span>– <span class="NLM_lpage">4155</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.07.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.bmcl.2017.07.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=28754362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GktLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=4150-4155&author=C.+Puauthor=R.+H.+Luoauthor=M.+Zhangauthor=X.+Houauthor=G.+Yanauthor=J.+Luoauthor=Y.+T.+Zhengauthor=R.+Li&title=Design%2C+synthesis+and+biological+evaluation+of+indole+derivatives+as+Vif+inhibitors&doi=10.1016%2Fj.bmcl.2017.07.026"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11cR"><div class="casContent"><span class="casTitleNuber">11c</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of indole derivatives as Vif inhibitors</span></div><div class="casAuthors">Pu, Chunlan; Luo, Rong-Hua; Zhang, Mengqi; Hou, Xueyan; Yan, Guoyi; Luo, Jiang; Zheng, Yong-Tang; Li, Rui</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4150-4155</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In this article, design, synthesis and biol. evaluation of indole derivs. as viral infectivity factor (Vif) inhibitors is reported.  Fragment-based virtual screening (FBVS) was conducted and a series of fragments was obtained, among which, 5-(pyridin-2-yl)-1H-indole can form H-bonds with Tyr148 and Ile155 and based on this fragment other indole derivs. were synthesized.  Through the immune-fluorescence staining and Western blot assays, 3-(1H-indol-5-yl)pyridin-6-amine (I) shows potent activity in inhibiting Vif-mediated A3G degrdn.  Further docking expt. shows that compd. I form H-bond interactions with residues His139, Tyr148 and Ile155.  Therefore, I is a promising lead compd. against Vif that can be used to treat AIDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXEEv18bl3rrVg90H21EOLACvtfcHk0lipHHVtJ7c4RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GktLjL&md5=57510f6ea51163fd75d7a405560dff35</span></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.07.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.07.026%26sid%3Dliteratum%253Aachs%26aulast%3DPu%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DR.%2BH.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26aulast%3DLi%26aufirst%3DR.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520indole%2520derivatives%2520as%2520Vif%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D4150%26epage%3D4155%26doi%3D10.1016%2Fj.bmcl.2017.07.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit11d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span> <span> </span><span class="NLM_article-title">Anti-HIV activities and mechanism of 12-O-tricosanoylphorbol-20-acetate, a novel phorbol ester from ostodes katharinae</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1498</span>, <span class="refDoi"> DOI: 10.3390/molecules22091498</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.3390%2Fmolecules22091498" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWgs7fO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1498&author=H.+Chenauthor=R.+Zhangauthor=R.+H.+Luoauthor=L.+M.+Yangauthor=R.+R.+Wangauthor=X.+J.+Haoauthor=Y.+T.+Zheng&title=Anti-HIV+activities+and+mechanism+of+12-O-tricosanoylphorbol-20-acetate%2C+a+novel+phorbol+ester+from+ostodes+katharinae&doi=10.3390%2Fmolecules22091498"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11dR"><div class="casContent"><span class="casTitleNuber">11d</span><div class="casTitle"><span class="NLM_cas:atitle">Anti-HIV activities and mechanism of 12-O-tricosanoylphorbol-20-acetate, a novel phorbol ester from Ostodes katharinae</span></div><div class="casAuthors">Chen, Huan; Zhang, Rong; Luo, Rong-Hua; Yang, Liu-Meng; Wang, Rui-Rui; Hao, Xiao-Jiang; Zheng, Yong-Tang</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1498/1-1498/18</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">APOBEC3G is a member of the human cytidine deaminase family that restricts Vif-deficient viruses by being packaged with progeny virions and inducing the G to A mutation during the synthesis of HIV-1 viral DNA when the progeny virus infects new cells.  HIV-1 Vif protein resists the activity of A3G by mediating A3G degrdn.  Phorbol esters are plant-derived org. compds. belonging to the tigliane family of diterpenes and could activate the PKC pathway.  In this study, we identified an inhibitor 12-O-tricosanoylphorbol-20-acetate (hop-8), a novel ester of phorbol which was isolated from Ostodes katharinae of the family Euphorbiaceae, that inhibited the replication of wild-type HIV-1 and HIV-2 strains and drug-resistant strains broadly both in C8166 cells and PBMCs with low cytotoxicity and the EC50 values ranged from 0.106 μM to 7.987 μM.  One of the main mechanisms of hop-8 is to stimulate A3G expressing in HIV-1 producing cells and upregulate the A3G level in progeny virions, which results in reducing the infectivity of the progeny virus.  This novel mechanism of hop-8 inhibition of HIV replication might represents a promising approach for developing new therapeutics for HIV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnLNnmLSNXrLVg90H21EOLACvtfcHk0lipHHVtJ7c4RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWgs7fO&md5=140d4150f28b7cbb9dd6ce9810f01221</span></div><a href="/servlet/linkout?suffix=cit11d&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22091498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22091498%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DLuo%26aufirst%3DR.%2BH.%26aulast%3DYang%26aufirst%3DL.%2BM.%26aulast%3DWang%26aufirst%3DR.%2BR.%26aulast%3DHao%26aufirst%3DX.%2BJ.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26atitle%3DAnti-HIV%2520activities%2520and%2520mechanism%2520of%252012-O-tricosanoylphorbol-20-acetate%252C%2520a%2520novel%2520phorbol%2520ester%2520from%2520ostodes%2520katharinae%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1498%26doi%3D10.3390%2Fmolecules22091498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Covino, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purificato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Catapano, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galluzzo, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauzzi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vella, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lefebvre, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seyedkazemi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreotti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fantuzzi, L.</span></span> <span> </span><span class="NLM_article-title">APOBEC3G/3A Expression in human immunodeficiency virus type 1-infected individuals following initiation of antiretroviral therapy containing cenicriviroc or efavirenz</span>. <i>Front. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1839</span>, <span class="refDoi"> DOI: 10.3389/fimmu.2018.01839</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.3389%2Ffimmu.2018.01839" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=30135687" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlWmu7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1839&author=D.+A.+Covinoauthor=C.+Purificatoauthor=L.+Catapanoauthor=C.+M.+Galluzzoauthor=M.+C.+Gauzziauthor=S.+Vellaauthor=E.+Lefebvreauthor=S.+Seyedkazemiauthor=M.+Andreottiauthor=L.+Fantuzzi&title=APOBEC3G%2F3A+Expression+in+human+immunodeficiency+virus+type+1-infected+individuals+following+initiation+of+antiretroviral+therapy+containing+cenicriviroc+or+efavirenz&doi=10.3389%2Ffimmu.2018.01839"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">APOBEC3G/3A expression in human immunodeficiency virus type 1-infected individuals following initiation of antiretroviral therapy containing cenicriviroc or efavirenz</span></div><div class="casAuthors">Covino, Daniela A.; Purificato, Cristina; Catapano, Laura; Galluzzo, Clementina M.; Gauzzi, Maria Cristina; Vella, Stefano; Lefebvre, Eric; Seyedkazemi, Star; Andreotti, Mauro; Fantuzzi, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Immunology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1839/1-1839/8</span>CODEN:
                <span class="NLM_cas:coden">FIRMCW</span>;
        ISSN:<span class="NLM_cas:issn">1664-3224</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Apolipoprotein B mRNA editing enzyme catalytic polypeptide-like 3 (APOBEC3) family members are cytidine deaminases that play crucial roles in innate responses to retrovirus infection.  The mechanisms by which some of these enzymes restrict human immunodeficiency virus type 1 (HIV-1) replication have been extensively investigated in vitro.  However, little is known regarding how APOBEC3 proteins affect the pathogenesis of HIV-1 infection in vivo and how antiretroviral therapy influences their expression.  In this work, a longitudinal anal. was performed to evaluate APOBEC3G/3A expression in peripheral blood mononuclear cells of antiretroviral-naive HIV-1-infected individuals treated with cenicriviroc (CVC) or efavirenz (EFV) at baseline and 4, 12, 24, and 48 wk post-treatment follow-up.  While APOBEC3G expression was unaffected by therapy, APOBEC3A levels increased in CVC but not EFV arm at week 48 of treatment.  APOBEC3G expression correlated directly with CD4+ cell count and CD4+/CD8+ cell ratio, whereas APOBEC3A levels inversely correlated with plasma sol. CD14.  These findings suggest that higher APOBEC3G/3A levels may be assocd. with protective effects against HIV-1 disease progression and chronic inflammation and warrant further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqW1mAXKsY6CLVg90H21EOLACvtfcHk0lipHHVtJ7c4RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlWmu7vP&md5=747c08523fdeebcfa94148358b95ab20</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3389%2Ffimmu.2018.01839&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffimmu.2018.01839%26sid%3Dliteratum%253Aachs%26aulast%3DCovino%26aufirst%3DD.%2BA.%26aulast%3DPurificato%26aufirst%3DC.%26aulast%3DCatapano%26aufirst%3DL.%26aulast%3DGalluzzo%26aufirst%3DC.%2BM.%26aulast%3DGauzzi%26aufirst%3DM.%2BC.%26aulast%3DVella%26aufirst%3DS.%26aulast%3DLefebvre%26aufirst%3DE.%26aulast%3DSeyedkazemi%26aufirst%3DS.%26aulast%3DAndreotti%26aufirst%3DM.%26aulast%3DFantuzzi%26aufirst%3DL.%26atitle%3DAPOBEC3G%252F3A%2520Expression%2520in%2520human%2520immunodeficiency%2520virus%2520type%25201-infected%2520individuals%2520following%2520initiation%2520of%2520antiretroviral%2520therapy%2520containing%2520cenicriviroc%2520or%2520efavirenz%26jtitle%3DFront.%2520Immunol.%26date%3D2018%26volume%3D9%26spage%3D1839%26doi%3D10.3389%2Ffimmu.2018.01839" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tam, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouyang, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Y. T.</span></span> <span> </span><span class="NLM_article-title">Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">965</span>– <span class="NLM_lpage">971</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.03.139</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1016%2Fj.bbrc.2004.03.139" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=15094363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjt1ams7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=965-971&author=J.+H.+Wangauthor=S.+C.+Tamauthor=H.+Huangauthor=D.+Y.+Ouyangauthor=Y.+Y.+Wangauthor=Y.+T.+Zheng&title=Site-directed+PEGylation+of+trichosanthin+retained+its+anti-HIV+activity+with+reduced+potency+in+vitro&doi=10.1016%2Fj.bbrc.2004.03.139"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Site-directed PEGylation of trichosanthin retained its anti-HIV activity with reduced potency in vitro</span></div><div class="casAuthors">Wang, Jian-Hua; Tam, Siu-Cheung; Huang, Hai; Ouyang, Dong-Yun; Wang, Yuan-Yuan; Zheng, Yong-Tang</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">965-971</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">Trichosanthin (TCS) was the first ribosome inactivating protein found to possess anti-HIV-1 activity.  Phase I/II clin. trial of this compd. had been done.  Antigenicity and short plasma half-life were the major side effects preventing further clin. trial.  Modification of TCS is therefore necessary to revive the interest to develop this compd. as an anti-HIV agent.  Three potential antigenic sites (Ser-7, Lys-173, and Gln-219) were identified by computer modeling.  Through site-directed mutagenesis, these three antigenic amino acids were mutated to a cysteine residue resulting in 3 TCS mutants, namely S7C, K173C, and Q219C.  These mutants were further coupled to polyethylene glycol with a mol. size of 20 kDa (PEG) via the cysteine residue.  This produced another three TCS derivs., namely PEG20k-S7C, PEG20k-K173C, and PEG20k-Q219C.  PEGylation had been widely used recently to decrease immunogenicity by masking the antigenic sites and prolong plasma half-life by expanding the mol. size.  The in vitro anti-HIV-1 activity of these mutants and derivs. was tested.  Results showed that the anti-HIV-1 activity of S7C, K173C, and Q219C was decreased by about 1.5- to 5.5-fold with slightly lower cytotoxicity.  PEGylation produced larger decrease (20- to 30-fold) in anti-HIV activity.  Cytotoxicity was, however, weakened only slightly by about 3-fold.  The in vitro study showed that the anti-HIV activity of PEGylated TCS was retained with reduced potency.  The in vivo activity is expected to have only slightly changed due to other beneficial effects like prolonged half-life.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppgNjt-zk_QLVg90H21EOLACvtfcHk0lipHHVtJ7c4RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjt1ams7k%253D&md5=a694d4a1a275132431272c7bc9bdbe95</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.03.139&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.03.139%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DTam%26aufirst%3DS.%2BC.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DOuyang%26aufirst%3DD.%2BY.%26aulast%3DWang%26aufirst%3DY.%2BY.%26aulast%3DZheng%26aufirst%3DY.%2BT.%26atitle%3DSite-directed%2520PEGylation%2520of%2520trichosanthin%2520retained%2520its%2520anti-HIV%2520activity%2520with%2520reduced%2520potency%2520in%2520vitro%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D965%26epage%3D971%26doi%3D10.1016%2Fj.bbrc.2004.03.139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Salie, Z. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirby, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michailidis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rohan, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodama, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parniak, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarafianos, S. G.</span></span> <span> </span><span class="NLM_article-title">Structural basis of HIV inhibition by translocation-defective RT inhibitor 4′-ethynyl-2-fluoro-2′-deoxyadenosine (EFdA)</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">9274</span>– <span class="NLM_lpage">9279</span>, <span class="refDoi"> DOI: 10.1073/pnas.1605223113</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1073%2Fpnas.1605223113" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=27489345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ygt73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2016&pages=9274-9279&author=Z.+L.+Salieauthor=K.+A.+Kirbyauthor=E.+Michailidisauthor=B.+Marchandauthor=K.+Singhauthor=L.+C.+Rohanauthor=E.+N.+Kodamaauthor=H.+Mitsuyaauthor=M.+A.+Parniakauthor=S.+G.+Sarafianos&title=Structural+basis+of+HIV+inhibition+by+translocation-defective+RT+inhibitor+4%E2%80%B2-ethynyl-2-fluoro-2%E2%80%B2-deoxyadenosine+%28EFdA%29&doi=10.1073%2Fpnas.1605223113"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of HIV inhibition by translocation-defective RT inhibitor 4'-ethynyl-2-fluoro-2'-deoxyadenosine (EFdA)</span></div><div class="casAuthors">Salie, Zhe Li; Kirby, Karen A.; Michailidis, Eleftherios; Marchand, Bruno; Singh, Kamalendra; Rohan, Lisa C.; Kodama, Eiichi N.; Mitsuya, Hiroaki; Parniak, Michael A.; Sarafianos, Stefan G.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">33</span>),
    <span class="NLM_cas:pages">9274-9279</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">4'-Ethynyl-2-fluoro-2'-deoxyadenosine (EFdA) is the most potent nucleoside analog inhibitor of HIV reverse transcriptase (RT).  It retains a 3'-OH yet acts as a chain-terminating agent by diminishing translocation from the pretranslocation nucleotide-binding site (N site) to the posttranslocation primer-binding site (P site).  Also, facile misincorporation of EFdA-monophosphate (MP) results in difficult-to-extend mismatched primers.  To understand the high potency and unusual inhibition mechanism of EFdA, we solved RT crystal structures (resolns. from 2.4 to 2.9 Å) that include inhibition intermediates (i) before inhibitor incorporation (catalytic complex, RT/DNA/EFdA-triphosphate), (ii) after incorporation of EFdA-MP followed by dT-MP (RT/DNAEFdA-MPSUP°P/SUP°buldT-MPSUP°N/SUP°), or (iii) after incorporation of two EFdA-MPs (RT/DNAEFdA-MPSUP°P/SUP°bulEFdA-MPSUP°N/SUP°); (iv) the latter was also solved with EFdA-MP mismatched at the N site (RT/DNAEFdA-MPSUP°P/SUP°bulEFdA-MPtSUP°N/SUP°).  We report that the inhibition mechanism and potency of EFdA stem from interactions of its 4'-ethynyl at a previously unexploited conserved hydrophobic pocket in the polymerase active site.  The high resoln. of the catalytic complex structure revealed a network of ordered water mols. at the polymerase active site that stabilize enzyme interactions with nucleotide and DNA substrates.  Finally, decreased translocation results from favorable interactions of primer-terminating EFdA-MP at the pretranslocation site and unfavorable posttranslocation interactions that lead to obsd. localized primer distortions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-6y_9SBl-hbVg90H21EOLACvtfcHk0liSWNm0ghMgXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ygt73K&md5=f3668fe0d312877907006a44549d1520</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1605223113&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1605223113%26sid%3Dliteratum%253Aachs%26aulast%3DSalie%26aufirst%3DZ.%2BL.%26aulast%3DKirby%26aufirst%3DK.%2BA.%26aulast%3DMichailidis%26aufirst%3DE.%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DSingh%26aufirst%3DK.%26aulast%3DRohan%26aufirst%3DL.%2BC.%26aulast%3DKodama%26aufirst%3DE.%2BN.%26aulast%3DMitsuya%26aufirst%3DH.%26aulast%3DParniak%26aufirst%3DM.%2BA.%26aulast%3DSarafianos%26aufirst%3DS.%2BG.%26atitle%3DStructural%2520basis%2520of%2520HIV%2520inhibition%2520by%2520translocation-defective%2520RT%2520inhibitor%25204%25E2%2580%25B2-ethynyl-2-fluoro-2%25E2%2580%25B2-deoxyadenosine%2520%2528EFdA%2529%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2016%26volume%3D113%26spage%3D9274%26epage%3D9279%26doi%3D10.1073%2Fpnas.1605223113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindstrom, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanner, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belew, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodsell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olson, A. J.</span></span> <span> </span><span class="NLM_article-title">AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility</span>. <i>J. Comput. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">2785</span>– <span class="NLM_lpage">2791</span>, <span class="refDoi"> DOI: 10.1002/jcc.21256</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=10.1002%2Fjcc.21256" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=19399780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=2785-2791&author=G.+M.+Morrisauthor=R.+Hueyauthor=W.+Lindstromauthor=M.+F.+Sannerauthor=R.+K.+Belewauthor=D.+S.+Goodsellauthor=A.+J.+Olson&title=AutoDock4+and+AutoDockTools4%3A+Automated+docking+with+selective+receptor+flexibility&doi=10.1002%2Fjcc.21256"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">AutoDock and AutoDockTools: Automated docking with selective receptor flexibility</span></div><div class="casAuthors">Morris, Garrett M.; Huey, Ruth; Lindstrom, William; Sanner, Michel F.; Belew, Richard K.; Goodsell, David S.; Olson, Arthur J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2785-2791</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">We describe the testing and release of AutoDock4 and the accompanying graphical user interface AutoDockTools.  AutoDock4 incorporates limited flexibility in the receptor.  Several tests are reported here, including a redocking expt. with 188 diverse ligand-protein complexes and a cross-docking expt. using flexible sidechains in 87 HIV protease complexes.  We also report its utility in anal. of covalently bound ligands, using both a grid-based docking method and a modification of the flexible sidechain technique. © 2009 Wiley Periodicals, Inc.  J Comput Chem, 2009.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqktE6WAo4GEbVg90H21EOLACvtfcHk0liSWNm0ghMgXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1GitrnK&md5=679ce22fc50e9291c9aa16e7a1855845</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1002%2Fjcc.21256&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.21256%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DG.%2BM.%26aulast%3DHuey%26aufirst%3DR.%26aulast%3DLindstrom%26aufirst%3DW.%26aulast%3DSanner%26aufirst%3DM.%2BF.%26aulast%3DBelew%26aufirst%3DR.%2BK.%26aulast%3DGoodsell%26aufirst%3DD.%2BS.%26aulast%3DOlson%26aufirst%3DA.%2BJ.%26atitle%3DAutoDock4%2520and%2520AutoDockTools4%253A%2520Automated%2520docking%2520with%2520selective%2520receptor%2520flexibility%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2009%26volume%3D30%26spage%3D2785%26epage%3D2791%26doi%3D10.1002%2Fjcc.21256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Case, D. A.</span>; <span class="NLM_string-name">Betz, R. M.</span>; <span class="NLM_string-name">Cerutti, D. S.</span>; <span class="NLM_string-name">Cheatham, T. E. I.</span>; <span class="NLM_string-name">Darden, T. A.</span>; <span class="NLM_string-name">Duke, R. E.</span>; <span class="NLM_string-name">Giese, T. J.</span>; <span class="NLM_string-name">Gohlke, H.</span>; <span class="NLM_string-name">Goetz, A. W.</span>; <span class="NLM_string-name">Homeyer, N.</span>; <span class="NLM_string-name">Izadi, S.</span>; <span class="NLM_string-name">Janowski, P.</span>; <span class="NLM_string-name">Kaus, J.</span>; <span class="NLM_string-name">Kovalenko, A.</span>; <span class="NLM_string-name">Lee, T. S.</span>; <span class="NLM_string-name">LeGrand, S.</span>; <span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Lin, C.</span>; <span class="NLM_string-name">Luchko, T.</span>; <span class="NLM_string-name">Luo, R.</span>; <span class="NLM_string-name">Madej, B.</span>; <span class="NLM_string-name">Mermelstein, D.</span>; <span class="NLM_string-name">Merz, K. M.</span>; <span class="NLM_string-name">Monard, G.</span>; <span class="NLM_string-name">Nguyen, H.</span>; <span class="NLM_string-name">Nguyen, H. T.</span>; <span class="NLM_string-name">Omelyan, I.</span>; <span class="NLM_string-name">Onufriev, A.</span>; <span class="NLM_string-name">Roe, D. R.</span>; <span class="NLM_string-name">Roitberg, A.</span>; <span class="NLM_string-name">Sagui, C.</span>; <span class="NLM_string-name">Simmerling, C. L.</span>; <span class="NLM_string-name">Botello-Smith, W. M.</span>; <span class="NLM_string-name">Swails, J.</span>; <span class="NLM_string-name">Walker, R. C.</span>; <span class="NLM_string-name">Wang, J.</span>; <span class="NLM_string-name">Wolf, R. M.</span>; <span class="NLM_string-name">Wu, X.</span>; <span class="NLM_string-name">Xiao, L.</span>; <span class="NLM_string-name">Kollman, P. A.</span></span> <i>AMBER 2016</i>, <span class="NLM_publisher-name">University of California</span>: <span class="NLM_publisher-loc">San Francisco</span>, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=D.+A.+Case&author=R.+M.+Betz&author=D.+S.+Cerutti&author=T.+E.+I.+Cheatham&author=T.+A.+Darden&author=R.+E.+Duke&author=T.+J.+Giese&author=H.+Gohlke&author=A.+W.+Goetz&author=N.+Homeyer&author=S.+Izadi&author=P.+Janowski&author=J.+Kaus&author=A.+Kovalenko&author=T.+S.+Lee&author=S.+LeGrand&author=P.+Li&author=C.+Lin&author=T.+Luchko&author=R.+Luo&author=B.+Madej&author=D.+Mermelstein&author=K.+M.+Merz&author=G.+Monard&author=H.+Nguyen&author=H.+T.+Nguyen&author=I.+Omelyan&author=A.+Onufriev&author=D.+R.+Roe&author=A.+Roitberg&author=C.+Sagui&author=C.+L.+Simmerling&author=W.+M.+Botello-Smith&author=J.+Swails&author=R.+C.+Walker&author=J.+Wang&author=R.+M.+Wolf&author=X.+Wu&author=L.+Xiao&author=P.+A.+Kollman&title=AMBER+2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DCase%26aufirst%3DD.%2BA.%26jtitle%3DAMBER%25202016%26pub%3DUniversity%2520of%2520California%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J2M" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5J2M','PDB','5J2M'); return false;">PDB: 5J2M</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i28"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00940">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87055"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00940?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00940</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Assay for non-specific activation of human cells (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_001.pdf">jm0c00940_si_001.pdf (186.56 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00940/suppl_file/jm0c00940_si_002.csv">jm0c00940_si_002.csv (1.67 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00940&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-15%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00940" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00940" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992c70df603cfa","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
